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ABSTRACT
CHARACTERIZATION OF MECHANISM OF ACTION OF HYDRGEN SULFIDE
(H2S) IN THE REGULATION OF SMOOTH MUSCLE FUNCTION
Ancy D. Nalli
A dissertation submitted in partial fulfillment of the requirement for the degree of
Doctor of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2015
Director: Dr. Karnam S. Murthy, Ph.D.
Department of Physiology and Biophysics

Hydrogen sulfide (H2S) is receiving increasing interest, as much as nitric oxide (NO) and
carbon monoxide have received previously, to understand its physiological functions as it meets
all the criteria to define as a third gasotransmitter. Endogenous synthesis from L-cysteine via
cystathionine-γ-lyase (CSE) and cystathionine-β-synthase (CBS) and the function of H2S as an
inhibitor of smooth muscle contraction in gastrointestinal tract are known. However, the loci of
generation and action of H2S, and the mechanism of inhibition of contraction are unknown. Hence,
my aims in the present study are to: i) identify the expression of enzymes in smooth muscle, ii)
determine the effects of endogenously released and exogenously applied H2S on smooth muscle
function; and iii) identify the targets and mechanism involved in mediating the effects of H2S using
isolated smooth muscle cells from rabbit colon.
I have identified the expression of CSE, but not CBS, in smooth muscle and demonstrated
that L-cysteine (an activator of CSE) and NaHS (H2S donor): 1) inhibited carbachol-induced
xvi

contraction in muscle strips and isolated muscle cells that was independent of KATP channels, a
known S-sulfhydration target of H2S; 2) induced S-sulfhydration of small G protein, RhoA leading
to inhibition of RhoA and Rho kinase activities, a key pathway in the sustained smooth muscle
contraction; and 3) inhibited PDE5 activity leading to augmentation NO-induced cGMP formation
and muscle relaxation. Sodium nitroprusside (an NO donor) induced an increase in H2S production
via PKG-dependent phosphorylation and activation of CSE.
We conclude that smooth muscle cells selectively express CSE, and endogenous generation
of H2S via activation of CSE inhibits muscle contraction and augments muscle relaxation.
Inhibition of contraction is mediated via S-sulfhydration of RhoA and suppression of RhoA/Rho
kinase pathway. Augmentation of relaxation is mediated via inhibition of PDE5 activity and
stimulation of cGMP/PKG pathway, which in addition initiates generation of H2S via PKGmediated phosphorylation and activation of CSE. The findings are important in providing the
underlying mechanisms involved in the regulation of smooth muscle function by H2S and could
offer insights for the development of therapeutic agents that may act on smooth muscle in the gut
to treat motility disorders.
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Chapter 1
INTRODUCTION
1.1 Gastrointestinal System
The gastrointestinal (GI) system of mammals is composed of neuro-muscular tissues,
endocrine cells and specialized epithelia that exhibit a diverse variety of absorptive and secretory
functions. The primary functions of the GI system are digestion of ingested food, absorption of
nutrient material into the bloodstream, and elimination of undigested material by excretion from
the body. The GI system carries out these functions by motility, secretion, digestion and
absorption.
Normal gut motility provides for the mixing of intraluminal contents to enable digestion of
food, progressive absorption of nutrients and elimination of wastes. Motility refers to the
movements that mix and propel the contents of the gastrointestinal tract from the oral end to the
caudad end in the orthograde (forward) direction. Motility functions are generated by a highly
regulated interaction between an intricate network of neurons located within the wall of the GI
tract which encompasses the enteric nervous system; an intrinsic pacemaker system known as the
interstitial cells of Cajal (ICCs) and the ultimate effector cells, which are the gastrointestinal
smooth muscle cells.
1.1.1 Functions of the Gastrointestinal System
The gastrointestinal system consists of the GI tract and the accessory organs. The GI tract
is composed of the oral cavity, pharynx, esophagus, stomach, small intestine, large intestine,
rectum, and anus. The accessory organs include the salivary organs, the exocrine pancreas and the
biliary system- (liver and gallbladder). Each component of the GI tract has a unique anatomy which
1

attributes to its functional role in secretion, absorption or digestion. The mouth aids in chewing
the food and preparing the food for digestion by the addition of secretions from the salivary glands.
The esophagus is responsible for conduit of the ingested food from the mouth to the stomach. The
stomach is the major storage organ of the digestive system and reduces the food to a solution
known as chyme. Other functions of the stomach include acidification of chyme and regulation of
flow into the intestine. The chyme then passes into the small intestine where most of the digestion
and absorption of food takes place. The large intestine which follows the small intestine is
responsible for drying the chyme into residual wastes and storage of the wastes.
Between each region is a thickening of the muscle layer called the sphincter: The upper
and lower esophageal sphincters flank the ends of the esophagus. The pyloric sphincter regulates
passage of chyme from the stomach to the intestine. Ileo-cecal sphincter regulates flow from the
small intestine to the large intestine. Internal and external sphincters regulate the flow of residual
wastes through the rectum.
1.1.2 Anatomy of the Gastrointestinal Tract
The anatomy of the GI tract varies greatly from region to region but common features exist
in the overall organization of the tissue. The wall of the GI tract can be broadly classified into
mucosa, submucosa, circular and longitudinal muscle layers and the associated plexuses [1].
Although each section of the tract has specialized functions, the entire tract has a similar basic
structure with regional variations. The mucosa is the innermost layer of the GI tract and lines its
luminal surface. It consists of the epithelium, lamina propria and the muscularis mucosae. The
epithelium is a special layer of cells which lines the lumen of the GI tract. The lamina propria
largely consists of loose connective tissue that contains collagen and elastin fibrils. It houses the
various glands and contains lymph nodes and capillaries. The muscularis mucosa is the thin,
innermost layer of the intestinal smooth muscle. The main component of the mucosa is the
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protective mucous membrane which lubricates the ingested food and facilitates propulsion and
absorption. The submucosa consists of connective tissue with collagen and elastin fibrils. In some
regions of the GI tract, glands are present in the submucosa. The larger nerve trunks and blood
vessels of the intestinal wall lie in the submucosa.
The muscularis externa consists of two layers of smooth muscle cells: an inner circular
muscle layer and an outer longitudinal muscle layer. In humans and most mammals, the inner
circular layer is divided into an inner dense circular layer and an outer circular layer. Contractions
of the muscluaris externa mix and circulate the contents of the lumen and propel them along the
GI tract. The circular and longitudinal muscle layers are separated by laminar septa into bundles.
The muscle layers are separated by neurons, glial cells, fibroblasts and ICCs [2, 4].
The wall of the GI tract contains many interconnected neurons. The submucosa contains a
dense network of nerve cells called the submucosal plexus (Meissner’s plexus). The prominent
myenteric plexus (Auerbach’s plexus) is located between the circular and longitudinal smooth
muscle layers [5]. These intramural plexuses, together with the other neurons of the GI tract
constitute the enteric nervous system. The enteric nervous system helps to integrate the motor and
secretory activities of the GI system [4, 5, 6]. This “little brain” employs the same modulators and
neurotransmitters present in the central nervous system, including the excitatory acetylcholine,
substance P and neurokinin A [6] and the inhibitory nitric oxide (NO), adenosine triphosphate
(ATP), vasoactive intestinal polypeptide (VIP), and pituitary adenylyl cyclase (AC) activating
peptide (PACAP) [7]. The serosa or the adventitia is the outermost layer of the GI tract. This layer
consists of connective tissue covered with a layer of squamous mesothelial cells.
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1.2 Gastrointestinal Motility
GI motility is an essential function of digestive and absorptive processes of the gut,
required for propelling intestinal contents, mixing them with digestive juices and propelling
unabsorbed particles for excretion. With the exception of the upper third esophagus and external
anal sphincter, the muscle layers of the GI tract are made up of smooth muscle cells. Two types of
coupling connect the neighbouring smooth muscle cells. Mechanical coupling is provided by the
intermediate junctions formed by juxtaposed dense bands from adjacent cells. Electrical coupling
is provided by gap junctions or nexuses. Gap junctions are patches of closely opposed plasma
membranes of adjacent cells, the space of which is bridged by intercellular channels through which
regulatory molecules like Ca2+ and cyclic nucleotides are capable of movement between
neighbouring cells [13].
1.2.1 Motility Patterns- Peristalsis
Stimulation of the gut by chemical components of chyme and movement of mucosa by
mechanical distention of the lumen results in contraction of the circular muscle and relaxation of
the longitudinal muscle orad to the site of distension (propulsive segment). This process increases
the intraluminal pressure in the propulsive segment and pushes the luminal contents anally in the
orthograde direction. Mechanical distension also causes a caudad relaxation of the circular muscle
and contraction of the londitudinal muscle which provides a region of relaxation (receiving
segment) into which the luminal contents are propelled into. The co-ordinated response orad and
caudad to the site of stimulation is known as the law of the intestine. This basic law defines the
movement of ingesta throughout the gut and is referred to as peristalsis [58].
The peristaltic reflex is mediated by neural circuits within the myenteric plexus and is
independent of the extrinsic nervous system. Contraction above the site of distenstion is mediated
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by cholinergic (acetlycholine) neurons and tachykinin (substance P) containing neurons.
Relaxation below the site is mediated by VIP and NO containing neurons [8].

1.2.2 Motility Patterns- Segmentation
Segmentation or mixing movements are the non-propulsive annular contractions of the
circular muscle layer which are primarily seen in the small intestine and colon. The major function
of this motility pattern is to mix intestinal chyme through its squeezing action. Mixing movements
are characteristic of a fed or digestive state. In the segmental contractions, the musculature is
organized to propel luminal contents in both directions over short distances. Segmentation is a
common characteristic in the small intestine and it facilitates optimum digestion and absorption of
nutrient across the gut.
1.2.3 Tonic or Sustained Contractions
Tonic contractions characterize regions of the gut which divide the gut into functional
segments. The smooth muscle sphincter regions found in the gastro-esophageal junction, ileocolonic junction and the internal and external sphincters always remain in a continuous state of
contraction. With the exception of the internal anal sphincter, the other sphincters function to
prevent the backward movement of the luminal contents. The tone in the sphincteric muscle is
generated by myogenic mechanisms. However, these sphincter regions relax when the luminal
contents must be passed on to the next segment by the activation of inhibitory motor neurons.
Tonic or sustained contractions are also seen in the proximal stomach and the gall bladder.
1.2.4 Gastric Motility
The stomach has three well defined functions- acting as a resorvoir for food, mixing the
food with gastric secretions to initiate digestion and passage of food into the small intestine for
further digestion and absorption. The stomach can be differentiated into an upper fundus, mid-orad
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corpus and a terminal antrum. The fundus is mostly in a non-propulsive segmented state but serves
as a major storage site for the meal. The corpus, which has a thicker musculature demonstrates
slow waves and serves as both storage and mixing sites. The antrum has a very thick muscular
layer and is characertistic of slow waves with superimposed action potentials to facilitate strong
contractions for grinding and propelling food into the small intestine.

1.2.5 Motility of the Small Intestine
The small intestine is an important site for digestion of ingested food and absoprtion of
nutrients across the lumen. To carry out this purpose, the small intestine exhibits mixing and
segmentation motility patterns. It is characteristic of annular contractions called segmentations
which move the chyme in a to-and-fro direction. The frequency of the segmental contractions is
dependent on the rate of slow waves in different regions of the intestine. The ileum contracts with
a basic rate of eight contractions per minute whereas the duodenum can contract with a basic rate
of about twelve contractions per minute. The decreasing gradient of slow waves frequency
promotes the distal movement of intestinal chyme.
1.2.6 Motility of the Colon
The first portion of the colon, the cecum, is shaped like a pouch, and is the area of storage
for the contents arriving from the ileum. The primary function of the large intestine or colon is to
absorb fluids and electrolytes, particularly sodium and potassium, and to convert remaining
luminal contents into more solid stool. The colon absorbs on average 1-1.5 liters of fluid every
day. The longitudinal layer of the colon is organized into flat bands called tenia coli. Segmental
contractions of the circular muscle layer divide the colon into segments called haustrations and
represent the motor activity in the colon. The colon exhibits segmentation patterns to promote
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mixing and absorption of fluids. A wave of intense contraction known as mass movement sweeps
the luminal contents in the aborad direction three to four times a day.

1.3 Electrical Properties of Gastrointestinal Smooth Muscle
The muscles of the gastrointestinal tract are long (about 120 m) and slender (5-20 m
across). The cells are arranged in bundles that are separated and defined by connective tissues. The
resting membrane potential of the GI smooth muscle ranges from approximately -40 to -70 mV.
The electrogenic Na+, K+ ATPase contributes significantly to the resting membrane potential. In
contrast to the stable resting membrane potential in other tissues, the resting membrane potential
in the GI smooth muscle varies or oscillates. These oscillations are called slow waves or basic
electrical rhythm [8, 13]. The frequency of slow waves varies from three per minute in the stomach
to twelve per minute in the duodenum.
Slow waves are generated by interstitial cells of Cajal. These cells are located in a thin
layer between the longitudinal and circular layers of the muscluaris externa. Interstitial cells of
Cajal have properties of both fibroblasts and smooth muscle cells. Their gap junctions enable the
slow waves to be conducted rapidly to both muscle layers [13]. Since gap junctions electrically
couple the smooth muscle cells of both the longitudinal and circular layers, the slow wave spreads
throughout the smooth muscle of each segment of the gastrointestinal tract.
The amplitude and frequency of the slow waves can be modulated by the activity of the
intrinsic and extrinsic nerves and by hormones and paracrine substances. The sympathetic nerve
activity decreases the amplitude of the slow waves, whereas stimulation of parasympathetic nerves
increases the amplitude of the slow waves. If the peak of the slow waves exceeds the cell’s
threshold to fire action potentials, then one or more spike action potentials may be triggered during
the peak. These action potentials enhance the contractile force of the smooth muscle [13].
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1.4 Contractile Proteins of Gastrointestinal Smooth Muscle
Gastrointestinal smooth muscles are mechanically coupled, which enables transmission of
force across the muscle layers. They are uninuclear cells and exhibit abundant caveolae and
numerous cell-to-cell junctions [14]. Intermediate junctions between cells enable mechanical
coupling and transmit force from cell to cell. Dense bodies and contractile filaments occupy about
80% of the interior of the cell. Three types of filaments can be distinguished in smooth muscle
cells- thin actin filaments (6-8 nm), thick myosin filaments (14 nm), and intermediate filaments
(10 nm). Intermediate filaments link dense bodies in the cytoplasm to dense bands on the plasma
membrane [15].
1.4.1 Thin Filaments
In smooth muscle, the actin filaments are organized through attachments to the dense
bodies that contain α-actinin, a Z-band protein in skeletal muscle. Actin is a ubiquitous 42-kDa
globular protein (G-actin) that polymerizes to form 2-stranded helical filaments (F-actin) [14].
Inserted in the grooves of the actin helix is another protein, tropomyosin (Tm). Tropomyosin is a
coiled-coil  helix that spans seven actin monomers. Individual molecules interact head to tail and
create a continuous strand along the actin filament. Thin filaments in smooth muscle have a distinct
polarity. They insert into and emerge from the dense bodies, and they are arranged in bundles that
run parallel to the long axis of the cells. GI smooth muscles contain a very large number of actin
filaments but lack the regulatory troponin protein. They also contain two unique proteins, calponin
and caldesmon. Both calponin and caldesmon are actin-binding proteins and have a role in
modulating the interaction of actin and myosin.
1.4.2 Thick Filaments
Thick filaments are aggregates of myosin molecules formed from the association of 6
proteins: 1 pair of myosin heavy chains (MHCs) and 2 pairs of myosin light chains (MLCs) [16].
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The heavy chains are coiled around each other to form an α-helical core or tail. Each strand of the
core terminates in a globular head surrounded by 2 MLCs: a 20-kDa regulatory or myosin light
chain, and a 17-kDa essential light chain. Each globular head contains a binding site for actin and
an actin-activated magnesium-adenosine triphosphatase (Mg-ATP) [16]. A hinge located at the
junction of the globular head and core enables the head to rotate about the core. Another hinge in
the core enables the globular heads to project laterally. The globular heads and tail segments of
the core between the 2 hinges are called cross-bridges because they constitute a link or bridge
between thick myosin and thin actin filaments.
In addition to thick and thin filaments, intermediate filaments are cytoskeletal components
which form an “internal skeleton” in the GI smooth muscle. The intermediate components along
with the associated dense bodies serve as anchor points for the contractile filaments and modulate
contractile activity.
1.4.3 The Acto-Myosin Crossbridge Cycling
The process of smooth muscle cell contraction is regulated by receptor and mechanical
(stretch) activation of the contractile proteins myosin and actin [17, 78]. A change in membrane
potential, brought on by the firing of action potentials or by activation of stretch-dependent ion
channels in the plasma membrane, can also trigger contraction. Regardless of the stimulus, smooth
muscle cells use cross-bridge cycling between actin and myosin to develop force, and calcium ions
(Ca2+) serve to initiate contraction.
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1.5 Smooth Muscle Contraction
For smooth muscle contraction, the Ca2+/calmodulin dependent myosin light chain kinase
(MLCK) must phosphorylate the 20-kDa light chain of myosin, enabling the molecular interaction
of myosin with actin [17, 78]. Energy released from ATP by myosin ATPase activity results in the
cycling of the myosin cross-bridges with actin for contraction. The hydrolysis of ATP is the
fundamental reaction whereby chemical energy is converted into mechanical energy in smooth
muscle. This reaction generates force or induces shortening as a result of the sliding of overlapping
of the thin and thick filaments. The force generated by crossbridge cycling depends on the number
of crossbridges acting in parallel. The contractile activity in GI smooth muscle is determined
primarily by the phosphorylation state of the light chain of myosin (MLC20) which is dependent
on MLCK activity. Phosphorylation of MLC20 is also governed by myosin light chain phosphatase
(MLCP) which can dephosphorylate MLC20 and lead to inhibition of contraction [17, 78]. Smooth
muscle contraction involves both stimulation of MLCK activity and an inhibition of MLCP activity
(Figure 1A).
1.5.1 Ca2+-Dependent Muscle Contraction
Contraction of the circular smooth muscle is initiated by an increase in the cytosolic
calcium concentration [Ca2+]i which is responsible for initial muscle contraction. [Ca2+]i combines
with the protein calmodulin (CaM) which is a cofactor required for the activation of MLCK. The
regulatory Ca2+/CaM binds to and activates the catalytic subunit of MLCK to phosphorylate the
MLC20 on the primary phosphorylation sites Ser19 and Thr18. Phosphorylation of MLC20 activates
myosin ATPase activity, increases the actin and myosin crossbridge and subsequent contraction.
Cytosolic Ca2+ is increased through Ca2+ release from intracellular stores (sarcoplasmic reticulum)
as well as entry from the extracellular space through Ca2+ channels (receptor-operated
Ca2+ channels).
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Contractile agonists such as acetylcholine and substance P bind to Gq-coupled receptors
and induce MLC20 phosphorylation and contraction via phospholipase C-1 activity (PLC-1) by
binding to its COOH terminal tail (Figure 1B). Gi-coupled receptor agonists induce initial
contraction via PLC-3 activation by GI binding to PLC-3’s NH2-terminal pleckstrinhomology (PH) domain. Both PLC-1 and PLC-3 are specific for the membrane lipid
phosphatidylinositol 4, 5-bisphosphate (PIP2) to catalyze the formation of two potent second
messengers: inositol trisphosphate (IP3) and diacylglycerol (DAG). The sarcoplasmic reticulum
contains the high-affinity IP3 receptor/Ca2+ channel, IP3R-I. An increase in IP3 leads to the binding
of IP3 to IP3R-I and results in the release of Ca2+ into the cytosol.
Increases in intracellular Ca2+ levels are very rapid and transient. Cytosolic Ca2+ is
efficiently removed by Ca2+ reuptake into the sarcoplasmic reticulum which results in a rapid
decline in the level of MLCK activity and MLC20 phosphorylation reflecting the transient phase
of initial contraction. MLCK activity is strictly dependent on [Ca2+]i which increases as a result of
agonist stimulation due to [Ca2+]i influx into the cytosol through voltage-gated channels and/or the
release of Ca2+ from intracellular stores. Resting levels of [Ca2+]i (70-100 nM) increases upto 8fold during maximum contraction. Subsequent studies also showed that despite the removal of
[Ca2+], MLC20 phosphorylation and contractile forces are well maintained. This suggests the
possiblilty of mechanisms for sustained contraction which are regulated by pathways independent
of intracellular [Ca2+]i levels.
In longitudinal smooth muscle cells, Ca2+ mobilization is dependent on a mandatory Ca2+
influx via voltage-dependent Ca2+ channels on the sarcolemma. Upon stimulation by contractile
agonists, both Gq and Gi- coupled receptors activate cytoplasmic phospholipase A (cPLA2)
resulting in the hydrolysis of phosphatidylcholine into arachidonic acid and inducing membrane
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depolarization and the opening of voltage gated Ca2+ channels. The entry of Ca2+ stimulates cyclic
ADP ribose formation and induces synergistic Ca2+ and cyclic ADP-ribose-induced Ca2+ release
via ryanodine receptors/ Ca2+ channels.
1.5.2 Ca2+-Independent Muscle Contraction
In addition to the Ca2+-dependent activation of MLCK, MLC20 phosphorylation is further
regulated by MLCP activity, which actively dephosphorylates MLC20 by removing the highenergy phosphate to promote smooth muscle relaxation [17, 78]. (Figure 1A) MLCP contains three
subunits- a catalytic subunit which is the 37-kDa-type 1-protein phosphatase delta isoform (PPIc),
a 20-kDa variable subunit, and a 110- to 130-kDa myosin-binding target subunit 1 (MYPT1) [82].
The interaction of the 3 subunits is required to form the functional enzyme. MYPT1 contains a
PPIc-binding motif occurring at amino acids 35-38, and this binding of PPIcwith MYPT1 alters
substrate specificity and enhances catalytic activity. MYPT1, when phosphorylated, inhibits the
enzymatic activity of MLCP and prevents dephosphorylation of MLC20, thereby promoting
contraction. The major regulatory phosphorylation sites of MLCP are Thr696, Thr853 and Ser695.
The small G protein RhoA and its downstream target Rho kinase play an important role in
the regulation of MLCP activity (Figure 1B). Rho kinase, a serine/threonine kinase, phosphorylates
MYPT1 at Thr696 and therefore leads to dissociation of the enzyme from PPIc and inhibits the
activity of the catalytic subunit of MLCP. Phosphorylation of Thr696 or Thr853 residue of MYPT1
by Rho kinase dissociates the enzyme from MLC20 and decreases the efficiency of the enzyme by
decreasing the availability of the substrate. Inhibition of MLCP activity prevents
dephosphorylation of MLC20 and promotes MLC20 phosphorylation and sustained contraction.
Several other kinases such as ZIP kinase, Ca2+-independent MLCK and p21-activated kinase also
phosphorylate MYPT1 at Thr696. Phosphorylation at Ser695 site of MLCP by cAMP-dependent
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kinase (PKA) or cGMP-dependent protein kinase (PKG) blocks the ability of Rho kinase to
phosphorylate nearby Thr696 and therefore increases MLCP activity. In addition to regulation of
MLCP by phosphorylation at Thr696 and Thr853 sites, protein kinase C (PKC) and arachidonic acid–
mediated pathways also inhibit MLCP activity. PKC is activated by DAG or phorbol ester and can
phosphorylate PKC-potentiated inhibitor protein (CPI-17), which directly or indirectly inhibits
MLCP.
RhoA/Rho kinase signaling is regulated by guanine nucleotide exchange factors
(RhoGEFs). RhoGEFs facilitate activation of RhoA and regulate the duration and intensity of
signaling via heterotrimeric G protein receptor coupling [79]. There are ∼70 RhoGEFs in the
human genome, and three RhoGEFs have been identified in smooth muscle- PDZ-RhoGEF,
LARG (leukemia-associated RhoGEF), and p115-RhoGEF. Increased expression and/or activity
of RhoGEF proteins could augment contractile activation of smooth muscle and therefore play a
role in diseases where an augmented response contributes to the pathophysiology.
Pharmacological inhibitors of Rho kinase, such as fasudil and Y-27632, block its activity
by competing with the ATP-binding site on the enzyme. Rho kinase inhibition induces relaxation
of isolated segments of smooth muscle contracted by many different agonists.

1.6 Smooth Muscle Relaxation
Smooth muscle relaxation occurs either as a result of removal of the contractile agonists or
by the direct action of a relaxant agent which stimulates inhibition of the contractile pathways [17,
78]. Relaxation of the muscle is initiated by active dephosphorylation of MLC20, which is
accomplished by inactivation of MLCK and/or augmentation of MLCP activity, eventually
inducing dephosphorylation of MLC20 and ultimately muscle relaxation (Figure 1C). In either
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processes, smooth muscle relaxation is caused by a decrease in intracellular Ca2+ concentration
and increased MLCP activity. The mechanisms that sequester or remove intracellular Ca2+ and/or
increase MLCP activity contribute to MLC20 dephosphorylation.
Several mechanisms are involved with the removal of cytosolic Ca2+ including
Ca2+ reuptake back into the sarcoplasmic reticulum and Ca2+ efflux through Na+/Ca2+ exchangers
on the sarcolemma. Ca2+ reuptake into the sarcoplasmic reticulum is dependent on ATP hydrolysis.
Sarcoplasmic reticular Ca2+-binding proteins such calsequestrin and calreticulin also contribute to
decreased intracellular Ca2+ levels. The plasma membrane also contains Ca, Mg-ATPases,
providing an additional mechanism for reducing the intracellular concentration of activator Ca2+ in
the cell. Na+/Ca2+ exchangers are also located on the plasma membrane and aid in decreasing
intracellular Ca2+. Inhibition of voltage-operated Ca2+ channels located in the plasma membrane
also elicits muscle relaxation.
1.6.1 Signaling Pathways in Muscle Relaxation
Smooth muscle relaxation is mediated by relaxant gasotransmitters such as NO, peptide
neurotransmitters like VIP and its homologue, PACAP. NO is synthesized in nerve terminals by
nNOS (neuronal nitric oxide synthase I) [43, 105]. NO released from the nerves stimulates the
release of VIP from the nerve terminal onto the smooth muscle layer. VIP interacts with
VPAC2 receptors on the smooth muscle membrane to stimulate AC activity which catalyses the
formation of cAMP from ATP. VIP also stimulates smooth muscle eNOS (endothelial nitric oxide
synthase III) to generate NO. NO derived from both nerves and smooth muscle cells stimulates
soluble guanylyl cyclase (sGC) activity and catalyses the formation of cGMP from GTP. cAMP
leads to the activation of cAMP dependent protein kinase (PKA) and cGMP leads to the activation
of cGMP dependent protein kinase (PKG), which act on various targets in the muscle cells to
mediate muscle relaxation (Figure 1D).
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1.6.2 Regulation of Cyclic Nucleotide Levels in Smooth Muscle
The levels of cAMP and cGMP in the cell depend on the rates of their synthesis by cyclases
and degradation by phosphodiesterases (PDEs) [106, 107, 108]. cAMP production is ~10-fold
greater than cGMP and is generated from ATP via the membrane bound AC type-V and VI. It is
rapidly degraded by the cAMP specific PDE4 and cAMP preferring PDE3 enzymes. On the other
hand, cGMP produced via sGC is rapidly degraded by cGMP-specific PDE5 enzyme. PKA inhibits
AC while PKG inhibits sGC in a feedback mechanism to regulate the stimulation of cAMP and
cGMP levels in the cell. Both PDE3 and PDE4 are activated by PKA, but only PDE3 is inhibited
by cGMP. On the other hand, PDE5 is activated by PKG. When both cAMP and cGMP are present,
PDE5 is also activated by PKA. Therefore, regulatory feedback from the protein kinases inhibits
synthesis, accelerates degradation and maintains cyclic nucleotide levels in a narrow range (Figure
1D).
1.6.3 Targets of PKA and PKG in Smooth Muscle
Both PKA and PKG act on different molecular targets in the smooth muscle cell leading to
MLC20 dephosphorylation and thus mediate muscle relaxation [17, 78]. PKA and PKG target
MLCK inactivation by primarily decreasing cytosolic [Ca2+]i. They can inhibit Ca2+ mobilization
by inhibiting IP3 formation in circular muscle and arachidonic acid formation in longitudinal
muscle. Inhibition of IP3 formation in circular muscle involves phosphorylation of RGS4, leading
to more rapid degeneration of Gq-GTP and inhibition of PLC-1 activity. Sarco-endoplasmic
reticulum Ca2+/ATPase (SERCA) and sarcoplasmic reticulur IP3 receptors accelerates Ca2+
reuptake into the stores and inhibits IP3-induced Ca2+ release, respectively. In addition, both
kinases inhibit the activity of membrane Ca2+ channels and stimulate the activity of membrane K+
channels, leading to hyperpolarization of the plasma membrane and interruption of Ca2+ influx
into the cell. This mechanism is important in the inhibition of rhythmic contraction.
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PKA and PKG also augment MLCP activity by various mechanisms. They can
phosphorylate the activated form of RhoA (RhoA-GTP) at Ser188 which leads to RhoA inactivation
and translocation back into the cytosol. Both PKA and PKG can phosphorylate MYPT1 at Ser695,
preventing the inhibitory regulation of Rho-kinase- mediated phosphorylation of MYPT1 at Thr696.
Both PKA and PKG can also phosphorylate and enhance telokin activity, which is a smooth
muscle-specific endogenous activator of MLCP [17, 78].
1.7 Regulation of Smooth Muscle Contraction
Control of the contractile activity of GI smooth muscle involves regulation by the enteric
nervous system, ICCs and paracrine substances. The autonomic nervous system typically
modulates the patterns of the enteric nervous system which in turn regulates muscular activity.
Afferent fibers arising from the sympathetic and parasympathetic nervous system carry signals
from chemo-sensitive and mechano-sensitive nerve endings in the wall of the GI tract. The
parasympathetic nervous system is comprised of cholinergic neurons which lead to an overall
excitation of the GI tract, promoting increased motility and secretions. The sympathetic nervous
system contains fibers which results in a general inhibition of gut function.
1.7.1 Role of ICC in Smooth Muscle Function
ICCs are of mesenchymal origin which interact with and form electrical connectivity with
smooth muscle cells [11]. They express c-kit, the proto-oncogene that encodes the receptor
tyrosine kinase. Mice with mutations in the protooncogene Kit have reduced populations of ICC
in the GI tract and develop striking functional phenotypes [7, 12]. ICCs are interposed between
enteric nerves and smooth muscle cells in the GI tract, with small cell bodies and several elongated
processes and are classified based on their location and distribution. Myenteric ICC (ICC-MY)
reside between the longitudinal and circular muscle layers in the myenteric region. These ICCs act
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as important pacemaker cells. They function autonomously and spontaneously generate slow wave
depolarization in different parts of the GI tract. Spontaneous pacemaker activity drives and times
the phasic contractile behavior. Intramuscular ICCs (ICC-IM) are cells distributed within the
smooth muscle cells [11]. A specialization of ICC-IM is found in the small intestine, where ICCs
are densely distributed and intimately associated with neurons of the deep muscular plexus.
Therefore these cells are referred to as ICC-DMP. ICC-IM and ICC-DMP are interposed between
nerve terminals and smooth muscle cells and closely associated with neuronal processes.
The electrical activity of slow waves is propagated through networks of ICC and conducted
passively to smooth muscle cells through gap junctions [13]. These low-resistance connections
between ICC and smooth muscle cells facilitate the propagation of electrical events from one cell
to another. Within regions of the GI tract which exhibit rhythmic movement (e.g., colon and
antrum part of the stomach), slow waves generated by ICC-MY depolarize smooth muscle cells to
induce the opening of voltage-gated L-type Ca2+ channels. The regulation of muscle tone in regions
which is devoid of ICC-MY (e.g., fundus part of the stomach), however, is not mediated by
changes in membrane potential of smooth muscle or slow wave generation but rather by signaling
cascades initiated mainly by enteric neurotransmitters acting directly on smooth muscle receptors
or indirectly via ICC-IM.
1.7.2 Role of the Enteric Nervous System in Smooth Muscle Function
The enteric nervous system plays an integral role in the regulation of GI mucosal and
smooth muscle function [3]. Although the enteric nervous system receives input from the central
and autonomic nervous systems, it can function independently [4, 5, 6]. The enteric nervous system
is organized into two major plexuses. The myenteric plexus lies between the external longitudinal
and internal circular muscle layers. The submucosal plexus lies between the circular muscle layer
and the mucosa. Most of the fibers of the submucosal plexus project into the mucosa, and nerves
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of the myenteric plexus project fibers primarily to the smooth muscle of the gut, with only a few
axons extending to the submucosal plexus. Myenteric plexus contains two main types of neurons.
One type contains excitatory neurotransmitters, mainly acetylcholine, tachykinins, neurokinins
and substance P. The other type contains the inhibitory neurotransmitters such as VIP or PACAP
together with NO synthase (NOS).
1.7.3 Excitatory Neurotransmitters
Excitatory neurotransmitters act on the muscle layer to release Ca2+, increase muscle tone
and depolarize the plasma membrane by triggering excitatory action potentials. The depolarization
could result from either a direct action of neurotransmitters on muscle cells or maybe mediated
through intramuscular ICCs (ICC-IM) which are coupled electrically to muscle cells. Excitatory
action potentials can induce Ca2+ influx and contraction if the depolarization reaches a level at
which voltage-gated calcium channels open; a phenomenon seen in tonic smooth muscle as the
membrane potential close to the Ca2+ threshold or in phasic smooth muscle during the peak of slow
wave activity.
A large variety of receptors and receptor subtypes have been identified as capable of
mediating smooth muscle contraction. These include receptors for excitatory neurotransmitters
such as acetylcholine, peptides (e.g., tachykinins, endothelin, motilin), amines (histamine, 5hydroxytryptamine), nucleotide triphosphates (UTP and ATP), and lipids (S1P, LPA). A type of
muscarinic receptors belonging to the heptahelical GPCR family is present on the smooth muscle
cell. There are five known muscarinic cholinergic receptors (m1 to m5). Muscarinic receptors can
be further classified based on receptor signal transduction, with m1, m3, and m5 activating
phospholipase C and m2 and m4 inhibiting AC activity. The m2 and m3 receptors are the main
types of muscarinic receptors expressed in GI smooth muscle. However, only m3 receptors
mediate smooth muscle contraction.
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Acetylcholine is stored in nerve terminals and is released by nerve depolarization. Released
acetylcholine binds to postsynaptic muscarinic receptors on the muscle cells. Acetylcholine (ACh)
interaction with m3 receptor couples it to Gαq leading to activation of phospholipase C (PLC) and
hydrolysis of phosphatidyl inositol (PI) into IP3 and DAG. IP3 binds to IP3 receptors on
sarcoplasmic reticulum and stimulates Ca2+ release and therefore smooth muscle contraction.
Acetylcholine also interacts with m2 receptor (the predominant 80% receptor species in smooth
muscle) and couples it to Gαi3 leading to inhibition of AC. Acetylcholine is degraded by the
enzyme acetylcholinesterase, and the products may be recycled through high-affinity transporters
on the nerve terminal.
Peptide neurotransmitters such as tachykinins also act as excitatory neurotransmitters. This
family of neurotransmitters includes substance P, neurokinin A, and neurokinin B [6]. Substance
P is a neurotransmitter of primary sensory afferent neurons and acts on three receptors for this
family of peptides which have been identified (NK-1, NK-2, and NK-3). Substance P is the primary
ligand for the NK-1 receptor, neurokinin A for the NK-2, and neurokinin B for the NK-3. However,
all peptides can bind and signal through all three receptor subtypes.
1.7.4 Inhibitory Neurotransmitters
Inhibitory neurotransmitters, on the other hand, inhibit Ca2+ release, decrease muscle tone
(i.e., relax), and hyperpolarize the plasma membrane directly or indirectly via ICC-IM (i.e., trigger
inhibitory junctional potentials or IJPs). IJPs lower the plateau potential of slow waves and inhibit
Ca2+ influx and phasic contraction. VIP or PACAP induce relaxation by interacting with VPAC2
receptors on the plasma membrane, which possess equal affinity for VIP and PACAP [7]. These
receptors couple to Gs and thereby lead to stimulation of AC which increases cAMP generation
and therefore PKA activation. NO diffuses through the sarcolemma and activates sGC which
increases cGMP formation, and therefore leads to activation of PKG. Both PKA and PKG act on
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different targets to induce hyperpolarization and relaxation of smooth muscle cells. VIP, along
with NO, is the primary component of nonadrenergic, noncholinergic (NANC) nerve transmission
in the gut.
1.7.5 Peptide Neurotransmitters
All GI peptides are synthesized via gene transcription of DNA into messenger RNA
(mRNA) and subsequent translation of mRNA into precursor proteins known as
preprotransmitters. Secretory peptides contain a signal sequence that directs the newly translated
protein to the endoplasmic reticulum, where the signal sequence is cleaved and the prepropeptide
product is prepared for structural modifications. These precursors undergo intracellular processing
and are transported to the golgi apparatus where they undergo structural modifications necessary
for the bioactivity of the peptide. These peptides are then packaged and stored in secretory
granules. When GI endocrine cells are stimulated, mature neurotransmitters are secreted into the
paracellular space or taken up into the bloodstream.
VIP is a peptide neurotransmitter and is synthesized as a precursor molecule which is
cleaved into an active peptide of 28 amino acids. VIP and its homologue, PACAP are released
from nerve terminals and act locally on muscle cells bearing VIP receptors, VPAC2 or PACAP
receptors, PAC1. Both VPAC2 and PAC1 are Gs-coupled receptors that stimulate intracellular
cAMP generation and ultimately PKA activation.
1.7.6 Purinergic Transmitters
Purine nucleosides and nucleotides also play important roles as signaling molecules in the
complex interactions between neurons and muscles which regulate intestinal motility. ATP acting
at P2Y receptors is an important component of inhibitory neuromuscular transmission, acting as a
cotransmitter with nitric oxide. In the GI tract, purinergic nerves contain ATP in the nerve
terminals and released into the synaptic cleft when stimulated. The nerve endings that release ATP
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are frequently colocalised with NOS and VIP. ATP is responsible for fast IJP and the associated
mechanical relaxation is mediated via the P2Y purinoreceptor and apamin sensitive small
conductance calcium activated potassium channels.

1.8 Gasotransmitters
Gases like nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H2S) were
originally thought to be extremely hazardous to humankind because of their toxic effects on
mammals and the environment. Both NO and its oxidative derivative, nitrogen dioxide (NO2),
present a serious health hazard especially for people with circulatory and respiratory diseases.
Similarly, CO and H2S are among the most abundant of air pollutants known. Acute intoxication
by H2S leads to the loss of central respiratory drive. The toxic effects of H2S have been known for
centuries, and it remains second only to CO as the most common cause of gas-related fatalities in
the workplace. However, studies over the past few decades have shown that these gases are
physiologically important and play a role in cellular functions and metabolism. Evidence that NO
is endogenously generated and has profound biological and physiological effects has changed its
relevance in mammalian physiology. Endogenous production of CO and the reevaluation of the
physiological importance of CO to the homeostatic control of the human body have been identified
in the past decade. Like NO and CO, H2S at physiologically relevant levels affects the structures
and functions of the human body at molecular, cellular, tissue, and system levels [57, 173].
To distinguish NO, CO, and H2S from classical neurotransmitters, these endogenous
gaseous transmitters have been defined as “gasotransmitters,” gauged by the following criteria
(Figure 1E).
(i) They are small molecules of gas.
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(ii) They are freely permeable through cellular membranes due to their lipophillic nature and do
not rely on the cognate membrane receptors. These gases can have endocrine, paracrine, and
autocrine effects.
(iii) They are endogenously and enzymatically generated and regulated by cellular functions.
(iv) They have well defined and specific functions at physiologically relevant concentrations.
(v) They should have specific cellular and molecular targets to physiologically regulate cellular
functions. Their cellular effects may or may not be mediated by second messengers.

1.8.1 Nitric oxide
Nitric oxide (NO), first known as endothelium-derived relaxing factor (EDRF) is a potent
gasotransmitter that acts along with VIP to induce muscle relaxation in GI smooth muscle. Nitric
oxide synthesis from L-arginine is catalyzed by NOS which is a Ca2+/calmodulin dependent
enzyme [43, 105]. Three types of NOS are known. Neuronal NOS (nNOS or Type III NOS) resides
in the extrinsic and intrinsic nerves of the GI tract. Endothelial NOS (eNOS or Type I NOS) resides
in the endothelial cells and smooth muscle cells. Small changes in NOS activities can occur
through elevations in intracellular calcium. The inducible form of NOS (type II) is apparent only
when cells become activated by specific inflammatory cytokines. This form of NOS is capable of
producing large amounts of NO and is calcium independent.
NO is synthesized by nNOS, released from the nerve terminal and diffuses across the
plasma membrane into smooth muscle cells. NO binds to and activates sGC, which converts GTP
to cGMP and causes smooth muscle relaxation via PKG mediated signaling [43, 78]. Studies have
shown that NO containing compounds mediate nonadrenergic and noncholinergic nerve-induced
hyperpolarization and relaxation in the circular muscle. NOS is often co-localized with VIP and
PACAP in neurons of the enteric nervous system. NO, being an unstable gas, has a relatively short
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half-life. Unlike most neurotransmitters and hormones, NO does not act via a membrane-bound
receptor- instead it readily diffuses into adjacent target cells to directly activate sGC. NO activity
is terminated by the oxidation of NO into nitrate and nitrite.
1.8.2 Carbon Monoxide
Carbon monoxide (CO) is a biologically active product of haem metabolism that
contributes to the normal physiology of the GI tract. CO is generated by haem oxygenase-1 (HO1) and haem oxygenase-2 (HO-2) in the enteric nervous system. HO-2 is constitutively expressed
in inhibitory neurons of the ENS and contributes to CO production in the nerve terminals. The
membrane potential gradients along and across the muscle layers of the GI tract require the
generation of CO by HO-2 [9]. The presence of CO is also necessary for normal inhibitory
neurotransmission in circular smooth muscle and appears to permit NO-mediated inhibitory
neurotransmission. Genetic deletion of the HO-2 gene in mice slows gut transit [10]. The other
major CO synthetic enzyme, HO-1 is induced under conditions of stress or injury.
Recent studies have demonstrated that up-regulation of HO-1 protects the gut from several
types of GI injury, suggesting that CO or induction of HO-1 may find therapeutic use in GI diseases
and injuries. Furthermore, it is anticipated that the understanding of CO-mediated signaling in the
GI tract will inform studies in other tissues which express haem oxygenases. In the enteric nervous
system, CO appears to play a crucial role with NO in inhibitory neurotransmission and setting the
resting membrane potential in enteric smooth muscle cells [10].

1.8.3 Hydrogen Sulfide (H2S)
Hydrogen sulfide (H2S) has been known as a toxic gas having a peculiar rotten-egg smell.
However, recent studies have shown that like NO and CO, H2S at physiologically relevant levels
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affects the functions of the human body at molecular, cellular, tissue, and system levels.
Production of H2S in mammalian tissues had been known, but it was largely ignored as a metabolic
waste. Significant H2S levels were detected in mammalian tissues from human, rat, and cow in the
range of 50–160 μM [115].
A significant development in linking the endogenous H2S levels and functional changes
came through when studies showed that H2S donor, sodium hydrosulfide (NaHS), facilitated the
induction of hippocampal long-term potentiation (LTP) in the brain at micromolar concentrations.
This effect is largely beneficial and essential, away from the conventionally assumed toxic image
of H2S.

Further studies confirmed the expression of a key enzyme for H2S production,

cystathionine--synthase (CBS) in the hippocampus using Northern blot. Pharmacological
manipulation of CBS activity altered H2S production correspondingly and affected the LTP
process, following which H2S was labeled a “neuromodulator” in the brain [115].
Another important enzyme for H2S production, cystathionine--lyase (CSE) gene was
cloned from rat vascular tissues and studies demonstrated that both the expression and activity of
CSE can be upregulated by NO, leading to increased production of H2S from vascular smooth
muscle cells. Studies demonstrated that cardiac-specific overexpression of CSE significantly limits
mouse cardiac ischemia-reperfusion damage due to increased endogenous level. Altered
expression of CBS and endogenous H2S in vivo leads to many neurodegenerative diseases, and
replenishment with exogenous H2S reversed the pathology [115]. Similarly, altered expression of
CSE and endogenous H2S levels were shown to be responsible for inflammation, atheroscleorosis,
diabetes and asthma.
1.9 Hydrogen Sulfide in the GI System
H2S participates in the regulation of various GI functions like motility, secretions and
inflammation. Several studies outline the physiological benefits of H2S in the GI tract [57, 115,
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137]. Similar to its inhibitory effect on cardiovascular muscle contractility, H2S inhibits the
motility of jejunum and colon in humans, mice, and rats. In animal models of gastritis and colitis,
H2S mostly takes an anti-inflammatory role. Macroscopic and microscopic analyses revealed that
H2S treatment prevented the gastric damage in a dose-dependent manner. H2S also regulates
gastric mucosal blood flow.
1.9.1 Bacterial Production of H2S in GI System
The luminal H2S levels in the GI system are made up of two components. The first source
is from the sulfate- reducing bacteria present in the lumen of the large intestine while the second
source is the endogenous production of the gas from the inner layers of the gut wall. H2S can be
produced at 0.2- 3.4 mM in the GI tract of humans and mice by the intestinal microbiota from
alimentary bacteria, such as the enterobacterial flora, which use endogenous sulfur-containing
compounds in the diet as well as amino acids like cysteine and methionine to synthesize H2S [115].
At this high concentration range, H2S likely interacts with other compounds and molecules in the
colon and affects colonic secretions and nutrient absorption through the gut wall.
At excessive concentrations, H2S is known to severely inhibit cytochrome c oxidase, the
terminal oxidase of the mitochondrial electron transport chain, and affects mitochondrial oxygen
consumption. However, the concentrations of free sulfide levels are lower due to rapid metabolism
of the H2S into thio-sulfite and sulfate and the capacity of fecal components to bind the sulfide.
1.9.2 Endogenous Production of H2S and GI motility
Both CSE and CBS have been found in different parts of the GI tracts of rats and mice and
in the healthy human colon. In rat ileum, both CBS and CSE mRNA were found. While the gastric
mucosa expresses both CSE and CBS, CSE appears to play a major role in H2S generation as
inhibitors of CSE such as DL-propargylglycine (DL-PPG) inhibits gastric H2S formation. Studies
confirm that H2S is released from rat gut tissues; however, the precise cellular site of H2S
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biosynthesis in the different parts of the GI tract (e.g. mucosa, ICCs, smooth muscle cells, nerves)
is unknown since most evidence with the effects of H2S on motility is presented in vivo or whole
tissue preparations. Studies show that precontracted ileum muscles from rats and guinea pigs are
relaxed by NaHS (a H2S donor) in vitro. The spontaneous contraction of isolated ileum tissues
from rabbits was also inhibited by NaHS. Studies on understanding the targets of H2S have
indicated that the gas has an effect on the potassium channels in GI muscle cells in the guinea pig.
The effects of H2S on guinea pig gastric antrum muscle strips show that NaHS at 0.3-1
mM inhibits the spontaneous contraction whereas lower concentrations of NaHS (100 M)
enhances the resting tension of muscle strips while slightly reducing the contractile amplitude. The
effect of NaHS at low concentrations was abolished by tetraethylammonium (TEA), a nonselective
potassium channel blocker, and 4-aminopyridine (4-AP), a voltage-gated K+ (Kv) channel blocker.
On the other hand, the relaxant effect of NaHS on the spontaneous contraction of gastric smooth
muscle appears to be mediated by the activation of KATP channels [50, 51, 52]. The opening of
KATP channels and closing of Kv channels by NaHS has also been demonstrated on freshly
dispersed gastric antrum myocytes using whole cell patch-clamp recording. These observations
suggest that two different types of ion channels are responsible for the dual actions of H2S on
gastric motility in the guinea pig. Another ion channel involved in the effect of NaHS on mouse
colon is SKCa channels, since apamin at 3 M inhibits NaHS-induced inhibition of colon motility.
KATP channel is the major molecular target of H2S for its vasorelaxant effect and smooth
muscle hyperpolarization. This target of H2S was confirmed based on the ability of glibenclamide,
a KATP channel antagonist, to block the vasorelaxant effects of H2S. In studies performed in the
guinea pig ileum, glibenclamide did not interfere with the relaxation induced by H2S, indicating
that the effects of H2S are independent of KATP in different parts of the GI tract in some species.
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This finding may be seen as different membrane excitation-contraction coupling mechanisms in
different muscle preparations.
Studies showing the relaxant effects of H2S also demonstrates that NaHS mimics and
augments the effect of NO donor, sodium nitro prusside, (SNP), in producing spontaneously
reversible and dose-related inhibition of contractions of the guinea-pig ileum to electrical field
stimulation (albeit with reduced potency). However, the precise nature of these mechanisms and
the manner by which H2S and NO interact at the cellular level remains to be elucidated by further
study.
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RATIONALE AND SIGNIFICANCE
GI motility and functional bowel disorders, such achalasia, gastroesophageal reflux
disease, gastroparesis, functional dyspepsia and irritable bowel syndrome affect up to 25% of the
US population. Gastrointestinal dysmotility also impacts on the quality of life of patients with
other disorders such as diabetes and Parkinson’s disease. Patients with motility disorders can be
complex and difficult to treat and a basic understanding of the inherent GI motility dysfunction
underpins the appropriate therapeutic approaches and treatment of these disorders.
H2S has now been identified as an important gasotransmitter and the mediator of cellular
functions in cardiovascular, aortic and hippocampal tissues, and renal and GI systems. The
endogenous production of H2S in the GI tract has been studied in different layers however, the
genesis of the gas has not been well-defined in the smooth muscle, which plays an important role
in gut motility. This study provides strong evidence for the presence of H2S- synthesizing enzymes
in the colonic smooth muscle, and the role of H2S synthesis and function in the regulation of gut
motility.
The important target of H2S identified so far is the KATP channels which mediates
hyperpolarization and causes relaxation in muscle layers. Some studies also elucidate that this
effect of H2S is not blocked by glibenclamide, suggesting that H2S targets alternate mechanisms
which regulate contractile pathways in the smooth muscle. This dissertaion work aims to
understand the contractile signaling pathways modulated by H2S independant of its effect on the
KATP channels exclusively in the muscle cells isolated from the circular muscle layer of the rabbit
colon.
The levels of H2S gas in the GI tract has largely been attributed to the production of gas by
sulfate-reducing bacteria lining the mucosa of the gut. The endogenous production of H2S also
contributes to the basal levels of the gas from the different layers in the gut wall. However, the
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reported levels have been controversial for a long time owing to the different protocols of
measuring the gas from the gut wall, as well as the extremely small half-life of H2S and rapid
metabolism of the gas in tissues. The studies in this work aim to measure the endogenous synthesis
of the gas solely from smooth muscle to define the endogenous production of the gas from the
muscle layers.
Gasotransmitters like NO and CO have been known to have physiological effects via
different cross-talk mechanisms. Studies done in the GI tract have explained that the relaxant effect
seen with H2S is augmented in the presence of NO-releasing agents such as SNP. However, these
effects are not explained in terms of the signaling pathways underlying the cross-talk between NO
and H2S. My dissertation work helps identify the role played by NO in mediating the activation of
H2S-synthesizing enzymes and the cellular targets involved in stimulating the production of H2S
and H2S-mediated effects in gut motility.
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SPECIFIC AIMS and HYPOTHESIS

Specific Aim 1: To examine the expression of H2S producing enzymes in the colonic smooth
muscle.
Hypothesis: Cystathionine--lyase and/or cytathionine--synthase are expressed in smooth
muscle cells isolated from the colonic smooth muscle.

Specific Aim 2: To determine the function and mechanism of action of HS in colonic smooth
smooth muscle cells.
Hypothesis: H2S regulates muscle function by inducing changes in the signaling pathways that
regulate contraction via RhoA/Rho kinase pathway and relaxation via cGMP/PKG pathway.

Specific Aim 3: To determine the mechanism of activation of cystathionine--lyase in colonic
smooth muscle.
Hypothesis: Stimulation of cystathionine-γ-Lyase (CSE) activity and generation of HS in smooth
muscle is mediated via the NO/cGMP/PKG pathway.
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Figure 1A

Figure 1A. Mechanism of smooth muscle contraction. Gastrointestinal smooth muscle
contraction is dependent on the phosphorylation of the 20-kDa myosin light chain (MLC20) by
contractile agonists such as acetlycholine (ACh) or substance P (SP). MLC20 phosphorylation
(MLC20-p) is initiated by the stimulation of Ca2+/calmodulin dependent myosin light chain kinase
(MLCK) activity which increases MLC20-p levels. MLC20 phosphorylation is maintained by the
inhibition of myosin light chain phosphatase (MLCP) activity mediated by phosphorylation of
MYPT1 by RhoA/Rho kinase pathway. Increase in MLC20-p levels leads to smooth muscle
contraction.
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Figure 1B

Figure 1B. Signaling mechanisms involved in initial and sustained contraction in smooth
muscle. Initial contraction by muscarinic m3 receptor is mediated by sequential activation of Gq
and phospholipase 1 (PLC-1), which hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2)
to generate Ca2+-mobilizing messenger, inositol 1,4,5-trisphosphate (IP3). Binding of IP3 to its
receptor leads to an increase in intracellular Ca2+ which binds to calmodulin, leading to activation
of myosin light chain kinase (MLCK) and phosphorylation of MLC20. Sustained contraction by
m3 receptors is mediated by sequential activation of G13, small G protein via RhoGEF, and Rho
kinase, which then inhibits myosin light chain phosphatase (MLCP) via phosphorylation of its
regulatory subunit, MYPT1, to increase MLC20 phosphorylation.

32

Figure 1C

Figure 1C. Mechanism of smooth muscle relaxation. Gastrointestinal smooth muscle relaxation
is initiated by inhibitory transmitters such as vasoactive intestinal peptide (VIP) or nitric oxide
(NO). The signaling mechanisms initiated by these agonists decrease intracellular Ca2+ and
inhibition of Ca2+/calmodulin-dependent myosin light chain kinase (MLCK) activity, and
stimulate myosin light chain phosphatase (MLCP) activity. Both of these events lead to a decrease
MLC20 phosphorylation, a key event in muscle relaxation.
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Figure 1D

Figure 1D. Signaling mechanisms initiated by VIP and NO to induce smooth muscle
relaxation. VIP binds to its cognate seven-transmembrane VPAC2 receptors coupled via Gs to
adenylyl cyclase V/VI, leading to cAMP generation and cAMP dependent protein kinase (PKA)
activation. NO formed in nerve terminals by nNOS diffuses to smooth muscle to stimulate soluble
guanylyl cyclase (sGC) activity, cGMP formation and cGMP dependent protein kinase (PKG)
activity. Both PKG and PKA induce relaxation by targeting components of the contractile
signaling pathways that lead to inhibition of MLCK activity and stimulation of MLCP activity.
cAMP signaling is terminated via PKA-mediated phosphorylation of cAMP-specific PDE4 and
cGMP signaling terminated via PKG-mediated phosphorylation of cGMP-specific PDE5, thus
regulating cyclic nucleotide levels in the cell.
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Figure 1E

Figure 1E. Physiological features of gasotransmitters. Nitric oxide (NO), carbon monoxide
(CO), and hydrogen sulfide (H2S) are considered “classical gasotransmitters” based on the
following criteria: i) they are small molecules of freely permeable gas; (ii) they are endogenously
generated by dedicated enzymes; (iii) they have well defined and specific functions at
physiologically relevant blood and plasma concentrations; (iv) they have specific cellular and
molecular targets to physiologically regulate cellular functions. NO and CO mediate cellular
effects via activation of soluble guanylyl cyclase (sGC) and the generation of cGMP, whereas H2S
mediates via direct post-translational modifications of its targets (e,g., KATP channels).
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Chapter 2
EXPRESSION OF H2S PRODUCING ENZYMES IN THE GI SMOOTH MUSCLE
2.1 Enzymatic Production of H2S
Hydrogen sulfide is produced via both enzymatic and nonenzymatic pathways in
mammalian cells. Most of the H2S levels in tissues are attributed to enzymatic synthesis. The
nonenzymatic pathways account for only a small portion of H2S production [18, 19].
The enzymes involved in H2S production are cystathionine-β-synthase (CBS),
cystathionine-γ-lyase (CSE) and β-mercaptopyruvate sulfurtransferase (MST). Both CBS and
CSE use pyridoxal 5’-phosphate (PLP or vitamin B6) as a cofactor. CSE and CBS are expressed
in many tissues, but the pattern of expression has been reported to be tissue-specific. Tissues
specific expression was demonstrated by western blot analysis and immunohistochemistry, and/or
by enzyme-specific inhibitors. CBS is predominantly found in the brain, nervous system, and liver
[20], while CSE is mostly found in the vasculature and liver. 3-MST can be found in the brain and
vasculature [10]. The enzymes also vary in cellular localization, CBS and CSE are reported to be
cytosolic and MST is expressed in the mitochondria [21, 23]. MST along with cysteine
aminotransferase (CAT) regulates endogenous H2S levels in specific types of cells and tissues such
as the blood capillaries. The involvement of mitochondria in oxidizing sulfide has been well
studied [21], and the specific affinity of the enzyme 3-MST to thiosulfate production has been
recently reported [22]. These enzymes are involved in transsulfuration and reverse transsulfuration
pathways in different capacities and utilize specific substrates.
2.1.1 Cystathionine-β-Synthase (CBS)
CBS is expressed mainly in the brain as the primary physiological source of H2S in the
central nervous system, and is reported to be of remarkable importance as a neuromodulator. CBS
was found to be highly expressed in the hippocampus and cerebellum when compared with the
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other brain regions such as cerebral cortex and brain stem [20]. CBS expression is almost rare or
absent in other tissues such as cardiovascular system, respiratory system, testes, adrenal, and
spleen from rats, mice or humans [24].
CBS catalyzes the production of H2S utilizing both cysteine and homocysteine as substrates
by reverse transulfuration. The most well-known reaction catalyzed by CBS is the condensation
of homocysteine and serine: L serine + L-homocysteine=L-cystathionine + H2O. This is the first
significant step in the biosynthesis of cysteine from methionine by reverse transsulfuration. CBS
catalyzes the condensation of cysteine with homocysteine to form cystathionine and H2S [25]. This
reaction involves the binding of co-factor, S-adenosyl-L-methionine (AdoMet or SAM) to the
COOH domain of CBS which causes a conformational change to activate the enzyme. The COOH
terminal domain of CBS is known to contain the calmodulin binding consensus sequence (19
amino acids) and facilitates calcium-activated calmodulin binding to this consensus sequence.
Binding of calmodulin to the COOH terminal opens up and the enzyme becomes active.
In the absence of CBS, tissues fail to catabolize homocysteine efficiently via
transsulfuration pathway and consequently become hypersensitive to homocysteine toxicity [25].
Many studies involving mutations in human CBS gene have been identified in patients with
homocystinuria, [26] characterized by an accumulation of homocysteine in the serum and urine.
Both gain-of-function polymorphisms and loss-of-function polymorphisms have been identified
with the CBS gene [26].
2.1.2 Cystathionine-γ-Lyase (CSE)
Cystathionine-γ-lyase has been conventionally abbreviated as CSE, CGL, or CTH. CSE is
expressed abundantly in mammalian cardiovascular system and respiratory system [27]. It is also
the primary H2S producing enzyme in the liver, kidney, uterus, placenta, as well as pancreatic islets

37

[28]. Low levels of CSE are also expressed in the small intestine and stomach of rodents [29] and
small amounts of CSE mRNA have also been detected in the brain [30].
CSE is a beta-replacing lyase with a strict specificity for the primary substrate L-cysteine
and for several sulfur-containing co-substrates [31, 32]. CSE is capable of using L-cysteine as the
substrate to form two gases, H2S and NH3, as well as pyruvate [33]. CSE can also utilize
homocysteine as a substrate to generate H2S. Because L-cysteine concentration exceeds that of Lhomocysteine, cysteine desulfhydration is the main mechanism of H2S production by CSE under
physiological conditions. There are two isoforms of human CSE. An internal deletion of 132 bp
separates the longer isoform from the shorter one which is a consequence of alternative splicing
[34].
Human deficiency of CSE may lead to a metabolic disorder named cystathioninuria that is
inherited in an autosomal recessive manner. These patients have an excess of cystathionine in their
urine. Other diseases related to CSE mutation include hypercystathioninemia and increase the risk
of developing atherosclerosis and bladder cancer [35].
2.1.3 β-Mercaptopyruvate Sulfurtransferase (MST)
β-mercaptopyruvate sulfurtransferase or MST is a mitochondrial enzyme which catalyzes
the production of H2S from L-cysteine. MST has A and B chains and functions in the presence of
its co-factor, zinc. It is essentially involved with cyanide detoxification and transfers the sulfane
sulfur from substrate to cyanide ion, giving nontoxic thiocyanate and pyruvate. MST can generate
H2S in the presence of another enzyme cysteine aminotransferase (CAT) and cofactors 2oxoglutarate and PLP [36, 37]. CAT converts cysteine to 3-mercaptopyruvate (3-MP), the
substrate for MST which would then transfer the sulfur from 3-MP to sulfite or other sulfur
acceptors or form elemental sulfur. The direct outcome of the CAT-MST pathway is the production
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of sulfane sulfur (or bound sulfur). H2S is consequently formed either through reduction of the
atomic sulfur or released from thiosulfate or persulfides.
Following its production in the cells, H2S is first oxidized to thiosulfate and then to sulfite
and sulfate in the mitochondria [38]. Methylation is another catabolic pathway for H2S. While the
oxidation of H2S occurs mainly in mitochondria, methylation mainly takes place in the cytosol.
H2S is metabolized by the colonic mucosa to thiosulfate and sulfate. The oxidation process in
colonic epithelial cells involves the activities of oxidizing enzymes such as sulfide quinone
oxidoreductase, sulfur dioxygenase and rhodanese. The GI system has a powerful sulfide oxidation
system in the epithelial cells to protect the gut layers against the high local concentrations of H2S
and the protection of the other remote tissues from potential damage induced by H2S.
Rationale. Both CSE and CBS have been found in different parts of the GI tracts of rats
and mice and in the healthy human colon [55, 57, 149, 150]. These studies confirm that H2S is
released from mammalian gut tissues; however, the precise cellular site of H2S biosynthesis in the
different parts of the GI tract (e.g. mucosa, ICCs, smooth muscle cells, nerves) is unknown since
most evidence with the effects of H2S on motility is presented in vivo or whole tissue preparations.
Studies from our lab reported the presence of CSE in the gastric smooth muscle cells where H2S
was demonstrated to have physiological effects on muscle contractility [39].

2.2 Materials and Methods
2.2.1 Reagents
Antibodies for cystathionine β synthase (CBS) (Catalog No 14787- 1AP) and cystathionine
γ lyase (CSE) (Catalog No 122217-1-AP) were obtained from proteintech (Chicago, IL). HRPconjugated secondary antibodies are obtained from Cell signaling (Danvers, MA). RNAqueousTM
kit was obtained from Ambion (Austin, TX); SuperScriptTM II Reverse Transcriptase kit was
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obtained from Applied Biosystems (Foster, CA); PCR reagents were obtained from Applied
Biosystems, Roche. HotMaster Taq DNA polymerase kit was obtained from Epicentre
Biotechnologies. Collagenase CLS type II and soybean trypsin inhibitor for cell isolation were
obtained from Worthington, (Freehold, NJ); Western blotting materials and protein assay kit, TrisHCl ready gels were all obtained from Bio-Rad Laboratories (Hercules, CA); Immobilon- FL
PVDF membranes were obtained from Millipore, (Billerica, MA). Dulbecco’s modified Eagle’s
medium (DMEM) for primary cell culture was obtained from Fisher Scientific (Carlsbad, CA).
NaCl, KCl, KH2PO4, MgCl2, HEPES, glucose, 2.1% (v/v) Eagle’s essential amino acid mixture,
phenol:chloroform:isoamylalcohol mixture and other chemicals were obtained from Sigma, (St.
Louis, MO). Agarose and Ethidium Bromide for gel electrophoresis purposes were obtained from
Invitrogen, Life technologies (Carlsbad, CA). Protease and phosphatase inhibitor cocktail
mixtures, PierceTM ECL Plus Substrate and CL-XPosure films were obtained from Life
technologies, Fisher Scientific (Carlsbad, CA).
2.2.2 Animals
New Zealand white rabbits (weight: 4-5 lbs) were purchased from RSI Biotechnology,
Clemmons, NC. Male C57BL/6 wild-type mice are obtained from Jackson Laboratory, (Bar
Harbor, ME).
Rabbits are sacrificed by Euthasol overdose (100 mg/kg), as approved by the Institutional
Animal Care and Use Committee (IACUC) of the Virginia Commonwealth University. Mice were
euthanized by CO2 asphyxiation under approved protocols. The animals were housed in the animal
facility administered by the Division of Animal Resources, Virginia Commonwealth University.
All procedures were conducted in accordance with the Institutional Animal Care and Use
Committee of the Virginia Commonwealth University.
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Normal human gastric and colon tissues were obtained from the National Disease Research
Interchange (NDRI, Philadelphia, PA), a nonprofit organization that provides human organs and
tissue. The studies using human tissues from NDRI are approved for exempt from VCU
Institutional Review Board.
2.2.3 Preparation of dispersed Smooth Muscle Cells
Smooth muscle cells were isolated from the circular muscle layer of the stomach and colon
of rabbit, mouse and human by sequential enzymatic digestion, filtration, and centrifugation, as
previously described [40, 41, 42]. Briefly, smooth muscle strips were incubated for 30 minutes at
31C in 15 ml of medium containing 120 mM NaCl, 4 mM KCl, 2.6 mM KH2PO4, 0.6 mM MgCl2,
25 mM HEPES, 14 mM glucose, 2.1% (v/v)

Eagle’s essential amino acid mixture, 0.1%

collagenase (type II), and 0.1% soybean trypsin inhibitor. Partly digested tissues were washed with
50 ml of enzyme-free medium and muscle cells were allowed to disperse spontaneously. The cells
were harvested by filtration through 500 m Nitex and centrifuged twice at 350 g for 10 minutes.
Dispersed smooth muscle cells were cultured in Dulbecco’s modified Eagles’s medium (DMEM)
containing 10% fetal bovine serum until they attained confluence and were then passaged once for
RT-PCR and western blot studies.
2.2.4 RNA Isolation and RT-PCR analysis of CBS and CSE
Specific primers were designed based on homologous sequences in human, rat, and mouse
CBS and CSE. Cultured gastric and colonic muscle cells were treated with RNaqueous reagent
followed by an extraction with phenol:chloroform:isoamylalcohol (25:24:1). RNA (5 μl) was used
to synthesize cDNA using Superscript II reverse transcriptase with random hexanucleotide
primers. Reversibly transcribed cDNA (5 μl) was amplified by PCR under standard conditions
using the HotMaster Taq DNA polymerase kit in a final volume of 50 μl containing 100 ng of each
primer. The PCR products were separated by electrophoresis in 1.2% agarose gel in the presence
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of ethidium bromide, visualized by ultraviolet fluorescence, and recorded by a ChemiImager 4400
Fluorescence system. PCR products were purified by using a QIAquick Gel Extraction Kit
(Qiagen) and sequenced.

Primer
Forward 5’→3’

Reverse 3’→5’

Size(bp)

ACATTTCGCCACGCAGGCCA

GCAGATTGGTCCACGCCCCT

560

TGGATGGGGCTAAGTACTGTTTGGC

CAGAGCCAAAGGGCGCTGGAAA

312

GGGCATCTGCAGGGAAAGGAACG

GCAGATTGGTCCACGCCCCT

851

GGTGGTGGCGTCTGCGTGTT

AGGCCTGGTCTCGTGATTGGATCT

345

set
Rabbit
CSE
Human
CSE
Mouse
CSE
Mouse
CBS

2.2.5 Western Blot Analysis for CBS and CSE
Freshly dispersed or cultured smooth muscle cells were solubilized in Triton X-100-based
lysis buffer plus protease and phosphatase inhibitor cocktail (104 mM AEBSF, 80 mM aprotinin,
4 mM bestatun, 1.4 mM E-64, 2 mM leupeptin, 1.5 mM pepstatin). After centrifugation of the
lysates at 20,000 g for 10 minutes at 4°C, protein concentrations of the supernatant were
determined with the DC Protein Assay kit from Bio-Rad. Proteins (50 µg) were then resolved by
SDS-PAGE and transferred to PVDF membranes. The blots were incubated in 5% non-fat milk in
Tris-buffered saline containing 0.1% tween-20 (TBST) for an hour. The blots are then incubated
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for 12 h at 4°C with anti-CBS, CSE and 3-MST antibodies (1:1,000) in 5% non-fat dry milk. The
blots are washed with TBST three to five times for 5 minutes and then incubated with secondary
antibody conjugated with horseradish peroxidase (HRP) for 1 hour at room temperature. The blots
were then washed as done previously. The blots were prepared using Pierce ECL Plus Substrate
and then blots were exposed to CL-XPosure Film. The protein bands were visualized by enhanced
chemi-luminescence.

2.3 Results
2.3.1 Expression of CSE mRNA in Smooth Muscle
Expression of the two main enzymes involved in the synthesis of H2S was determined by
RT-PCR and western blot. mRNA expression was determined in cultured muscle cells to avoid
amplification from cells other than muscle cells. Previous studies have determined the purity of
cultured muscle cells with smooth muscle-specific -actin and absence of interstitial cells of Cajal
and endothelial cells in the primary cultures after first passage [43]. Expression of mRNA for CSE
was detected in muscle cells from colon of mouse, rabbit and human. A PCR product of the
expected size was obtained with CSE specific primers using RNA isolated from cultured muscle
cells derived from stomach and colon of rabbit (560 bp), mouse (851 bp) and human (312 bp)
(Figure 2A).
Under similar conditions, there was no detectable PCR product with CBS-specific primers
from cultured muscle cells of stomach and colon of rabbit, mouse and human (Figure 2B, left
panel). However, a PCR product of expected size was obtained using CBS-specific primers with
RNA isolated from mouse brain (Figure 2B, right panel).
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2.3.2 Expression of CSE Protein in Smooth Muscle
Western blot analysis using specific antibody to CSE demonstrated the presence of CSE
protein (66 kDa) in lysates derived from cultured muscle cells of colon and stomach of mouse,
rabbit and human (Figure 2C, upper panel). Under similar conditions, there was no detectable
expression of CBS protein in lysates derived from dispersed muscle cells of stomach and colon of
rabbit, mouse and human. However, expression of CBS protein was obtained using CBS-specific
antibody with lysates prepared from mouse brain (Figure 2C, lower panel). These results suggest
that muscle cells selectively express CSE and this is consistent with the tissue-specific expression
of CSE and CBS [44].
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Figure 2A

Figure 2A. Expression of CSE mRNA in colonic smooth muscle cells. CSE expression was
identified in cultured muscle cells from the stomach (control) and colon of rabbit, human and
mouse by RT-PCR. A PCR product of the expected size was obtained with CSE specific primers
using RNA isolated from cultured muscle cells derived from the stomach and colon of rabbit (560
bp), human (312 bp) and mouse (851 bp).
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Figure 2B

Figure 2B. Expression of both CSE and CBS in mouse brain. CBS expression was examined
in cultured muscle cells from colon of rabbit, mouse and human by RT-PCR. CBS expression was
not obtained in colonic muscle cells (left panel). However, a PCR product of the expected size was
obtained with CBS and CSE specific primers using RNA isolated from mouse brain (control
studies, right panel). RT-PCR was performed in the presence (+) or absence (−) of reverse
transcriptase (RT). Both CBS expression (337 bp) and CSE expression (384 bp) were identified in
mouse brain by RT-PCR using specific primers for CBS and CSE.
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Figure 2C

Figure 2C. Expression of CSE in colonic smooth muscle. Western blot analysis using specific
antibody to CSE (1:1000) demonstrated the presence of CSE protein (66 kDa) in lysates derived
from muscle cells of colon and stomach (control) of mouse, rabbit and human. (Upper panel).
Western blot analysis using specific antibody to CBS (1:1000) showed an absence of CBS protein
(61 kDa) in lysates derived from colonic muscle cells of rabbit, mouse and human; however CBS
protein was identified in cell lysates obtained from the mouse brain (control studies) (Lower
Panel).
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2.4 Discussion
Several studies performed in the GI tract confirm that H2S synthesizing enzymes are
expressed in enteric neurons, ICCs and in the epithelium [46, 115, 138]. Expression appears to be
heterogenous across different cell types; some cells expressing both, while other cell types
expresses only one type of enzyme. Most of these studies are performed in whole tissue [45, 55,
57, 149, 150]. Expression of both CSE and CBS have been reported in the lamina propria of rat
colon, neurons of enteric nervous system of mouse, guinea pig and human, and epithelium of rat
colon [55, 57, 139]. Other studies performed a comparative analysis of CBS and CSE across tissues
in mouse. These studies confirm the presence of both CSE and CBS enzmyes in the GI tract, as
well as other organs such as brain, liver and kidney [47]. According to these studies, CSE was
expressed in all tissues examined, but particularly abundant in the liver and low in the brain and
lung. CBS enzyme expression was particularly high in the brain, and relatively low in the
duodenum and jejunum.

Expression studies were corroborated by synthesis of H2S from

exogenous substrates in GI tract employing selective inhibitors of CSE (DL-propargylglycine, DLPPG) or CBS (aminooxyacetic acid, AOAA); however the relative tissue- and enzyme-specific
contribution is not clear [47, 57].
Expression of CSE and CBS also varies with the different regions of the GI tract. In the
rat, CSE expression was more abundant in the proximal regions (stomach, duodenum and
jejunum), compared to distal regions (ileum and colon). In contract, CBS expression was low in
proximal regions (duodenum and jejunum) and high in the distal regions (ileum and colon) [47].
In spite of expression of both enzymes, H2S generation in stomach, duodenum, jejunum, and colon
was significantly blocked by the CBS inhibitor, suggesting that synthesis of H2S occurs throughout
the GI tract, and CBS is the main enzyme involved in H2S generation in GI tract [47]. In rat colon,
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CBS staining was localised primarily to cells within the muscularis mucosa, sub-mucosa and
lamina propria. On the other hand, CSE immunoreactivity was more diffuse, possibly as a result
of associations with the vasculature [47]. Studies by Kasparek et al., [167] have shown
immunoreactivity for both CSE and CBS in myenteric neurons, but not in smooth muscle cells of
rat jenunum. While the immunohistochemical analysis are helpful to identify the presence of the
proteins, it is still unclear the cells which carry the inherent transcripts for CBS and CSE.
To understand the impact of the H2S on GI motility, it would be of critical importance to
understand the endogenous production of the gas in the muscle tissue which is primarily
responsible for generation of force in the gut. Hence, this study was focussed on understanding the
presence of the CBS and CSE in the colonic smooth muscle by using dispersed and cultured muscle
cells devoid of epithelial cells, enteric neurons, and ICCs. Our studies showed that the mRNA
transcripts and protein for CSE enzyme are expressed in colonic muscle cells derived from rabbit,
mouse and human. Consistent with the literature so far which suggests that CSE is primarily
expressed in the visceral organ systems, we show that CSE is expressed in the GI muscle layers in
the species tested. CBS was not identified in GI smooth muscle cells, however, we show mRNA
transcripts for CBS as well as protein expression in mouse brain homogenates, as reported earlier
[30]. These findings are of great importance and further establish the reports that CSE is the
primary source of H2S in the GI system.
In summary, our results demonstrated selective expression of CSE in smooth muscle from
stomach and colon of rat, mouse and human. Futher studies in the following chapters decribe the
functional importance of the enzyme CSE in H2S production and GI motility.
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Chapter 3
EFFECT OF H2S ON COLONIC SMOOTH MUSCLE FUNCTION
3.1 Introduction
Smooth muscle cells are an important component in GI tract and the muscle cells are
arranged in two layers: an outer longitudinal muscle layer and an inner circular muscle layer. The
layers in the circular and longitudinal muscles are mechanically coupled allowing them to function
in a highly coordinated fashion. Smooth muscles shorten in response to contractile agonists (e.g.,
acetylcholine) and this shortening of the muscle layers provides contractile force to propel food
along the GI tract. Smooth muscle cells in the GI tract are also electrically coupled via gap
junctions such that electrical stimulation of one cell is followed by stimulation of the adjacent
smooth muscle cells. These gap junctions also allow secondary messengers like IP3/cAMP and
ions (e.g., Ca2+) to spread from cell to cell. The coupling of muscle cells enables the muscle layer
to function as a contractile sheet of muscle. This is called a functional syncytium.
3.1.1 Slow Waves
Resting membrane potential in the muscular layers of the colon is not stable but shows
cycles of depolarization and repolarization. These cycles differ in speed, amplitude, frequency and
duration in different areas of the gut. The wave consists of a rapid upstroke (depolarization), a
partial repolarization, a sustained plateau lasting several seconds and a complete repolarization to
resting level. Slow waves are originated in the pacemaker regions generated by the ICCs and
spread electrically in the longitudinal and circular directions as well as through the thickness of
the muscle.
3.1.2 Phasic versus Tonic Contraction
Colonic muscle layers exhibit both phasic and tonic contraction patterns. Phasic smooth
muscles contract transiently in response to neural stimulation. In contrast, tonic smooth muscles
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develop and sustain contraction [49, 50]. During a phasic contraction, cytoplasmic [Ca2+] and
MLC20 phosphorylation and muscle force reach a peak and return to baseline. In contrast, during
a tonic contraction, cytoplasmic [Ca2+]i declines, but phosphorylation and contraction are
maintained.
3.1.3 Regulation of Muscle Tone by Hydrogen Sulfide
Regulation of GI motility in vivo is complex and reflects interplay of the autonomic
nervous system, enteric nervous system, ICCs, and smooth muscle cells. Excitatory transmitters
such as acetylcholine and substance P initiate muscle contraction and inhibitory neurotransmitters
such as NO and VIP are responsible for the inhibition of muscle contraction [52, 53].
Recent studies with H2S show that it can act as a gasotransmitter like NO. The effect of
H2S has been clearly established as a physiological modulator in the cardiovascular, respiratory,
urinary and gastrointestinal systems [55, 56, 70, 145, 148, 149, 150]. H2S is an important
vasodilator in the cardiovascular system. It dilates vascular smooth muscle mainly by opening
ATP-sensitive K+ (KATP) channels [50, 51, 52]. This opening of KATP channels in response to H2S
hyperpolarizes membrane potential of the smooth muscle inducing relaxation. The effect of H2S
was also reported in human airway smooth muscle cells [57]. In isolated airway myocytes, cell
stiffness was seen to be decreased in response to H2S donor, GYY4137. KATP channel blocker,
glibenclamide markedly attenuated GYY4137-mediated muscle relaxation suggesting the
involvement of KATP channels in smooth muscle relaxation [57]. Liu et al [92] showed that low
concentrations of a H2S donor, NaHS (100 µM) H2S increases basal tension via inhibition of KV4.3
current and membrane potential [92]. However, a high concentration (0.3 to 1 mM) NaHS
suppressed the amplitude of spontaneous contraction of guinea pig gastric muscle via activation
of KATP channels.
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In gastrointestinal tract, studies using whole segments of intestine or muscle strips from
rat, mouse, guinea pig and human have shown that H2S inhibits contraction [54, 55, 56]. H2S is
reported to inhibit both spontaneous and electrical field stimulation-induced contractions in the
human colon [54]. NaHS concentration-dependently inhibited the spontaneous contractions in
muscle strips from human colon [55]. The inhibitory effect of NaHS on colonic strips was
unaffected by the neural blocker, tetrodotoxin (TTX), but significantly reduced by KATP channel
blocker glibenclamide suggesting that the effect of NaHS was independent of neural activation
and probably involved activation of KATP channels and hyperpolarization of smooth muscle [55].
In contrast, studies by Teague et al in guinea pig ileum demonstrated that NaHS caused inhibition
of acetylcholine- or electrical field-stimulated muscle contraction and the effect was independent
of KATP channel activation as the KATP channel inhibitor glibenclamide had no effect on NaHSinduced decrease in muscle contraction [56]. In the GI tract, H2S-synthesizing enzymes have been
reported to be expressed by enteric neurons, interstitial cells of Cajal, and epithelial cells [57].
Thus, the effect of H2S could be due to release of inhibitory neurotransmitters from the enteric
neurons, inhibition of pacemaker activity of ICC and/or its direct effect on smooth muscle.
Rationale. Our studies showed that CSE is expressed in the isolated muscle cells of the
colon of rabbit, mice and human [39] (Chapter 2 Figure 2A, 2C). The studies performed in this
section aim to determine the effect of H2S on agonist-induced contractions in muscle strips from
colon. To avoid the confounding effects of H2S on enteric neurons and ICCs, we also examined
the effect of L-cysteine (endogenous activator of CSE) and NaHS on carbachol-induced muscle
contraction in dispersed muscle cells by scanning micrometry. Our results demonstrate that H2S
causes inhibition of agonist-induced contraction by acting directly on smooth muscle cells and the
inhibitory effect of H2S is independent of KATP channel activation, a known target of H2S in
vascular smooth muscle.
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3.2 Materials and Methods
3.2.1 Reagents
Chemicals for the preparation of Kreb’s solution: NaCl, KCl, KH2PO4, MgSO4. CaCl2,
NaHCO3, glucose and carbachol, L-cysteine and sodium hydrosulfide (NaHS), glibenclamide,
levcromakalim were all obtained from Sigma-Aldrich (St. Louis, MO). Forskolin and
myristoylated PKI were obtained from Tocris Bioscience (Minneapolis, MN).

S-

nitrosoglutathione was obtained from Abcam Biochemicals (Cambridge, MA). Rp-8-Br-cGMPS
was obtained from Alexis Corporation (Switzerland). Force transducers model FT03C were
obtained from Grass Technologies. The organ bath setup was obtained from Radnoti Technologies,
(Monrova, CA). Model 15LT amplifier system relayed to Polyview Imager was obtained from
Grass technologies, (Quincy, MA). [125I]cAMP and [125I]cGMP were obtained from Perkin Elmer
Life sciences (Cambridge, MA).
3.2.2 Animal and Strip Preparation
Contraction studies were performed in colon strips obtained from rabbits. Rabbits are
euthanized by intravenal injection of sodium pentobarbital overdose (100 mg/kg), as approved by
the Institutional Animal Care and Use Committee (IACUC) of the Virginia Commonwealth
University. The colon is dissected out, emptied of contents and placed in oxygenated Kreb’s
solution composed of 118 mM NaCl, 4.75 mM KCl, 1.19 mM KH2PO4, 1.2 mM MgSO4, 2.54 mM
CaCl2, 25 mM NaHCO3, 11 mM glucose at 37oC and pH 7.4. Sections of the colon were threaded
onto a glass rod and the longitudinal muscle and myenteric plexus (LM-MP) was removed by
radial abrasion with kimwipes. The resultant circular muscle strip of colon was freed of excess fat
and mesenteric attachments and held in oxygenated Krebs buffer until use for tension recordings
using the organ bath set up. The organ bath setup is a reliable measurement of muscle tension in
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response to contractile agonists. To measure muscular activity, the muscle strip isolated from the
colon is attached by wire or silk suture to a force transducer which converts the force generated by
the muscle into an electrical signal. This signal is then detected on a chart recorder or a computer
based data acquisition system. For our experiments, we use the Polyview system to graph force
transduction measurements. The force transducer may make an isometric or isotonic measurement.
In an isometric measurement, the muscle length remains constant as force changes while in an
isotonic system the muscle shortens against a constant force. Our experiments study isometric
measurements, which are measured in grams or milli newtons. Force measurements can be
converted to tension measurements, permitting the experimenter to control for the differences
caused by the size of the preparation and its effect on force output.
Strips destined for recordings of contractile behavior were tied at both ends with surgical
silk. On one end is a simple loop for attachment to a glass hook, and the other end is tied to a brass
ring. The strip was then placed in a vertical orientation with the loop secured to a glass hook and
the brass ring to a Model FT03C Force transducer. The strip is then submerged in an organ bath in
5 ml of continuously oxygenated and warmed Krebs solution. Force recordings were amplified by
a 15A12 model amplifier (contained within a Model 15LT Amplifier System), relayed to a PVA16 Polyview Adaptor Unit (A/D-D/A converter), and displayed/stored by a PC running Polyview
Version 1.3. Force was recorded in grams as per the software specifications. All analysis of data
traces was performed within the Polyview software itself, because exportation of usable raw data
was limited by software design.
3.2.3 Isometric Force Measurement
Force experiments were conducted in the following manner. Following hanging of the strip
and submersion in the organ bath, strips were subjected to approximately 2 gram of pre-tension
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via the mounting rack-and-pinion. Strips were allowed to equilibrate to a passive tension of 2 gram
for at least 30 minutes before experiments were conducted and bath buffer solution was changed
every 15 minutes during equilibration and data collection. Carbachol (CCh), a mimetic of
acetylcholine was used as a contractile agonist. L-cysteine (L-cys), a substrate for H2S production
and NaHS, a spontaneous donor of H2S were used to produce H2S. Exposure to NaHS, L-cysteine
and carbachol occurred within the organ bath. Concentrations were appropriate and in agreement
with the current literature and are reported in the results [27, 56, 71]. At the end of each experiment,
the strips were blotted dry and weighed (tissue wet weight).
Contractile activity of muscle strips was calculated as maximum force generated in
response to CCh, and the effect of L-cysteine or NaHS was calculated as percent decrease in
maximum contraction. Only muscle strips that developed ∼2 gram of tension above basal levels
were used to test the effect of L-cysteine or NaHS. Time control studies demonstrated that response
to 10 μM CCh was reproducible following 2 hour incubation in Krebs buffer. Muscle strips were
used within 2 hour after isolation. Following an experiment, strip data were reviewed and analyzed
from within the Polyview software suite. All experiments were designed to compare treatment to
control conditions. Paired t-tests were conducted in Graphpad (La Jolla, CA), and significance
assumed at p < 0.005.
3.2.4 Measurement of Contraction in Isolated Muscle by Scanning Micrometry
Cell length measurement is recorded by image scanning micrometry technique [52, 53, 77,
78, 170]. The technique involves direct measurement of cell lengths by eyepiece micrometer,
image-scanning micrometer and computerized image analysis. The lengths of the first 50
encountered cells in separate slides prepared from control and stimulant-treated suspensions are
measured and compared. Contraction is expressed as the absolute decrease in mean cell length
(m) from control cell length in the presence of contractile agonist. All cell suspensions were used
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within 1 hour after dispersion for cell length measurements. Freshly isolated muscle cells (0.4 ml
containing 104/cell ml) from circular muscle layer of colon were preincubated for 5 minutes with
different concentrations of L-cysteine or NaHS, and then CCh was added for 10 minutes. The
reaction was terminated with 1% acrolein. After termination, an aliquot of cell suspension was
placed on a slide under a coverslip. The slide was scanned at ×100 magnification, and the length
of first 50 cells randomly encountered was measured using an image-splitting eyepiece connected
to a micrometer. The resting cell length was determined in control experiments in which muscle
cells were incubated with 100 μl of 0.1% bovine serum albumin in the absence of CCh. In some
experiments cells were preincubated for 5 minutes with different inhibitors: a KATP channel
inhibitor, glibenclamide (10 μM), PKA inhibitor, myristoylated PKI (1 μM), PKG inhibitor, RpcGMPs (1 μM) before addition of L-cysteine or NaHS.
3.2.5 Assay for cAMP or cGMP by Radioimmunoassay
Cyclic AMP and cyclic GMP production in dispersed colonic muscle cells is measured by
radioimmunoassay as described previously [52]. Briefly, muscle cells (3 X 106 cells) are treated
with L-cysteine (10 mM) and NaHS (1 mM) for 5 minutes in the presence of IBMX (100 µM) and
the reaction is terminated with 10% trichloroacetic acid. The samples are centrifuged and the
supernatants extracted three times with water-saturated diethyl ether. The resultant aqueous phase
is lyophilized and reconstituted in 500 l of 50 mM sodium acetate (pH 6.2). The samples were
acetylated with triethylamine/acetic anhydride (2:1, v/v) for 30 minutes and cGMP or cAMP is
measured in triplicate using 100 l aliquots. The results are expressed as pmol/mg protein.
3.2.6 Data Analysis
The results were expressed as means ± S.E of n experiments and analyzed for statistical
significance using Student t-test for paired and unpaired values. Each experiment was performed
on cells and tissues obtained from different animals. Difference of responses among different
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groups were tested and confirmed for significance using Fisher’s protected least significance
difference test. The results were analyzed using GraphPad software, San Diego, CA. A probability
of p< 0.005 was considered significance.
3.3 Results
3.3.1 Inhibition of Contraction by L-cysteine in Muscle Strips
Isometric contraction was measured in muscle strips isolated from the circular layer of the
colon from rabbit. Muscle strips were allowed to equilibrate to a passive tension of 2 gram for 30
minutes before experiments were conducted. Area under curve (AUC) measurements representing
force versus time in response to carbachol (CCh) was defined as muscle tone above basal. AUC
was recorded for the first 2 minutes in response to CCh. The strips were then incubated in different
concentrations of L-cysteine for 5 minutes before the addition of CCh and AUC measurements are
recorded again to estimate the amount of inhibition of contraction in response to L-cysteine. These
force measurements are normalized by tissue mass and demonstrate the variability among strips
used in these experiments.
As shown previously [58], carbachol (CCh, 10 µM) induced a contraction of 367 ± 26
gram-seconds above basal tension. Addition of L-cysteine (an endogenous activator of CSE)
caused inhibition of CCh-induced contraction in a concentration-dependent fashion (Figure 3A
and 3C). Contraction in response to CCh (10 µM) were 352 ± 12 gram-seconds at 0.1 mM Lcysteine (5% inhibition, NS), 279 ± 65 gram-seconds at 1 mM L-cysteine (25% inhibition, p<0.01),
127 ± 16 gram-seconds at 10 mM L-cysteine (65% inhibition, p<0.001) and 71 ± 13 gram-seconds
at 100 mM L-cysteine (81% inhibition, p<0.001). Previous studies [60] in vascular and visceral
muscle have shown that inhibitory effect of H2S was mediated by activation of plasma membrane
KATP channels and hyperpolarization. The notion was examined using KATP channel inhibitor
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glibenclamide in our studies. Incubation of muscle strips with glibenclamide (10 μM) did not affect
the relaxation in response to L-cysteine (data not shown). These results suggest that inhibition of
CCh-induced contraction by L-cysteine was not due to activation of KATP channels.
3.3.2 Inhibition of Contraction by NaHS in Muscle Strips
Area under curve (AUC) measurements in response to carbachol (CCh) was also tested in
the presence and absence of H2S donor, NaHS. The strips were incubated in different
concentrations of NaHS for 5 minutes before the addition of CCh (10 M) and AUC measurements
are recorded to estimate the amount of inhibition of contraction in response to NaHS.
Similar to the inhibitory response obtained with L-cysteine, addition of NaHS also caused
an inhibition of CCh-induced contraction in a concentration-dependent fashion (Figure 3B and
3C). Carbachol (CCh, 10 µM) induced a contraction of 369 ± 26 gram-seconds above basal
tension. Contraction in response to CCh (10 µM) were 290 ± 30 gram-seconds at 0.01 mM NaHS
(21% inhibition, NS), 133 ± 17 gram-seconds at 0.1 mM NaHS (63% inhibition, p<0.001), and 50
± 9 gram-seconds at 1 mM NaHS (86% inhibition, p<0.001) and 21 ± 5% at 10 mM NaHS (95%
inhibition, p<0.001).
3.3.3 Inhibition of Muscle Contraction by H2S in Isolated Muscle Cells
Contractile agonists (e.g., CCh) induce biphasic contraction in isolated muscle cells: a rapid
contraction within 30 seconds followed by a sustained contraction for 20 minutes [78]. To study
the effect of L-cysteine and NaHS on sustained contraction, muscle cells were treated with
different concentrations of CCh (0.01 nM to 1 μM) in the presence or absence of L-cysteine (10
mM) and NaHS (1 mM) for 10 minutes. CCh caused concentration-dependent increase in
contraction in dispersed muscle cells with EC50 of 1 nM and a maximal contraction of 32 ± 4%
decrease in cell length from the control cell length (109 ± 5 µm). The amount of contraction in
response to CCh is similar to that reported in previous studies [77]. In the presence of L-cysteine
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or NaHS the contractile response to CCh was shifted to the right with EC50 values of 35 nM and
89 nM, respectively, suggesting that inhibition of contraction is mediated by H2S (Figure 3D).
Addition of different concentrations of L-cysteine caused inhibition of CCh-induced
contraction in a concentration-dependent fashion (Figure 3E). CCh-induced contraction responses
were 32 ± 3% at 0.01 mM L-cysteine (6% inhibition of contraction, NS), 30 ± 5% at 0.1 mM Lcysteine (7% inhibition, NS), 22 ± 6% at 1 mM L-cysteine (31% inhibition, p<0.001), 18 ± 4% at
10 mM L-cysteine (43% inhibition, p<0.001) and 15 ± 2% at 100 mM L-cysteine (53% inhibition,
p<0.001). Addition of different concentrations of NaHS also caused inhibition of CCh-induced
contraction in a concentration-dependent fashion. CCh-induced contraction responses were 27 ±
2% at 0.01 mM NaHS (15% inhibition, NS), 25 ± 7% at 0.1 mM NaHS (21% inhibition, p<0.01),
16 ± 3% at 1 mM NaHS (50% inhibition, p<0.001), 10 ± 5% at 10 mM NaHS (68% inhibition,
p<0.001) and 7 ± 2% at 100 mM NaHS (78% inhibition, p<0.001) (Figure 3E).
3.3.4 Inhibition of Muscle Contraction by H2S is Independent of KATP Channel Activation
Studies in vascular muscle showed that the effect of H2S is mediated via activation of KATP
channels and hyperpolarization of smooth muscle [65, 66]. The effect of both L-cysteine and NaHS
on CCh-induced contraction was examined in the presence and absence of KATP channel blocker,
glibenclamide to test the involvement of KATP channels in isolated colonic smooth muscle cells.
Glibenclamide (10 M) had no effect on the inhibition of CCh-induced contraction by L-cysteine
(10 mM) (53 ± 2% inhibition alone vs 52 ± 4% inhibition in the presence of glibenclamide) or
NaHS (1 mM) (63 ± 3% inhibition alone versus 60 ± 6% inhibition in the presence of
glibenclamide) (Figure 3F). These results demonstrate that both endogenous H2S (via activation
of CSE by L-cysteine) and exogenous H2S inhibit muscle contraction and suggest that the
inhibitory effect of H2S is independent of KATP channel activation. Control studies showed that
inhibition of contraction in response to levcromakalim (crmk), a potassium channel activator, was
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reversed by glibenclamide (52 ± 7% inhibition of contraction alone versus 8 ± 4% inhibition in the
presence of glibenclamide) (Figure 3G).
3.3.5 Inhibition of Muscle Contraction by H2S is Independent of cAMP/PKA and cGMP/PKG
Pathways
Previous studies in dispersed smooth muscle cells have shown that increase in intracellular
cGMP and cAMP and subsequent activation of cGMP-dependent protein kinase (PKG) and
cAMP-dependent protein kinase (PKA), respectively lead to inhibition of contraction in response
to acetylcholine [52]. To examine the possibility that H2S caused inhibition of contraction is
mediated by increase in cGMP/cAMP and activation of PKG/PKA pathways, we used two
approaches.
In the first approach the effect of both L-cysteine (10 mM) and NaHS (1 mM) on CCh (1
M)-induced contracted was examined in the presence and absence of inhibitor of PKA
(myristoylated PKI) or PKG (RpcGMPS). Myristoylated PKI (1 µM) had no effect on the
inhibition of CCh-induced contraction by L-cysteine (55 ± 3% inhibition vs 49 ± 2% inhibition in
the presence of PKI) or NaHS (63.3 ± 3% inhibition alone vs. 60 ± 6% inhibition in the presence
of PKI) (Figure 3H). Control studies showed that the inhibition of contraction (61 ± 8% inhibition)
in response to forskolin, an activator of adenylyl cyclase and cAMP/PKA pathway was reversed
by myristoylated PKI (12 ± 5% inhibition) (Figure 3I). Similarly, Rp-cGMPS (1 µM) had no effect
on the inhibition of CCh-induced contraction by L-cysteine (52 ± 3% inhibition vs 46 ± 6%
inhibition in the presence of Rp-cGMPS) or NaHS (63 ± 3% inhibition vs. 58 ± 4% inhibition in
the presence of Rp-cGMPS) (Figure 3J). Control studies showed that the inhibition of contraction
(53 ± 7% inhibition) in response to nitric oxide donor, GSNO (10 µM), an activator of guanylyl
cyclase and cGMP/PKG pathway, was reversed by Rp-cGMPS (9 ± 5% inhibition) (Figure 3K).
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These results suggest that the inhibitory effect of both endogenous and exogenous H2S on CChinduced muscle contraction is independent of increase in cAMP and cGMP in colonic smooth
muscle cells.
In the second approach, the effect of L-cysteine and NaHS on cyclic nucleotide levels was
measured. Muscle cells were treated with L-cysteine (10 mM), NaHS (1 mM), forskolin (10 µM)
or GSNO (10 µM) for 5 minutes in the presence of phosphodiesterase inhibitor, IBMX (100 µM)
and changes in cAMP and cGMP levels are measured by radioimmunoassay. Basal levels of cAMP
(3.3 ± 0.4 pmol/mg protein) were not significantly different when cells were treated with either Lcysteine (3.1 ± 0.2 pmol/mg protein) or NaHS (3.0 ± 0.5 pmol/mg protein) (Figure 3L). Forskolin,
used as a positive control, caused a significant increase (18 ± 3 pmol/mg protein, p<0.001) in
cAMP levels above basal levels (Figure 3L). Similarly, basal levels of cGMP (0.6 ± 0.01 pmol/mg
protein) were not significantly different when cells were treated with L-cysteine (0.5 ± 0.09
pmol/mg protein) or NaHS (0.9 ± 0.6 pmol/mg protein) (Figure 3M). GSNO (an NO donor), used
as a positive control, caused a significant increase (4.2 ± 0.61 pmol/mg protein, p<0.001) in cGMP
levels above basal levels (Figure 3M). These results suggest that H2S does not directly stimulate
adenylyl cyclase or soluble guanylyl cyclase activities and increase the cAMP or cGMP levels in
the colonic muscle cells.
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Figure 3A

Figure 3A. Effect of L-cysteine on carbachol-induced contraction in colon muscle strips.
Muscle strips from the circular layer of rabbit colon were allowed to equilibrate to a passive tension
of 2 g for 30 minutes and then treated with carbachol (CCh, 10 µM). The increase in tension (area
under curve) in response to CCh from t=0 minutes to t=2 minutes was calculated as contraction.
In separate experiments, muscle strips were incubated in different concentrations of L-cysteine
(0.1 to 100 mM) for 5 minutes before addition of carbachol. Inhibition of contraction was measured
as the decrease in AUC in the presence of L-cysteine. Values are means ± SEM of 4 experiments.
*p<0.01 and **p<0.001 significant inhibition of CCh-induced contraction of 369 ± 26 gramseconds (AUC) above basal tension.
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Figure 3B

Figure 3B. Effect of NaHS on carbachol-induced contraction in colon muscle strips. Muscle
strips from the circular layer of rabbit colon were allowed to equilibrate to a passive tension of 2
g for 30 minutes and then treated with carbachol (CCh, 10 µM). The increase in tension (area under
curve, AUC) in response to CCh from t=0 minutes to t=2 minutes was calculated as contraction.
In separate experiments, muscle strips were incubated in different concentrations of sodium
hydrosulfide (NaHS, 0.01 to 10 mM) for 5 minutes before addition of carbachol. Inhibition of
contraction was measured as the decrease in AUC in the presence of NaHS. Values are means ±
SEM of 4 experiments. **p<0.001 significant inhibition of CCh-induced contraction 369 ± 26
gram-seconds (AUC) above basal tension.
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Figure 3C

Figure 3C. Inhibitory effect of L-cysteine and NaHS on carbachol-induced contraction in
colon muscle strips. Muscle strips from the circular layer of rabbit colon were allowed to
equilibrate to a passive tension of 2 grams for 30 minutes and then treated with carbachol (CCh,
10 µM). The increase in tension (area under curve) in response to CCh from t=0 minutes to t=2
minutes was calculated as contraction. The muscle strips were then incubated in different
concentrations of L-cysteine or and sodium hydrosulfide (NaHS) for 5 minutes before addition of
carbachol (10 M). Inhibition of contraction was measured as a percent decrease in AUC in the
presence of L-cysteine or NaHS compared to control response. Values are means ± SEM of 4
experiments. *p<0.01 and ** p<0.001 significant inhibition of CCh-induced contraction 369 ± 26
gram-seconds (AUC) above basal tension.

64

Figure 3D

Figure 3D. Effect of L-cysteine and NaHS on carbachol-induced contraction in isolated
muscle cells. Muscle cells isolated from circular muscle layer of rabbit colon were treated with
increasing concentrations of CCh (0.01 nM to 1 µM) for 10 minutes to induce sustained
contraction. In some experiments cells were pretreated with L-cysteine (10 mM) and NaHS (1
mM) for 5 minutes and then treated with CCh for 10 minutes. Muscle cell length was measured
by scanning micrometry. Contraction by CCh was calculated as decrease in muscle length from
control cell length (30 ± 3% decrease in cell length from the basal cell length of 109 ± 5 m).
Values are means ± SEM of 5 experiments.
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Figure 3E

Figure 3E. Concentration-dependent effect of L-cysteine and NaHS on carbachol-induced
contraction in isolated muscle cells. Muscle cells isolated from rabbit colon were treated with
CCh (0.1 µM) for 10 minutes to induce sustained contraction. In some experiments cells were
pretreated with different concentrations of L-cysteine (0.01 mM to 100 mM) and NaHS (0.01 mM
to 100 mM) for 5 minutes and then treated with CCh for 10 minutes. Muscle cell length was
measured by scanning micrometry. Contraction by CCh was calculated as a percent decrease in
muscle length from control cell length (30 ± 3% decrease in cell length from the basal cell length
of 109 ± 5 m). Values are means ± SEM of 7 experiments. *p<0.01 and ** p<0.001, significant
inhibition of CCh-induced contraction.
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Figure 3F

Figure 3F. Effect of glibenclamide on inhibition of contraction by L-cysteine or NaHS in
isolated muscle cells. Muscle cells isolated from circular muscle layer of rabbit colon were treated
with CCh (0.1 µM) for 10 minutes to induce sustained contraction. In some experiments cells were
pretreated with L-cysteine (10 mM) or NaHS (1 mM) in the presence or absence of glibenclamide
(10 µM), a KATP channel blocker, for 5 minutes and then treated with CCh for 10 minutes. Muscle
cell length was measured by scanning micrometry. Contraction by CCh was calculated as a percent
decrease in muscle length from control cell length (32 ± 4% decrease in cell length from the basal
cell length 104 ± 5 m). Values are means ± SEM of 7 experiments. **p< 0.001, significant
inhibition of CCh-induced muscle contraction.
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Figure 3G

Figure 3G. Effect of glibenclamide on inhibition of contraction induced by levcromakalim in
isolated muscle cells of colon. Muscle cells isolated from circular muscle layer of colon were
treated with CCh (0.1 µM) to induce contraction. In some experiments cells were pretreated with
levcromakalim (10 µM), a KATP channel activator, in the presence or absence of glibenclamide (10
µM) for 5 minutes and then treated with CCh. Muscle cell length was measured by scanning
micrometry. Contraction by CCh was calculated as a percent decrease in muscle length from
control cell length (32 ± 4% decrease in cell length from the basal cell length 104 ± 5 m). Values
are means ± SEM of 4 experiments. **p< 0.001, significant reversal of levcromakalim (crmk)
induced inhibition by glibenclamide.

68

Figure 3H

Figure 3H. Effect of myristoylated PKI on inhibition of contraction by L-cysteine and NaHS
in isolated muscle cells. Muscle cells isolated from circular layer of rabbit colon were treated
with CCh (0.1 µM) for 10 minutes to induce sustained contraction. In some experiments cells were
pretreated with L-cysteine (10 mM) or NaHS (1 mM) in the presence or absence of cAMPdependent kinase (PKA) inhibitor, myristoylated PKI (1 µM) for 5 minutes and then treated with
CCh for 10 minutes. Muscle cell length was measured by scanning micrometry. Contraction by
CCh was calculated as a percent decrease in muscle length from control cell length (30 ± 4%
decrease in cell length from the basal cell length 106 ± 5 m). Values are means ± SEM of 7
experiments. ** p< 0.001, significant inhibition of CCh-induced muscle contraction.
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Figure 3I

Figure 3I. Effect of myristoylated PKI on inhibition of contraction by forskolin in isolated
muscle cells. Muscle cells isolated from circular muscle layer of rabbit colon were treated with
CCh (0.1 µM) for 10 minutes to induce sustained contraction. In some experiments cells were
pretreated with forskolin (10 µM), an activator of adenylyl cyclase, in the presence or absence of
myristoylated PKI (1 µM) for 5 minutes and then treated with CCh for 10 minutes. Muscle cell
length was measured by scanning micrometry. Contraction by CCh was calculated as a percent
decrease in muscle length from control cell length (30 ± 4% decrease in cell length from the basal
cell length 106 ± 5 m). Values are means ± SEM of 4 experiments. **p< 0.001, significant
reversal of forskolin (Fsk) induced inhibition by myristoylated PKI.
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Figure 3J

Figure 3J. Effect of Rp-cGMPS on inhibition of contraction by L-cysteine or NaHS in
isolated muscle cells. Muscle cells isolated from circular layer of rabbit colon were treated with
CCh (0.1 µM) for 10 minutes to induce sustained contraction. In some experiments cells were
pretreated with L-cysteine (10 mM) or NaHS (1 mM) in the presence or absence of PKG inhibitor,
Rp cGMPS (1 µM) for 5 minutes and then treated with CCh for 10 minutes. Muscle cell length
was measured by scanning micrometry. Contraction by CCh was calculated as a percent decrease
in muscle length from control cell length (33 ± 4% decrease in cell length from the basal cell length
105 ± 5 m). Values are means ± SEM of 7 experiments. **p< 0.001, significant inhibition of
CCh-induced muscle contraction.
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Figure 3K

Figure 3K.

Effect of Rp-cGMPS on inhibition of contraction by S-nitrosoglutathione

(GSNO) in isolated muscle cells. Muscle cells isolated from circular layer of rabbit colon were
treated with CCh (0.1 µM) for 10 minutes to induce sustained contraction. In some experiments
cells were pretreated with the NO donor, GSNO (10 µM) in the presence or absence of Rp-cGMPS
(1 µM) for 5 minutes and then treated with CCh for 10 minutes. Muscle cell length was measured
by scanning micrometry. Contraction by CCh was calculated as a percent decrease in muscle
length from control cell length (33 ± 4% decrease in cell length from the basal cell length 105 ± 5
m). Values are means ± SEM of 4 experiments. ** p< 0.001, significant reversal of GSNO
induced inhibition by Rp-cGMPs.
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Figure 3L

Figure 3L. Effect of L-cysteine and NaHS on adenylyl cyclase activity in isolated muscle cells.
Muscle cells isolated from rabbit colon were treated with NaHS (1 mM) and L-cysteine (10 mM),
or forskolin (10 µM), an activator of adenylyl cyclase, for 5 minutes in the presence of IBMX (100
µM). Stimulation of adenylyl cyclase activity was measured as an increase in cAMP levels above
basal levels. cAMP levels were measured by radioimmunoassay. Results are expressed as pmol/mg
protein. Values are means ± SEM of 4 experiments. ** p< 0.001, significant stimulation.
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Figure 3M

Figure 3M. Effect of L-cysteine and NaHS on soluble guanylyl cyclase (sGC) activity in
isolated muscle cells. Muscle cells isolated from circular layer of rabbit colon were treated with
NaHS (1 mM), L-cysteine (10 mM), or GSNO (10 µM), a NO donor, for 5 minutes in the presence
of IBMX (100 µM). Stimulation of sGC activity was measured as an increase in cGMP levels
above basal levels. cGMP levels were measured by radioimmunoassay. Results are expressed as
pmol/mg protein. Values are means ± SEM of 4 experiments. ** p< 0.001, significant stimulation.
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3.4 Discussion
Gases like NO and CO have been proven to be transmitters with physiological effects over
the past few decades [60]. The first identified gasotransmitter, NO is known to relax smooth
muscle via activation of sGC and cGMP/PKG pathway [78, 99, 105, 168]. Substances other than
NO, including low-molecular weight S-nitrosothiol intermediates also contribute to relaxation of
smooth muscle [44, 45]. CO, like NO, activates sGC and several types of K+ channels leading to
hyperpolarization and relaxation of smooth muscle [27, 60, 64, 183].
Recent studies have demonstrated a role of H2S in the regulation of smooth muscle tone in
different systems including cardiovascular, urinary and gastrointestinal systems [54, 55, 56, 57].
One of the physiologically significant studies performed with H2S has shown the effect of H2S in
the cardiovascular and arterial system [65]. CSE is expressed abundantly in mammalian
cardiovascular system and respiratory system and is the primary H2S-producing enzyme in these
tissues [65, 66]. Studies from these groups indicate that the EC50 of H2S in inducing vasorelaxation
is quite close to the reported endogenous levels of H2S in plasma, which suggests that under
physiological in vivo conditions, the vascular tone of resistance arteries is likely regulated by
endogenous H2S produced from L-cysteine. CSE-/- mice are hypertensive and exhibit reduced
endothelium-dependent vasorelaxation in mice [66]. These effects are associated with a significant
decrease in H2S generation in these mice, which emphasizes the importance of H2S as a
physiological modulator [66]. The administration of exogenous H2S had profound effects on
reducing blood pressure, whereas inhibition of CSE activity with CSE inhibitor, DL-PPG
increased blood pressure in rats [67].
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H2S produces relaxation in pig bladder neck relaxation via activation of KATP channels and
by smooth muscle intracellular Ca2+ desensitization dependent mechanisms [69]. These studies
utilize the slow-releasing donor of H2S, GYY4137 and report that H2S induces a reduction in
frequency, which was reduced by desensitizing capsaicin sensitive primary afferents with
capsaicin, and the blockade of KATP channels with glibenclamide. Studies by Pataccini et al
however, have demonstrated an excitatory action of H2S on bladder contraction, which was
mediated by capsaicin sensitive nerves [67].
The biological effects of H2S have been studied in the GI tract using either H2S gassaturated solutions, NaHS or CSE activator, L-cysteine. Although, it is well-established that H2S
inhibits GI motility in vivo and both agonist- and electrically-induced contractions in vitro, it is
not known for certain the loci of H2S generation and its direct on smooth muscle. Furthermore, the
effect of NaHS on GI motility appears to be regions- and species-specific. Previous studies have
shown that H2S has an inhibitory effect on spontaneous and agonist-induced conctraction in
different regions of the GI tract of various species. Exposure of isolated intestinal segments from
rabbit, guinea pig and mouse to NaHS showed reduced contraction in response to acetylcholine
[55, 74]. Teague et al reported the relaxant effects of NaHS on spontaneously contracted muscle
tissues isolated from rabbit ileum [56]. They also demonstrate that NaHS could inhibit
acetylcholine-precontracted or electrical field-stimulated muscle tissue isolated from guniea-pig
ileum [56]. In these studies the effect of NaHS was not mediated by activation of KATP channels
as the KATP channel inhibitor glibenclamide had no effect on NaHS-induced decrease in muscle
contraction. Teague et al also showed that inhibition of CSE, but not CBS, caused an increase in
basal contraction in guinea pig ileum suggesting a role for endogenous H2S in the regulation of
muscle contraction [56].
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Studies by Disrutti et al showed that intraperitoneal administration of NaHS or L-cysteine
inhibited contraction in rat colon and the inhibition was reversed by glibenclamide suggesting that
the effect is mediated by activation of KATP channels [44]. Other studies by Gallego et al
demonstrate that the relaxant effects caused by NaHS on spontaneous contractions are not affected
in the presence of neuronal blockers such as tetrodotoxin and capsaicin [70]. These studies were
performed in intestinal segments from mouse jejunum and colon, and muscular strips from the
human and rat colon. The effect of H2S on human colonic muscle was cumulatively inhibited by
glibenclamide and apamin suggesting that the effect is mediated via both KATP and small
conductance (SK) K+ channels. Inhibition of spontaneous contraction after NaHS addition also
suggests a putative action of H2S in K+ channels located in ICC. Gil et al identified CSE
immunoreactivity in smooth muscle cells and enteric neurons of rat colon and showed that
inhibition of CSE augmented spontaneous contractions suggesting that H2S is an endogenous
inhibitory signaling molecule [75]. The effect of L-cysteine is thought to be a result of H2S
generation from smooth muscle as well as neurons and ICCs as the expression of H2S-synthesizing
enzymes is demonstrated in ICCs and enteric neurons as well [73]. Parajuli et al showed that NaHS
inhibited pacemaker activity in mouse small intestine and the effect is mediated probably via
inhibition of intracellular Ca2+ release from ICC as glibenclamide or other potassium channel
blockers (TEA, BaCl2, apamin or 4-aminopydirine) did not have an effect on NaHS-induced action
in ICC, eliminating the role of potassium channels as cellular targets of H2S in ICCs [76]. It is also
possible that H2S might release inhibitory transmitters from enteric neurons. Thus, these previous
studies raise important questions about the role of smooth muscle CSE and mechanism of action
of H2S to mediate inhibition of contraction. Using dispersed muscle cells, devoid of enteric
neurons and ICC, we demonstrate that both L-cysteine and NaHS cause reduction in muscle
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contraction in a concentration-dependent fashion. Our studies suggest show that H2S can inhibit
contraction by acting directly on smooth muscle cells.
The aim of the present study was to determine the effect of endogenously released and
exogenous H2S on CCh-induced contraction in muscle strips and dispersed muscle cells from
rabbit colon. L-cysteine, a common precursor of H2S was used to increase endogenous levels of
H2S via CSE, and NaHS was used as an H2S donor. L-cysteine, a precursor of H2S, was often used
in high concentrations to stimulate H2S synthesis [27, 56, 70, 73]. NaHS dissociates to Na+ and
HS- in aqueous solution and subsequent association of HS- with H+ results in the formation of H2S
[73]. We have used 10 M - 10 mM NaHS in our studies. As 18.5% of NaHS in solution exists
as H2S, the estimated concentration of H2S reflects 1.85 to 1850 M [73]. The concentrations of
NaHS and L-cysteine used in our studies are similar to those used in other studies to induce a
response [27, 56, 71]. These high concentrations reflect local concentrations of a gasotransmitter
near the target site rather than general tissue concentration [57]. The concentration of H2S near the
target site may be greater than the general tissue or serum concentrations because H2S is released
locally. Metabolism of H2S may also be very different near the site of release and the site of
action [57]. The concentrations of both L-cysteine and NaHS did not cause any tissue toxicity,
because the recovery of contractile activity after washout of bath solution was rapid and complete
even after treatment of strips with 10 mM L-cysteine or NaHS.
Our results showed that both L-cysteine and NaHS inhibited CCh-induced contraction in a
concentration-dependent fashion. The effects are significant at micromolar concentrations,
consistent with concentrations that showed physiological effects in other studies [71, 72]. The
results suggest that both exogenous H2S and endogenously synthesized H2S caused a decrease in
muscle contraction in response to contractile agonists. Several studies in vascular muscle showed
that H2S-induced inhibition of contraction is mainly caused by KATP channel openings. Some
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studies in GI tract also showed that the inhibitory effect is mediated through activation of K ATP
channels and hyperpolarization of smooth muscle. This notion is largely based on the ability of
glibenclamide, a KATP channel antagonist, to block the inhibitory effect of H2S. Studies in Our
studies, in contrast, showed that the inhibition of contraction by H2S in colonic smooth muscle
cells is independent of activation of KATP channels as preincubation of cells with glibenclamide
did not affect the ability of L-cysteine or NaHS to inhibit muscle contraction. We also show that,
unlike inhibitory transmitters such as VIP, NO and CO, H2S-induced inhibition of contraction is
independent of cAMP/PKA and cGMP/PKG pathway. This notion was corroborated by direct
measurement of cyclic nucleotides in response to L-cysteine and NaHS and measurement of
functional response in the presence of PKA and PKG inhibitors. Both L-cysteine and NaHS had
no effect on intracellular cAMP and cGMP levels (measured in the presence of IBMX). Inhibition
of contraction in response to both L-cysteine and NaHS was also not affected by PKA and PKG
inhibitors. These studies suggest that H2S can inhibit contraction by a mechanism that is distinct
from cAMP/PKA and cGMP/PKG pathways. Studies by Nagoa et al., [73] also showed that
blockade of nNOS with L-NNA had no effect on inhibition of contraction by NaHS in rat ileum
longitudinal muscle strips.
In summary, our results demonstrate that both endogenous and exogenous H2S inhibit
colonic muscle contraction by directly acting on smooth muscle cells. Unlike vascular smooth
muscle cells, inhibition of contraction is independent of KATP channel activation. Unlike inhibitory
transmitters- NO and VIP, the effect of H2S is independent of cGMP/PKG or cAMP/PKA
pathways. Further studies explore the targets of H2S and mechanism of action involved in the
inhibition of contraction in colonic smooth muscle.
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Chapter 4
INHIBITION OF CONTRACTION BY H2S: MECHANISM OF ACTION
4.1 Mechanisms of Smooth Muscle Contraction
Smooth muscle contraction is mediated by phosphorylation of serine 19 on the 20-kDa
regulatory light chain of myosin II (MLC20) [78]. MLC20 phosphorylation is regulated by a
Ca2+/calmodulin-dependent MLCK, which initiates phosphorylation of MLC20; and MLCP, which
dephosphorylates MLC20 [78]. Excitatory neurotransmitters such as acetylcholine initiate
contraction by increasing [Ca2+]i, and activating MLCK. The initial increase in [Ca2+]i and MLCK
activity are transient. MLC20 phosphorylation and muscle contraction, however, are sustained and
mediated via inhibition of MLCP which dephosphorylates MLC20. Inhibition of MLCP activity is
initiated by dual RhoA-dependent pathways: one involves phosphorylation of myosin phosphatase
target subunit 1 (MYPT1), the regulatory subunit of MLCP by Rho kinase and the other involves
phosphorylation of the endogenous MLCP inhibitor CPI-17 by protein kinase C (PKC) [77].
Smooth muscle contraction is biphasic: a transient initial phase that is dependent on the
Ca2+/calmodulin-dependent activation of MLCK and a sustained phase that is dependent on the
inhibition of MLCP activity via RhoA-dependent pathways.
4.1.1 The RhoA/Rho kinase Pathway
The RhoA/Rho kinase signaling pathway regulates muscle contraction by suppression of
MLCP activity leading to increase in MLC20 phosphorylation. RhoA is a small G protein with
inherent GTPase activity and functions as a molecular switch, cycling between an inactive GDPbound state and an active GTP-bound state. The activity of the Rho GTPases is determined by the
ratio of their GTP/GDP-bound forms in the cell [79]. The ratio of the two forms is regulated by
the opposing effects of guanine nucleotide exchange factors (GEFs), which enhance the exchange
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of bound GDP for GTP leading to activation of RhoA. Inactivation of RhoA is mediated by the
GTPase-activating proteins (GAPs), which increase the intrinsic rate of hydrolysis of bound GTP.
The signaling pathways that lead to inhibition of MLCP activity are mediated by G q/13-coupled
muscarinic m3 receptors. Binding of contractile agonist, acetylcholine leads to sequential
activation of Gαq/α13, RhoGEF, and RhoA [80, 81, 82, 83, 84, 85]. Activated RhoA (RhoA.GTP)
binds to the Rho-binding domain of Rho kinase, causing the enzyme to unfold and freeing its
catalytic activity [131, 169].
Myosin light chain phosphatase (MLCP) is a heterotrimer with a 110- to 130-kDa
regulatory subunit [myosin phosphatase target subunit 1 (MYPT1), a 37-kDa catalytic subunit of
type 1 phosphatase (PP1cδ), and a 20-kDa subunit of unknown function [82]. Rho kinase
phosphorylates the regulatory subunit of MYPT1 at Thr696 and fosters dissociation of MYPT1
from its catalytic subunit causing inhibition of catalytic activity. Inhibition of MLCP activity
prevents dephosphorylation of MLC20, thus maintaining muscle contraction.
4.1.2 Inhibition of Smooth Muscle Contraction
Inhibitory neurotransmitters such as VIP and NO induce relaxation through generation of
cAMP and cGMP and activation of cAMP-dependent protein kinase (PKA) or cGMP-dependent
protein kinase (PKG) [52, 53]. Inactivation of specific targets in the signaling pathways mediating
contraction due to phosphorylation by PKA or PKG leads to inhibition of muscle contraction [41,
78, 52, 53, 97, 98]. Unlike NO, H2S causes relaxation by direct post-translational modification of
proteins. S-sulfhydration provides a possible mechanism by which H2S alters the function of
several proteins and this process appears analogous to S-nitrosylation of proteins by NO [61, 93,
94]. In this process, a hydropersulfide (-SSH) moiety is generated by the addition of sulfur from
H2S to the –SH groups of cysteine residues and this results in altered chemical and biological
reactivity of proteins including β-tubulin, actin, glyceraldehyde 3-phosphate dehydrogenase and
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KATP channels [87, 88]. Snyder and colleagues have shown a hypertensive phenotype and loss of
protein sulfhydration in CSE-/- mice compared to proteins in control mice [66]. These studies
emphasize the physiological relevance of H2S-induced S-sulfhydration in causing vasodilation of
blood vessels.
The role of H2S as an endogenous inhibitory signaling molecule of GI motility was
demonstrated using innervated muscle strips and whole organ [56, 86, 92, 95]. These studies show
that H2S can cause either contraction or relaxation and the actions of H2S might be nerve mediated
or direct effect on smooth muscle [56, 92, 95]. The mechanism of action of H2S to inhibit
contraction also varies with species and regions of GI tract. Thus, both KATP channel-dependent
and -independent inhibition of contraction by H2S was reported [56, 70, 92, 148].
Rationale. Our studies so far have identified both mRNA and protein expression of CSE,
but not CBS, in colonic smooth muscle (Chapter 2, Figure 2A and 2C). We also showed that
endogenous H2S, generated via CSE and exogenous H2S inhibits CCh-induced sustained
contraction in isolated muscle cells. The inhibitory effect was not affected by blockers of KATP
channel, and PKA or PKG activities suggesting that the effect is independent of KATP channels, a
known target of H2S, and cAMP/PKA and cGMP/PKG pathways (Chapter 3). These studies lead
to hypothesize that inhibition of contraction by H2S is mediated via inhibition of RhoA/Rho kinase
pathway that regulates contraction.
Studies in this chapter are focused on understanding the mechanism of action of H2S in
dispersed muscle cells of the rabbit colon. We demonstrate that in colonic smooth muscle cells,
H2S causes S-sulfhydration of RhoA and inhibition of RhoA and Rho kinase activity, a key enzyme
in the regulation of MLCP activity and sustained smooth muscle contraction.
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4.2 Materials and Methods
4.2.1 Reagents
Chemicals for the preparation of Kreb’s solution: NaCl, KCl, KH2PO4, MgSO4. CaCl2,
NaHCO3, and glucose, reagents for HENS buffer (250 mM Hepes, pH 7.5, 1 mM EDTA,
0.1mMneocuproine,and 0.1%SDS): HEPES, NaOH, EDTA, neocuproine, deferoxamine salt,
chemicals: Carbachol, L-cysteine and sodium hydrosulfide (NaHS), DL-propargylglycine (DLPPG) were all obtained from Sigma-Aldrich (St. Louis, MO). Lipofectamine 2000 transfection
reagent was obtained from Invitrogen (Carlsbad, CA). RhoA activation assay kit was obtained
from NewEast Biosciences (Malvern, PA). Methyl methanethiosulfonate (MMTS) and EZ-Link
Biotin-HPDP was obtained from Pierce Biotechnology (Waltham, MA), Thermo Fisher Scientific,
(Rockford, IL). Antibodies for Rho kinase, Rock-2 were obtained from Santa Cruz Biotechnology
(Dallas, TX). CSE small interfering RNA (siRNA) was obtained from Ambion Life technologies
(Frederick, MD). [32P]ATP was obtained from Perkin Elmer Life sciences (Cambridge, MA).
4.2.2 Preparation of Dispersed Smooth Muscle Cells
Smooth muscle cells were isolated from the circular muscle layer of the colon of rabbit by
sequential enzymatic digestion, filtration, and centrifugation, as previously described [40, 41, 42].
Briefly, smooth muscle strips were incubated for 30 minutes at 31C in 15 ml of medium
containing 120 mM NaCl, 4 mM KCl, 2.6 mM KH2PO4, 0.6 mM MgCl2, 25 mM HEPES, 14 mM
glucose, 2.1% (v/v) Eagle’s essential amino acid mixture, 0.1% collagenase (type II), and 0.1%
soybean trypsin inhibitor. Partly digested tissues were washed with 50 ml of enzyme-free medium
and muscle cells were allowed to disperse spontaneously. The cells were harvested by filtration
through 500 m Nitex and centrifuged twice at 350 g for 10 minutes. Dispersed smooth muscle
cells were cultured in Dulbecco’s modified Eagles’s medium containing 10% fetal bovine serum
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until they attained confluence and were then passaged and used for Rho kinase activity and
transfection studies.
4.2.3 Transfection of CSE siRNA into Cultured Smooth Muscle Cells
CSE siRNA was transiently transfected into smooth muscle cultures for 48 hours. Control
cells were cotransfected with scrambled siRNA for 48 hours. The level of CSE protein expression
was evaluated by western blot to monitor efficiency of CSE siRNA.
4.2.4 Assay for RhoA GTPase Activation
RhoA activation was evaluated in pull-down assays using specific anti-RhoA-GTP
antibody and protein A/G beads. In brief, cultured cells were treated with carbachol (1 M), Lcysteine (10 mM) and NaHS (1 mM). In some cases, the cells were preincubated with CSE
inhibitor, DL-PPG (1 mM) for 5 minutes before stimulation with CCh and/or L-cysteine and
NaHS. After stimulation, cell lysates were collected, and GTP-bound RhoA was captured using
pull-down assays with specific monoclonal antibody (NewEast Biosciences, Malvern, PA) that
specifically recognizes RhoA-GTP, anti-RhoA-GTP antibody. RhoA-GTP bound antibody are
pulled down by protein A/G, washed with lysis buffer and processed for separation by SDS-PAGE.
The level of activated RhoA was evaluated by Western blot analysis.
4.2.5 Biotin Switch Assay to detect S-sulfhydration
The assay was carried out as described previously [88] with modification. HEK293 cells
transfected with RhoA cloned pcDNA 3 vector were homogenized in HEN buffer (250 mM
HEPES-NaOH [pH, 7.7], 1 mM EDTA, 2.5% SDS, and 0.1 mM neocuproine) supplemented with
100 μM deferoxamine. Protein samples (250 μg) were then treated in the presence or absence of
NaHS (1 mM). The treated samples were added to blocking buffer (HEN buffer adjusted to 2.5%
SDS and 20 mM methylmethane thiosulfonate, (MMTS) at 50°C for 20 minutes with frequent
vortexing. After acetone precipitation, the proteins were resuspended in HENS buffer (adjusted to
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1% SDS). A total of 4 mM biotin-HPDP (N-[6-(biotinamido) hexyl]-3′-(2′-pyridyldithio)propionamide) in dimethyl formamide was added to the suspension. After 3-hour incubation at
37°C, biotinylated proteins were precipitated by streptavidin-agarose beads, which were then
washed with HENS buffer. The biotinylated proteins were eluted by SDS-PAGE sample buffer
and subjected to Western blot analysis. Polyclonal RhoA antibody was used at 1:1000 dilution.
4.2.6 Assay for Rho kinase Activity
Rho kinase activity was determined in cell extracts by immunokinase assay as previously
described [60]. Freshly dispersed colonic smooth muscle cells were treated with carbachol (1 µM)
in the presence or absence of different concentrations of NaHS or L-cysteine for 5 minutes and
solubilized in lysis buffer containing 50 mM Tris HCl (pH 7.5), 0.1% SDS, 0.5% sodium
deoxycholate, 1% Nonidet P-40, 150 mM NaCl, 1 mM phenylmethylsulfonylfluoride (PMSF), 10
μg/ml aprotinin, 10 μg/ml pepstatin A, and 10 μg/ml leupeptin. Equal amounts of protein extracts
were incubated with Rock-2 antibody (sc-5561) plus protein A/G agarose overnight at 4°C.
Immunoprecipitates were washed twice with a phosphorylation buffer containing 10 mM
MgCl2 and 40 mM HEPES (pH 7.4) and then incubated for 5 minutes on ice with myelin basic
protein (1 mg/ml) as a substrate for Rho kinase activity. The kinase reaction was initiated by the
addition of 10 μCi of [32P]ATP (3,000 Ci/mmol) and 20 μM ATP, followed by an incubation for
10 minutes at 37°C. 32P-labeled myelin basic protein was absorbed onto phosphocellulose disks,
and repeated washings with 75 mM phosphoric acid removed free radioactivity. The extent of
phosphorylation was determined from the radioactivity on phosphocellulose discs by liquid
scintillation.
4.2.7 Measurement of Contraction by Scanning Micrometry
Cell lengths were measured by image scanning micrometry technique [52, 53, 77, 78, 113,
114, 170]. All cell suspensions were used within 1 hour after dispersion for cell length
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measurements. Freshly isolated muscle cells (0.4 ml containing 104/cell ml) from circular muscle
layer of colon were preincubated for 5 minutes with different concentrations of L-cysteine or
NaHS, and then CCh was added for 10 minutes. In some experiments cells were preincubated for
5 minutes with CSE inhibitor, DL-PPG (1 mM) before addition of L-cysteine or NaHS. The
reaction was terminated with 1% acrolein. After termination, an aliquot of cell suspension was
placed on a slide under a coverslip. The slide was scanned at ×100 magnification, and the length
of first 50 cells randomly encountered was measured using a micrometer. The resting cell length
was determined in control experiments in which muscle cells were incubated with 100 μl of 0.1%
bovine serum albumin in the absence of CCh. Contraction is expressed as the absolute decrease in
mean cell length (m) from control cell length in the presence of contractile agonist.
4.2.6 Data analysis
The results were expressed as means ± S.E of n experiments and analyzed for statistical
significance using Student t-test for paired and unpaired values. Each experiment was performed
on cells and tissues obtained from different animals. Difference of responses among different
groups were tested and confirmed for significance using Fisher’s protected least significance
difference test. The results were analyzed using GraphPad software (San Diego, CA). A
probability of p< 0.05 was considered significance.

4.3 Results
4.3.1 Sustained Muscle Contraction is mediated via RhoA/Rho kinase Pathway
Previous studies in GI smooth muscle have shown that sustained MLC20 phosphorylation
and contraction in response to contractile agonists was blocked in the presence of an inhibitor of
Rho kinase (Y27632) suggesting that sustained contraction was mediated by activation of
RhoA/Rho kinase pathway [77]. As shown in Figure 4A, sustained contraction induced by CCh
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(31 ± 3% decrease in cell length) in colonic smooth muscle was blocked in the presence of Y27632
(1 µM) (4 ± 4% decrease in cell length) raising the possibility that the inhibition of contraction by
H2S could be due to inhibition of RhoA/Rho kinase activity. This notion was examined the
studying the effect of L-cysteine and NaHS on CCh-induced stimulation of RhoA and Rho kinase
activity in the dispersed and cultured muscle cells.
4.3.2 Inhibition of CCh-induced RhoA Activity by H2S
RhoA is small G protein that is bound to GDP in the basal state and GTP in the activated
state. Treatment of muscle cells for 10 minutes with CCh (1 μM) caused an increase in the RhoA
activity; increase in RhoA activity was measured as increase in the incorporation of GTP into
RhoA using antibody that specifically recognizes RhoA-GTP (Figure 4A). Pre-incubation of cells
with L-cysteine (10 mM) or NaHS (1 mM) caused inhibition of CCh-induced RhoA activity
(Figure 4B). These results suggest that endogenous and exogenous H2S inhibits CCh-induced
RhoA activity in colonic muscle cells. The notion that the effect of L-cysteine is due to activation
of CSE was examined using a selective inhibitor of CSE, DL-PPG. Incubation of cells with DLPPG (1 mM) in the presence of L-cysteine reversed the inhibitory effect of L-cysteine on CChinduced RhoA activity (Figure 4B). These results suggest that the effect of L-cysteine is mediated
via activation of CSE and generation of H2S.
4.3.3 S-Sulfhydration of RhoA by H2S
S-sulfhydration is known primary mechanism through which H2S signals. Previous studies
have shown that H2S alters the function of KATP channels via S-sulfhydration. Therefore, we
examined if H2S alters the activity of RhoA via S-sulfhydration. S-sulfhydration of RhoA in
response to 1 mM NaHS was analyzed using a biotin switch assay. As shown in Figure 4C, there
was no basal sulfhydration of RhoA in control samples. Treatment of cells with NaHS, however,
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caused sulfhydration of RhoA (Figure 4C). These results suggest that inhibition of RhoA activity
by H2S could be due to S-sulfhydration of RhoA.
4.3.4 Inhibition of Rho kinase Activity by H2S
Contractile agonists induce an increase in Rho kinase activity in smooth muscle via
activation of RhoA [77]. Consistent with the previous studies [77], treatment of colonic smooth
muscle cells with CCh for 10 minutes caused a significant increase in Rho kinase activity in a
concentration-dependent fashion with an EC50 of 5 nM. In the presence of L-cysteine (10 mM) or
NaHS (1 mM), the concentration-dependent curve in response to CCh was shifted to the right with
EC50 values of 25 nM and 98 nM, respectively, suggesting that the inhibition of Rho kinase activity
by H2S (Figure 4D).
The inhibitory effect of L-cysteine and NaHS on CCh-induced Rho kinase activity was
concentration-dependent. Preincubation of cells with increasing concentrations of L-cysteine or
NaHS caused inhibition of CCh-induced Rho kinase activity in a concentration-dependent manner
(Figure 4E). The EC50 was 56 ± 12 μM for NaHS and 105 ± 24 μM for L-cysteine. Maximal
inhibition of 89 ± 9% and 73 ± 7% was obtained with NaHS (10 mM) and L-cysteine (10 mM),
respectively (Figure 4E). L-cysteine and NaHS at concentrations <1 μM had no effect on CChinduced Rho kinase activity. These results suggest that endogenous and exogenous H2S inhibits
CCh-induced Rho kinase activity in colonic muscle cells. The notion that the effect of L-cysteine
is due to activation of CSE was examined by using CSE siRNA and a selective inhibitor of CSE,
DL-PPG in dispersed muscle cells.
4.3.5 Inhibition of Rho kinase Activity by L-cysteine is mediated via CSE/H2S
The involvement of endogenous H2S generation in the inhibition of Rho kinase by Lcysteine was examined by two approaches: i) by transfection of cultured muscle cells with CSE
specific siRNA, and ii) by treatment of dispersed muscle cells with a selective CSE inhibitor, DL88

PPG. CCh induced a significant increase in Rho kinase activity in cultured muscle cells. (28,819
± 2,312 cpm/mg protein; p < 0.001; n = 5) that is similar to the increase in dispersed muscle cells.
Addition of L-cysteine (10 mM) caused significant inhibition of CCh-stimulated Rho kinase
activity (63 ± 8% inhibition) in cells transfected with control siRNA. The inhibitory effect of Lcysteine was blocked in cells transfected with CSE-specific siRNA (7 ± 1% inhibition, NS) (Figure
4F) suggesting that the effect of L-cysteine was mediated via activation of CSE. Addition of NaHS
(1 mM) also caused a significant inhibition of CCh-stimulated Rho kinase activity in cells
transfected with control siRNA (66 ± 7% inhibition). The inhibitory effect of NaHS, however, was
not affected in cells transfected with CSE-specific siRNA (60 ± 7% inhibition).
Similar studies were performed using CSE inhibitor, DL-PPG (1 mM) in the presence of
both L-cysteine and NaHS in dispersed muscle cells. Addition of L-cysteine (10 mM) caused
significant inhibition of CCh-stimulated Rho kinase activity (53 ± 7% inhibition). The inhibitory
effect of L-cysteine was blocked in the presence of DL-PPG (1 mM) (11 ± 5% inhibition, NS)
(Figure 4G). Addition of NaHS (1 mM) also caused a significant inhibition of CCh-stimulated Rho
kinase activity in control cells (64 ± 8% inhibition). The inhibitory effect of NaHS, however, was
not affected in the presence of DL-PPG (65 ± 3% inhibition). These results provide evidence for
the involvement of CSE, via generation of H2S, in the inhibition of Rho kinase activity by Lcysteine.
4.3.6 Inhibition of Muscle Contraction by L-cysteine is mediated via CSE/ H2S
Consistent with the reversal of L-cysteine-induced inhibition of Rho kinase activity in the
presence of DL-PPG, treatment of cells in the presence of DL-PPG (1 mM) also blocked the
inhibitory effect of L-cysteine on CCh-induced sustained contraction in freshly dispersed muscle
cells (Figure 4H). Treatment of cells with L-cysteine (10 mM) caused significant inhibition (59 ±
3% inhibition) of CCh-induced sustained contraction. The inhibitory effect of L-cysteine was
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attenuated (15 ± 8% inhibition) in the presence of DL-PPG (1 mM). In contrast, inhibition of
sustained contraction by NaHS was not affected by DL-PPG (59 ± 3% inhibition versus 60 ± 9%
inhibition with DL-PPG). These results suggest that inhibition of muscle contraction by L-cysteine
was mediated by the activation of CSE and generation of H2S.

90

Figure 4A

Figure 4A. Effect of Rho kinase inhibitor (Y27632) on CCh-induced sustained contraction.
Muscle cells isolated from colon were treated with CCh (0.1 µM) in the presence or absence of the
Rho kinase inhibitor Y27632 (1 µM) for 10 minutes to induce sustained contraction. Muscle cell
length was measured by scanning micrometry. Contraction by CCh was calculated as a percent
decrease in muscle length from control cell length (31 ± 3% decrease in cell length from the basal
cell length 101 ± 6 m). Values are means ± SE of 4 experiments. ** p< 0.01, significant inhibition
of CCh-induced muscle contraction by Y27632, a specific Rho kinase inhibitor.
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Figure 4B

Figure 4B. Effect of L-Cysteine and NaHS on CCh-induced RhoA activity. Muscle cells
isolated from circular layer of rabbit colon were treated with CCh (0.1 µM) in the presence or
absence of the L-cysteine (10 mM) and NaHS (1 mM) for 10 minutes. In some experiments cells
were treated with L-cysteine or NaHS in the presence of DL-PPG (1 mM). RhoA activity in
response to CCh was measured by incorporation of GTP into RhoA by western blot using an
antibody that is specific for RhoA.GTP. Figure depicts representative blot of 3 separate
experiments.
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Figure 4C

Figure 4C. S-Sulfhydration of RhoA by NaHS. Lysates obtained from HEK cells were treated
in the presence or absence of NaHS (1 mM) for 16 min and blocked with methyl
methanethiosulfonate (MMTS). H2S modified –SSH residues are labelled with N-[6-(biotinamido)
hexyl]-3′-(2′-pyridyldithio)-propionamide (HPDP-biotin) and biotinylated proteins were pulled
down and analyzed by western blot. Western blot analysis showed the difference in the
sulfhydration levels in the control and NaHS (1 mM) treated samples. Total RhoA present in the
samples was shown as a loading control. Figure depicts representative blot of 3 separate
experiments.
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Figure 4D

Figure 4D. Effect of L-cysteine and NaHS on carbachol-stimulated Rho kinase activity in
dispersed muscle cells. Muscle cells isolated from rabbit colon were treated with different
concentrations of CCh for 10 minutes. In some experiments cells were pretreated with L-cysteine
(10 mM) or NaHS (1 mM) for 5 minutes and then treated with CCh for 10 minutes. Rho kinase
activity was measured by immunokinase assay using [32P]ATP. Results are expressed as cpm/mg
protein. Values are means ± SE of 4-6 experiments.
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Figure 4E

Figure 4E. Concentration-dependent effect of L-cysteine and NaHS on carbachol-stimulated
Rho kinase activity in smooth muscle cells. Muscle cells isolated from rabbit colon were treated
with CCh for 10 min. In some experiments cells were pretreated with different concentrations of
L-cysteine (0.01 mM to 100 mM) or NaHS (0.01 mM to 100 mM) for 5 minutes and then treated
with CCh (1 M) for 10 minutes. Rho kinase activity was measured by immunokinase assay using
[32P]ATP. Results are expressed as a percent inhibition of CCh-induced Rho kinase activity.
Values are means ± SE of 4-6 experiments. **p<0.001 significant inhibition of CCh-stimulated
Rho kinase activity.
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Figure 4F

Figure 4F. Effect of CSE siRNA on L-cysteine-induced inhibition of Rho kinase activity.
Cultured rabbit colonic muscle cells were transfected with control siRNA or CSE-specific siRNA
for 48 hours. Cells were treated with CCh (1 µM) for 10 minutes in the presence or absence of Lcysteine (10 mM) or NaHS (1 mM). Rho kinase activity was measured by immunokinase assay
using [32P]ATP. Results are expressed as cpm/mg protein. (B:basal) Values are means ± SE of 46 experiments. **p<0.001, significant inhibition of CCh-stimulated Rho kinase activity.
Expression of CSE in cells transfected with control siRNA or CSE siRNA was analyzed by western
blot (inset).

96

Figure 4G

Figure 4G. Effect of CSE inhibitor, DL-propargylglycine (DL-PPG) on L-cysteine-induced
inhibition of Rho kinase activity. Dispersed muscle cells from rabbit colon were treated with
CCh (1 µM) for 10 minutes in the presence or absence of L-cysteine (10 mM) or NaHS (1 mM).
In some experiments, cells were treated with L-cysteine (10 mM) or NaHS (1 mM) in the presence
of CSE inhibitor, DL-PPG (1 mM). Rho kinase activity was measured by immunokinase assay
using [32P]ATP. Results are expressed as cpm/mg protein. (B:basal) Values are means ± SE of 46 experiments. **p< 0.001, significant inhibition of CCh-stimulated Rho kinase activity.
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Figure 4H

Figure 4H. Effect of CSE inhibitor, DL-propargylglycine (DL-PPG) on L-cysteine-induced
inhibition of sustained contraction. Muscle cells isolated from colon were treated with CCh (1
µM) for 10 minutes in the presence or absence of L-cysteine (10 mM) or NaHS (1 mM). In some
experiments, cells were treated with L-cysteine (10 mM) or NaHS (1 mM) in the presence of CSE
inhibitor DL-PPG (1 mM). Muscle cell length was measured by scanning micrometry. Contraction
in response to CCh was calculated as a percent decrease in muscle length from control cell length
(32 ± 4% decrease in cell length from the basal cell length 109 ± 6 m). Values are means ± SE
of 4 experiments. **p< 0.01, significant inhibition of CCh-induced muscle contraction.
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4.4 Discussion
H2S may directly inhibit the contraction in a variety of smooth muscle such as bladder,
vascular, and in gastrointestinal smooth muscle strips [56, 59, 69]. In isolated guinea pig detrusor
smooth muscle, a slow release H2S donor, GYY4137, increased ACh release from bladder nerves,
and significantly increased the spontaneous phasic and nerve-evoked muscle contractions [165].
The blockade of neuronal voltage-gated Na+ channels with tetradotoxin or muscarinic ACh
receptors with atropine, reduced the stimulatory effect of GYY4137. In isolated detrusor smooth
muscle cells, GYY4137 decreased the amplitude and frequency of transient BK currents and
hyperpolarization suggesting that H2S increases spontaneous phasic and nerve-evoked muscle
contractions by inducing ACh release from bladder nerves as well as direct inhibition of smooth
muscle BK channels [165]. In gastric smooth muscle, Liu et al have reported that KV4.3 subunit is
the possible target of exogenous H2S to enhance the tension. They showed that low concentrations
of NaHS (100 µM) H2S increases basal tension via inhibition of KV4.3 current and membrane
potential [92]. However, a high concentration (0.3 to 1 mM) of NaHS suppressed the amplitude of
spontaneous contraction of guinea pig gastric muscle via activation of KATP channels [92].
In the ileum of both rabbits and guinea pigs, H2S induces dose-related inhibition of
spontaneous contraction, but the underlying mechanism appears to be different in the two species
[56]. In human, rat and mouse colon and jejunum tissues, H2S was shown to inhibit spontaneous
contraction, and this effect was blocked by a small-conductance Ca2+-dependent potassium
channel (SK channel) inhibitor [70]. In rat colon, exogenous NaHS hyperpolarizes the resting
membrane potential of smooth muscle cells [149]. Gallego et al., [70] showed that in isolated
segments of mouse colon and jejunum, NaHS caused inhibition of spontaneous contractions;
inhibitory effect was unaffected by tetrodotoxin (TTX), capsaicin, and N-nitro-L-arginine
suggesting a non-neural effect, but significantly reduced by apamin. NaHS also inhibits
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spontaneous motility in strips from human and rat colon and the inhibitory effect of NaHS on
colonic strips was unaffected by the neural blocker TTX, but significantly reduced by
glibenclamide (KATP channel blocker), apamin (selective calcium activated SK-channel blocker)
and TEA (non-selective potassium channel blocker) [70]. This effect appears to be critically
dependent on K+ channels particularly apamin-sensitive SK channels and glibenclamide-sensitive
KATP channels. These studies conclude that H2S strongly inhibits in vitro intestinal and colonic
motor patterns [70]. The effect of H2S in human and rodent smooth muscle is direct via the
activation of K+ channels possibly located in smooth muscle. Inhibition of spontaneous contraction
after NaHS addition also suggests a putative action of H2S in K+ channels located in ICC. In
permeabilized smooth muscle of guinea pig taenia coli, the inhibitory effect of H2S was associated
with the reactive oxygen species and mitochondria, but not with the contractile pathway [148].
These results suggest that the effect of H2S and the mechanism of action vary with smooth muscle
from different regions and from different species. The use of innervated muscle strips in GI studies
limits the interpretation about the precise site of H2S synthesis and its mechanism of action in
mediating inhibition of contraction.
Our studies using dispersed muscle cells demonstrated that L-cysteine and NaHS have a
direct effect on smooth muscle. Both L-cysteine and NaHS inhibited muscle contraction in
response to CCh. In contrast to studies in the vascular smooth muscle [59] and intestinal muscle
strips [70], the inhibitory effect of L-cysteine and NaHS in colonic smooth muscle was
independent of KATP channels (Chapter 3, Figure 3F). Studies using inhibitors of PKA and PKG
also suggested that the inhibitory effect was independent of cyclic nucleotide generation (Chapter
3, Figure 3H, 3J).
Our studies in this chapter provide evidence for the mechanism of action of H2S in the
regulation of contraction in colonic smooth muscle. Our results demonstrate that the inhibition of
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sustained contraction by H2S is mediated via suppression of RhoA/Rho kinase pathway. We show
that both endogenous and exogenous H2S inhibit muscle contraction, and the mechanism involves
S-sulfhydration of RhoA and inhibition of RhoA and Rho kinase activity. The evidence was based
on: 1) NaHS, a donor of H2S, caused S-sulfhydration of RhoA; 2) L-cysteine, an activator of CSE,
and NaHS inhibited CCh-induced RhoA and Rho kinase activities and muscle contraction; 3) the
inhibitory effect of L-cysteine, but not NaHS, was mediated via activation of CSE as the effect of
L-cysteine on RhoA and Rho kinase activities and sustained contraction were blocked upon
inhibition of its activity by DL-propargylglycine (DL-PPG) suggesting that the effect of L-cysteine
is mediated via activation of CSE. The involvement of CSE activation with L-cysteine was further
corroborated in studies using CSE siRNA. Thus, the evidence for the activation of CSE in
mediating the effect of L-cysteine was based on the use of DL-PPG in dispersed muscle cells and
CSE siRNA in cultured muscle cells.
Our studies also suggest that inhibition of RhoA activity could be due to S-sulfhydration
of RhoA. H2S-mediated change in the activity of signaling proteins was shown to be due to post
translational modifications induced by H2S [87, 92, 88]. The most important modification is the
reaction of H2S with protein thiol (-SH) groups to form persulfides (-SSH), defined as protein Ssulfhydration. S-sulfhydration of several proteins including receptors, ion channels and enzymes
have been described in previous studies [88, 91, 92]. Initially, it was suggested that S-sulfhydration
always results in the increase of protein activity; however, inhibitory effect of sulfhydration was
also demonstrated [91]. Previous studies in gastric muscle strips demonstrate a regulation of
MLCP activity by H2S [86]. NaHS induced concentration-dependent inhibition of contraction in
pre-contracted mouse gastric fundus strips. MLCP inhibitor, calyculin-A (1 µM) reduced the
NaHS-induced relaxations in these studies suggesting regulation of MLCP activity by H2S [86],
however, the precise mechanism of MLCP regulation has not been identified. In the GI smooth
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muscle, activation of RhoA/Rho kinase pathway inhibits MLCP activity that dephosphorylates
MLC20 leading to increase in MLC20 phosphorylation and muscle contraction. Inhibition of
RhoA/Rho kinase pathway by H2S disinhibits the inhibitory pathway leading to augmentation of
MLC20 dephosphorylation and suppression of muscle contraction.
In summary, our studies in this chapter demonstrate that the inhibition of CCh-induced
contraction by H2S is mediated via S-sulfhydration of RhoA and inhibition of RhoA/Rho kinase
activity, a key pathway to inhibit MLCP activity and to maintain MLC20 phosphorylation and
muscle contraction.
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Chapter 5
AUGMENTATION OF RELAXATION BY H2S: MECHANISM OF ACTION
5.1 Introduction
Smooth muscle relaxation occurs either as a termination of contractile stimulus that target
receptors, G proteins and ion channels or by exposure to relaxant neurotransmitters which
stimulates inhibition of the contractile mechanism. In either case, the process of relaxation requires
a decreased intracellular Ca2+ concentration and increased MLCP activity. The relaxant
mechanisms converge to dephosphorylate MLC20 and thus inhibit signaling pathways that mediate
initial or sustained MLC20 phosphorylation and contraction [78].
Relaxation of smooth muscle in the gut is initiated by the release of NO from neuronal NO
synthase (nNOS) and the peptide neurotransmitters VIP and its homologue, PACAP from the
nerve terminals [78, 99, 100, 101, 102]. VIP interacts with VPAC2 receptors on the smooth muscle
to stimulate adenylyl cyclase activity and cAMP formation [39]. NO diffuses through the smooth
muscle cells and stimulates soluble guanylyl cyclase (sGC) activity and cGMP formation. cAMP
and cGMP along with associated kinases, PKA and PKG initiate relaxant signaling pathways
leading to a decrease in intracellular Ca2+ and/or increase in MLCP activity.
5.1.1 The NO/cGMP/PKG Pathway
NO as the “first signaling messenger” in the NO/cGMP/PKG signaling pathway initiates a
cascade of reactions in which the magnitude of each step is enzymatically amplified. Signaling by
NO is primarily mediated by cGMP, which is synthesized by NO-activated soluble guanylyl
cyclase (sGC) [103]. Activation of sGC increases conversion of GTP to cGMP, resulting in
elevation of cGMP, which initiates the cGMP-signaling pathway and subsequent muscle relaxation
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[104, 105]. Intracellular cGMP levels are largely regulated by cGMP-hydrolyzing
phosphodiesterase enzymes (PDEs) that break down cGMP.
PDEs are a large group of structurally related enzymes that catalyze the hydrolysis of 3’,5’cyclic nucleotides to the corresponding inactive nucleoside 5’-monophosphates. cGMP-specific
PDEs such as PDE5, PDE6, and PDE9, which have much higher affinity for cGMP than for cAMP.
PDE5 is the predominant cGMP-specific PDE expressed in smooth muscle [106, 107]. PKGdependent phosphorylation of PDE5 enhances its activity, thereby attenuating the levels of cGMP
[108]. cGMP binds to an allosteric site in PDE5 and activates PDE5 catalytic function; this binding
is also essential for regulatory phosphorylation of PDE5 by PKG [108].
5.1.2 Effect of H2S on PDE5 Activity
Cross-talk between NO/sGC/cGMP pathway and H2S has been previously reported with
conflicting results. Although, H2S-induced relaxation of rat aorta vascular muscle independent of
endothelium, blockade of eNOS or denudation of endothelium attenuated H2S-induced relaxation
suggesting NO-dependent regulation of H2S activity. Both expression and activity of eNOS were
decreased upon chronic inhibition of eNOS. Other studies report negative feedback regulations
between NO and H2S. On one hand, NO production by H2S is inhibited [163]. On the other hand,
H2S can act as a scavenger of NO, by spontaneous chemical reactions leading to formation of an
unidentified nitrosothiol [164].
The regulation of intracellular cGMP is a further key factor accounting for a positive
interaction between H2S and NO. A number of studies used a functional approach to test the
contribution of cGMP to the relaxing effects of H2S. Endogenous H2S has been reported to be
essential for NO-mediated increase of cGMP, since CSE silencing abolishes the NO-induced
cGMP accumulation [94]. Exposure of rat aortic smooth muscle cells to different concentrations
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of NaHS leads to an increase in cGMP levels [110]. These studies suggest that H2S amplifies NO
signaling by inhibiting cGMP-specific PDE5 [110].
Rationale. Release of NO from nNOS of enteric neurons and activation of NO/sGC/PKG
pathway in smooth muscle is a physiological norm during descending relaxation phase of
peristalsis. H2S was shown to induce descending relaxation and inhibit colonic motility [171].
Since NO and H2S use distinct mechanisms to regulate smooth muscle function, it is possible that
there could a synergistic or antagonist interaction between the mechanisms activated. Hence,
studies in the present chapter examined the link between NO and H2S in the regulation of colonic
smooth muscle function. Our results demonstrate that H2S augments NO-induced relaxation and
the mechanism involves inhibition of NO-stimulated PDE5 activity and augmentation of cGMP
levels.

5.2 Materials and Methods
5.2.1 Reagents
Chemicals for the preparation of Kreb’s solution: NaCl, KCl, KH2PO4, MgSO4. CaCl2,
NaHCO3, and glucose, chemicals: L-Cysteine and sodium hydrosulfide (NaHS), DLpropargylglycine (DL-PPG) were all obtained from Sigma-Aldrich (St. Louis, MO). Snitrosoglutathione was obtained from Santa Cruz biotechnology (Dallas, TX), Western blotting,
chromatography materials and protein assay kit were from Bio-Rad Laboratories (Hercules, CA).
Polyclonal anti-PDE5 antibody was purchased from Calbiochem (La Jolla, CA) Crotalus atrox
snake venom, cGMP and all other chemicals were from Sigma Chemical Co (St. Louis, MO).
[3H]cGMP and [125I]cGMP was obtained from Perkin Elmer Life sciences (Cambridge, MA).
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5.2.2 Assay for PDE5 Activity
PDE5 activity was measured in immunoprecipitates of PDE5 by the method of Wyatt et al
[112]. PDE5 was immunoprecipitated from lysates of dispersed rabbit colonic muscle cells (3x106
cells/ml) using an anti-PDE5 antibody and the immunoprecipitates were washed in a solution of
50 mM Tris/HCl (pH 7.5), 200 mM NaCl and 5 mM EDTA. The immunoprecipitates were then
incubated for 15 minutes at 30°C in a reaction mixture containing 100 mM Mes (pH 7.5), 10 mM
EDTA, 0.1 M magnesium acetate, 0.9 mg/ml BSA, 20 µM cGMP and [3H]cGMP. The samples
were boiled for 3 minutes, chilled for 3 minutes and then incubated at 30°C for 10 minutes in 20
mM Tris/HCl (pH 7.5) containing 10 µl of C. atrox snake venom (10 µg/µl). The samples were
added to DEAE-Sephacel A-25 columns and the radioactivity in the effluent was counted. The
results were expressed as cpm/mg of protein.
5.2.3 Radioimmunoassay for cGMP
cGMP production was measured by radioimmunoassay as described previously [113, 114].
Briefly, muscle cells (3X106 cells) were treated with GSNO (0.1 nM-100 nM) in the presence or
absence of L-cysteine (10 mM) or NaHS (1 mM) for 5 minutes and the reaction was terminated
with 10% trichloroacetic acid. The samples were centrifuged and the supernatants extracted three
times with water-saturated diethyl ether. The resulting aqueous phase was lyophilized and
reconstituted in 500 µl of 50 mM sodium acetate (pH 6.2). The samples were acetylated with
trimethylamine/acetic anhydride (2: 1, v/v) for 30 minutes and cGMP was measured in duplicate
using 100 µl aliquots. The results were expressed as pmol/mg of protein.
5.2.4 Measurement of Contraction by Scanning Micrometry
Cell lengths were measured by image scanning micrometry technique [51, 53, 77, 78, 113,
114, 170]. All cell suspensions were used within 1 hour after dispersion for cell length
measurements. Freshly isolated muscle cells (0.4 ml containing 104/cell ml) from circular muscle
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layer of colon were preincubated for 5 minutes with different concentrations of GSNO, L-cysteine
or NaHS, and then CCh was added for 10 minutes. The reaction was terminated with 1% acrolein.
After termination, an aliquot of cell suspension was placed on a slide under a coverslip. The slide
was scanned at ×100 magnification, and the length of first 50 cells randomly encountered was
measured using a micrometer. The resting cell length was determined in control experiments in
which muscle cells were incubated with 100 μl of 0.1% bovine serum albumin in the absence of
CCh. Contraction is expressed as the absolute decrease in mean cell length (m) from control cell
length in the presence of contractile agonist. Relaxation is calculated as a percent decrease in
contractile response in the presence of GSNO or GSNO plus L-cysteine or NaHS.
5.2.5 Data Analysis
Results are expressed as means ± SE of n, where n represents one sample from one animal
for single experimental replicate. Differences were analyzed by Student's t-test and considered
significant with a probability of P < 0.05. Regression analysis was performed using GraphPad
Prism 5, a statistical software program (GraphPad Software, San Diego, CA).

5.3 Results
5.3.1 Augmentation of NO-induced Relaxation by H2S in Isolated Muscle Cells
Previous studies in dispersed muscle cells showed that relaxation in response to NO is
mediated via activation of sGC/cGMP/PKG pathway [78]. Treatment of dispersed colonic smooth
muscle cells with NO donor, GSNO induced relaxation in a concentration-dependent fashion with
an EC50 of 50 nM and maximum relaxation of 57 ± 3% with 10 µM of GSNO. Treatment of colonic
smooth muscle cells with GSNO in the presence of L-cysteine (10 mM) and NaHS (1 mM)
augmented NO-induced relaxation shifting the concentration-response curve to left with an EC50
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of 5 nM and maximum relaxation of 65 ± 4% with 0.1 to 1 µM GSNO. These results suggest that
H2S augments relaxation in response to sGC/cGMP/PKG pathway (Figure 5A).
5.3.2 Augmentation of cGMP by H2S in Isolated Muscle Cells
We next investigated the effect of H2S on NO-induced cGMP levels in the presence of NO
donor, GSNO. Treatment of dispersed colonic smooth muscle cells with GSNO caused an increase
in cGMP levels in a concentration-dependent fashion with an EC50 of 40 nM and maximum
response (4.7 ± 0.6 pmol/mg protein above basal levels of 0.5 ± 0.09 pmol/mg protein) at 10 M
GSNO. Treatment of cells with GSNO in the presence of L-cysteine (10 mM) and NaHS (1 mM)
augmented NO-induced cGMP shifting the concentration-response curve to left with an EC50 value
of 1 nM and maximum response (5.1 ± 0.03 pmol/mg protein above basal levels of 0.5 ± 0.09
pmol/mg protein) at1 M GSNO. These results suggest that H2S augments relaxation in response
to NO and the mechanism involves augmentation of cGMP levels (Figure 5B).
5.3.3 Inhibition of PDE5 Activity by H2S in Isolated Muscle Cells
Augmentation of NO-induced cGMP levels by H2S could be due to increase in NO-induced
sGC activity and/or decrease in PDE5 activity. Studies in Chapter 3 (Figure 3M), however, had
shown that both L-cysteine and NaHS did not affect sGC activity as treatment of cells with either
L-cysteine or NaHS had no effect on cGMP levels. These experiments were performed in the
presence of PDE5 inhibitor, IBMX (100 µM) to avoid the effect on L-cysteine or NaHS on PDE5.
The results suggests that, unlike NO and CO, H2S had no effect on sGC activity [74, 124].
In this chapter, we examined the hypothesis that augmentation of NO-induced cGMP in
response to H2S is due to inhibition of NO-stimulated PDE5 activity and suppression of cGMP
hydrolysis. To examine this notion, the effect of L-cysteine and NaHS on NO-induced cGMP
levels were measured in the absence of PDE inhibitor, IBMX.
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As shown previously [108], treatment of cells GSNO (1 M) for 5 minutes caused a
significant increase in PDE5 activity (3,479 ± 634 cpm/mg protein; P < 0.001; n = 5) above basal
levels (264 ± 43 cpm/mg protein). GSNO-stimulated PDE5 activity was significantly attenuated
in the presence of L-cysteine (52% inhibition) or NaHS (65% inhibition) (Figure 5C). These
results suggest that augmentation of NO-induced cGMP levels and relaxation by H2S is due to
inhibition of PDE5 activity and suppression of cGMP hydrolysis.
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Figure 5A

Figure 5A. Effect of L-Cysteine and NaHS on GSNO-induced muscle relaxation. Dispersed
muscle cells from rabbit colon were treated with CCh (0.1 M) for 10 minutes in the presence or
absence of increasing concentrations of S-nitrosoglutathione (GSNO, 0.1 nM to 10 M). In some
experiments, cells were pretreated with L-cysteine (10 mM) or NaHS (1 mM) for 5 minutes and
then treated with GSNO. Muscle cell length was measured by scanning micrometry. Contraction
by CCh was calculated as a percent decrease in muscle length from control cell length (35 ± 5%
decrease in cell length from the basal cell length 97 ± 5 m). Relaxation in response to GSNO, LCysteine and NaHS was expressed as percent decrease in CCh-induced contraction. Values are
means ± S.E. of 4 experiments.
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Figure 5B

Figure 5B. Effect of L-Cysteine and NaHS on GSNO-induced cGMP levels. Dispersed muscle
cells from rabbit colon were treated with increasing concentrations of S-nitrosoglutathione
(GSNO, 0.1 nM to 10 M) for 5 minutes. In some experiments cells were pretreated with Lcysteine (10 mM) or NaHS (1 mM) for 5 minutes and then treated with GSNO. cGMP levels were
measured by radioimmunoassay using [125I]cGMP. Results are expressed as pmol/mg protein.
Values are means ± S.E of 5 experiments.
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Figure 5C

Figure 5C. Inhibition of GSNO-stimulated PDE5 activity by L-Cysteine and NaHS. Dispersed
rabbit colonic smooth-muscle cells were treated with GSNO (1 µM) for 5 minutes. PDE5 was
immunoprecipitated from lysates of muscle cells and PDE5 activity was measured using
[3H]cGMP as the substrate. In some experiments, muscle cells were pretreated with L-cysteine (10
mM) and NaHS (1 mM) for 5 minutes followed by treatment with GSNO. Increase in PDE5
activity in response to GSNO was measured by an increase in [3H]GMP levels in the effluent
(3,479 ± 634 cpm/mg protein) compared to basal [3H]GMP levels (264 ± 43 cpm/mg protein).
Results are expressed as cpm/mg of protein. Values are means ± S.E of 4 experiments. **p < 0.001,
significant inhibition of GSNO-induced PDE5 activity.
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5.4 Discussion
Endogenously produced H2S is a signaling molecule which participates in the regulation
of physiological processes in the cardiovascular, nervous and gastrointestinal systems in which
H2S utilizes a variety of signaling pathways [115, 116, 117, 118, 119]. Many of the effects
produced by H2S do not require the participation of a second messenger, but rather result from
protein modification, S-sulfhydration of target proteins [120]. In comparison, the other known
gasotransmitters like NO exert physiological responses through the sGC/cGMP signaling pathway
[78]. There is growing interest in understanding the interaction of NO and H2S (“NO/H2S crosstalk”) to mediate interdependent biological actions. Our results demonstrate that the effect of NO
in colonic smooth muscle cells is augmented by H2S. The synergistic effect of the interactions
between NO and H2S arises from their different signaling cascades and the ability of H2S to
enhance cGMP levels by diminishing its degradation. In smooth muscle, intracellular cGMP levels
in response to NO reflect the balance between the rate of cGMP synthesis via sGC activity and
degradation by PDE5. Our studies have shown that H2S does not activate sGC, because H2S had
no effect on cGMP levels (Chapter 3, Figure 3M) measured in the presence of PDE inhibitor and
inhibition of contraction by H2S was not affected by PKG blocker, a downstream target of
sGC/cGMP pathway (Chapter 3, Figure 3J).
A number of studies have debated the role of cGMP in H2S-induced responses. The first
study to measure cGMP levels in NaHS-treated cells was performed in 2004 which showed that
exposure of monkey retinal RF/6A endothelial cells to 10–200 M NaHS did not increase cGMP
levels [121]. Similar studies performed in the cardiovascular system showed that H2S did not alter
the levels of cGMP in cardiomyocytes isolated from Wistar Kyoto and spontaneously hypertensive
rats [122]. These studies report that sGC/cGMP pathway is not involved in H2S-mediated
physiological responses. Studies by Bucci et al [110] have shown that incubation of cultured rat
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aortic smooth muscle cells with NaHS caused an increase in cGMP levels. Blockade of CSE
activity by DL-PPG or suppression of CSE mRNA led to a significant reduction of cGMP levels.
Overexpression of CSE, in contrast, led to an increase in intracellular cGMP levels. Levels of
cGMP in vascular tissue of CSE null mice were lower than those in wild type control mice. Further
studies showed that H2S acts as an endogenous inhibitor of PDE. Bucci et al. demonstrated in vitro
studies that NaHS significantly inhibits phosphodiesterase activity and causes a reduction in the
breakdown of GMP [110].
Studies demonstrate both mutual attenuation and potentiation of responses with NO and
H2S. Coletta et al. reported that H2S and NO are mutually dependent to regulate endotheliumdependent vasorelaxation [111]. These reports show that NaHS inhibits purified PDE5 activity as
effectively as sildenafil with an IC50 of 1.55 M [111]. Exposure of endothelial cells to H2S
increases intracellular cGMP in a NO-dependent manner, and activates PKG and its downstream
effector, the vasodilator-stimulated phosphoprotein (VASP) to augment relaxation [111]. These
studies also confirmed that the inhibition of eNOS or PKG-I attenuated H2S-stimulated
vasorelaxation, demonstrating the requirement of NO in vascular H2S signaling. Silencing of the
H2S-producing enzyme CSE also abolished NO-stimulated cGMP accumulation and attenuated
the NO-induced vasorelaxation in response to acetylcholine. These studies clearly indicate a partial
requirement of H2S in the relaxant activity of NO. While NO enhances cGMP synthesis by
activating sGC activity, H2S maintains a tonic inhibitory effect on PDE5, thereby delaying the
degradation of cGMP [111].
Studies on NO-H2S interaction in the GI system, however report that endogenous NO and
H2S play opposite roles in the regulation of gastric smooth muscle motility [123]. These studies
indicate that lower concentrations of H2S act as an excitatory regulator and NO acts as an inhibitor
of motility [123]. These reports explain the effects of NO and H2S on spontaneous contractions of
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the mouse gastric fundus, but does not elucidate the effect of NO and H2S on acetylcholinestimulated contractions [123]. Contradicting studies in the GI tract report that NO and H2S produce
a synergistic relaxant effect on the guinea pig ileum [56]. The combination of low doses of NaHS
and NO donor, SNP resulted in a greater inhibition of the contractile response to electrical
stimulation than might be expected from either H2S or NO alone [56].
Our studies in this chapter clearly show that H2S augments NO-induced smooth muscle
relaxation in response to CCh in colonic muscle cells. We also provide evidence that augmentation
of relaxation is mediated via inhibition of PDE5 activity and increase in cGMP levels. The
evidence was based on measurements of both cGMP levels and PDE5 activity in response to NO
in the presence or absence of L-cysteine and NaHS. Both L-cysteine and NaHS inhibited PDE5
activity and stimulated cGMP levels and the results are consistent with the augmentation of NOinduced relaxation. Although L-cysteine or NaHS had no effect on cGMP levels in the absence of
NO, both L-cysteine and NaHS caused augmentation of NO-induced cGMP levels. These results
suggest that H2S did not affect basal PDE5 activity, but inhibited NO-stimulated PDE5 activity.
Stimulation of sGC activity in response to NO causes stimulation of PDE5 activity via cGMP/PKG
pathway. Thus, although H2S does not directly activate sGC activity, it induces a synergistic
relaxant effect in muscle cells in the presence of NO. These studies suggest that H2S amplifies
NO-induced relaxation in gastrointestinal muscle cells by the inhibition of cGMP specific PDE5
activity.
In summary, our studies in this chapter demonstrate that relaxation in response to NO was
augmented by H2S and the mechanism involves increase in cGMP levels via inhibition of NOstimulated PDE5 activity, a key enzyme in cGMP degradation in smooth muscle.
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Chapter 6
ACTIVATION OF CYSTATHIONINE--LYASE (CSE) VIA CGMP/PKG PATHWAY
6.1 Introduction
Cystathionine--lyase (CSE) is expressed in numerous organisms including mammals [34],
amphibians [125] and plants [126]. In the mammalian systems, CSE is abundantly expressed in
mammalian cardiovascular system and respiratory system and appears to be the primary H2S
producing enzyme in the liver, kidney, uterus, placenta, as well as in the small intestine and
stomach of rodents [27, 28, 65, 115]. Small amounts of CSE mRNA are also detected in the brain
[20]. The endogenous enzymes for H2S production, CBS and CSE use pyridoxal-5-phosphate
(PLP or vitamin B6) as a cofactor for activation [127, 129]. The PLP binding domain in both the
enzymes is considered to be the catalytic domain important for enzyme activity [128, 129].
6.1.1 H2S production in the GI Tract
In the gastrointestinal tract, H2S-synthesizing enzymes have been shown to be expressed
by enteric neurons, interstitial cells of Cajal and epithelial cells [55, 57, 149, 150]. Expression of
CBS and CSE is reported to be tissue-specific [57, 137]. Several groups have explored the
enzymatic production of H2S in the gastrointestinal tract [27, 29, 138, 160, 165]. H2S released
from tissues can be measured quantitatively with numerous techniques. One of the most common
methods of H2S gas measurement is the methylene blue assay, the use of which is described by
Jacobs and colleagues [133]. Other methods are developed to assay H2S gas production are
polarographic technology used to demonstrate H2S release from sulfide-containing compounds
[134] and H2S-sensitive electrodes which are being used in a variety of tissues [135].
Unlike H2S-production assays in other physiological systems, the presence of sulfatereducing commensal bacteria within the lumen of the GI tract can also contribute to the amount of
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H2S that is measured. To eliminate the contribution of luminal bacteria, research groups have
developed a novel adaptation of the methylene blue assay to quantitatively measure the
endogenous generation and release of H2S gas in intact and living muscle layers of the GI tract
[57]. This system is designed to trap physiologically produced H2S that allowed the tissue to
survive during gas collection.
These tissue preparations contained the myenteric plexus dissected away from the mucosa,
without contamination of luminal bacteria [57]. The rate of H2S gas production and release from
intact mouse colon tissue averaged 0.45 pmol/min/mg tissue [57]. H2S gas production was
inhibited when the tissue was treated simultaneously with CSE and CBS inhibitors. These studies
showed that the production of H2S is dependent on the endogenous activity of CSE and/or CBS.
However, a mechanism of action for the stimulation of these enzymes has not been reported in the
GI system.
Rationale. Our studies in this chapter investigate the endogenous production of H2S from
smooth muscle from rabbit colon and human stomach tissues. Using H2S gas trapping method
followed by detection of H2S levels by methylene blue assay, we demonstrated that L-cysteine
stimulates CSE activity in smooth muscle from both colon and stomach. Our studies also showed
that NO-induced relaxation was mediated, in part, via activation of CSE and generation of H2S.
Activation of CSE was dependent on the PKG-mediated phosphorylation of CSE in smooth
muscle.

6.2 Materials and Methods
6.2.1 Reagents
Chemicals for the preparation of potassium phosphate buffer: KH2PO4, MgSO4, CaCl2,
NaHCO3, and glucose, chemicals: L-cysteine was obtained from Sigma-Aldrich (St. Louis, MO).
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Ferric chloride was obtained from MP biomedicals (Solon, OH). N, N-dimethyl-Pphenylenediamine sulfate was obtained from Alfa Aezer (Ward Hill, MA). S-nitrosoprusside was
obtained from Sigma-Aldrich (St. Louis, MO). Forskolin and H-89 were obtained from Tocris
Bioscience (Minneapolis, MN). 8-Br-cGMP was obtained from Abcam Biochemicals (Cambridge,
MA). Rp-8-Br-cGMPS was obtained from Alexis Corporation (Switzerland). Western blotting and
autoradiogram materials and protein assay kit were from Bio-Rad Laboratories (Hercules, CA).
Polyclonal anti-CSE antibody was purchased from Proteintech (Chicago, IL). All other chemicals
were from Sigma Chemical Co. (St. Louis, MO). [32P]ATP was obtained from Perkin Elmer Life
sciences (Cambridge, MA).
6.2.2 Measurement of H2S Production
Synthesis of H2S in smooth muscle from rabbit colon and human stomach was measured
using the method of Abe & Kimura [20], and modified by Qu et al [136]. Freshly obtained rabbit
colonic or human gastric smooth muscle tissue was homogenized in ice-cold 50 mM potassium
phosphate buffer, pH 8.0 (12% w/v), with a Polytron homogenizer. The homogenate (0.5 ml) and
buffer (0.4 ml) were then cooled on ice for 10 minutes before L-cysteine (10 mM) and pyridoxal
5′-phosphate (2 mM) were added. The final volume was 1 ml. A smaller 2-ml tube containing a
piece of filter paper (0.5×1.5 cm) soaked with zinc acetate (1%; 0.3 ml) was put inside the larger
vial. The vials were then flushed with nitrogen gas for 20 seconds and capped with an airtight
serum cap. The vials were then transferred to a 37°C shaking water bath and, after 90 minutes,
trichloroacetic acid (TCA; 50%; 0.5 ml) was injected into the reaction mixture through the serum
cap. The mixture was left to stand for another 60 min to allow for the trapping of evolved H2S by
the zinc acetate.
The serum cap was then removed and N, N-dimethyl-p-phenylenediamine sulfate (20 mM;
50 μl) in 7.2 mol/L HCl and FeCl3 (30 mM; 50 μl) in 1.2 mol/L HCl were added to the inner tube
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containing zinc acetate soaked filter paper. After 20 minutes, absorbance at 670 nm was measured
with a spectrophotometer. The calibration curve of absorbance vs. H2S concentration was obtained
by using NaHS solution of varying concentrations as described previously [20]. When NaHS is
dissolved in water, HS- is released which forms H2S with H+. H2S concentration is taken as 30%
of the NaHS concentration in the calculation [20]. The calibration curve in our studies was linear
from 0 to 400 M NaHS or 120 M H2S. Smooth muscle homogenates were incubated with Lcysteine (10 mM) or sodium nitroprusside (1 µM) in the presence or absence of CSE inhibitor,
DL-propargylglycine (DL-PPG, 1mM). The amount of H2S released from tissue preparation was
studied by spectrophotometry. The results are expressed as nmoles H2S/mg tissue.
6.2.3 Phosphorylation of CSE
A back phosphorylation approach was used to determine in situ phosphorylation of CSE
as described earlier [108]. Phosphorylation of CSE was determined from the amount of [32P]
incorporated into the enzyme after immunoprecipitation with anti-CSE antibody. Cultured cells
(4X106 cells/ml) were incubated with NO donor, SNP (1 M) for 5 minutes in the presence or
absence of the specific PKG inhibitor, Rp-cGMPS (10 M). In some cases, cultured cells are
treated with cAMP activator, forskolin (10 M) in the presence or absence of specific PKA
inhibitor, H-89 (10 M). The reaction was terminated with an equal volume of lysis buffer [1%
(v/v) Triton X-100, 0.5% (w/v) SDS, 0.75% (w/v) deoxycholate, 10 mM EDTA, 1 mM PMSF, 10
µg/ml leupeptin, 100 µg/ml aprotinin, 10 mM sodium pyrophosphate, 50 mM NaF and 0.2 mM
sodium vanadate], and placed on ice for 30 minutes. The cell lysates were separated from the
insoluble material by centrifugation at 13,000 g for 15 minutes at 4 °C, precleared with 40 µl of
Protein A–sepharose and incubated with anti-CSE antibodies for 2 hours at 4°C. The
immunoprecipitates were washed five times with 1 ml of wash buffer [10 mM Tris/HCl (pH 7.4),
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150 mM NaCl and 0.5% (v/v) Triton X-100] and then incubated with purified type I PKG (PKGI) (0.5 µg) and 1 µM cGMP and 100 µM [γ-32P] ATP (5 µCi/sample) for 10 minutes at 30 °C. The
samples were treated with laemelli buffer, boiled for 5 minutes and resolved by SDS/PAGE using
a 10% (w/v) polyacrylamide gel. After transfer of the proteins on to PVDF membranes,

32

P-

labelled CSE was visualized by autoradiography and the amount of radioactivity in the bands was
examined. The decrease in 32P incorporation in CSE samples treated with SNP (1 µM) or forskolin
(10 µM) was compared with basal CSE phosphorylation which incorporated higher [ 32P] in the
presence of purified PKG.
6.2.4 Isometric Force Measurement
Contractile activity of muscle strips was calculated as maximum force generated in
response to acetylcholine (ACh). In some experiments, the strips were incubated with NO donor,
SNP and CSE inhibitor, DL-PPG before ACh treatment. Strips obtained from the circular layer of
rabbit colon were allowed to equilibrate to a passive tension of 2 gram for atleast 30 minutes before
experiments were conducted and bath buffer solution was changed every 15 minutes during
equilibration and data collection. Only muscle strips that developed ∼2 gram of tension above
basal levels were used to test the effect of SNP and PPG on ACh-induced contraction. Time control
studies demonstrated that response to 10 μM ACh was reproducible following 2 hour incubation
in Krebs buffer. Muscle strips were used within 2 hour after isolation. At the end of each
experiment, the strips were blotted dry and weighed (tissue wet weight). Following an experiment,
strip data were reviewed and analyzed from within the Polyview software suite. All experiments
were designed to compare treatment to control conditions. Paired t-tests were conducted in
Graphpad (Graphpad software, La Jolla, CA), and significance assumed at p < 0.005.
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6.2.5 Data Analysis
The results were expressed as means ± S.E of n experiments and analyzed for statistical
significance using Student t-test for paired and unpaired values. Each experiment was performed
on cells and tissues obtained from different animals. Difference of responses among different
groups were tested and confirmed for significance using Fisher’s protected least significance
difference test. The results were analyzed using GraphPad software (San Diego) CA. A probability
of P< 0.05 was considered significance.

6.3 Results
6.3.1 H2S production in Gastric and Colonic Smooth Muscle
Incubation of smooth muscle homogenates from rabbit colon with L-cysteine (10 mM)
caused a significant increase in H2S production (58.6 ± 4.6 nmol H2S/mg tissue above basal levels
of 24.5 ± 3.4 nmol H2S/mg tissue). L-cysteine-induced H2S production was inhibited by the
selective CSE inhibitor DL-PPG (1 mM) to 39.2 ± 3.2 nmol H2S/mg tissue (33% inhibition)
(Figure 6A). Similarly, incubation of smooth muscle homogenates from human stomach with Lcysteine (10 mM) caused a significant increase in H2S production (46.2 ± 2.9 nmol H2S/mg tissue
above basal levels of 19.8 ± 2.3 nmol H2S/mg tissue). L-cysteine-induced H2S production was
inhibited by the selective CSE inhibitor DL-PPG (1 mM) to 25.4 ± 3.5 nmol H2S/mg tissue (46%
inhibition) (Figure 6B). These studies show that endogenous H2S production from gastric and
colonic smooth muscle is generated by the activation of CSE. The results are consistent with the
expression of CSE in smooth muscle cells of rabbit and human stomach (Figure 2A and 2C,
Chapter 2).
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6.3.2 Stimulation of CSE by Sodium Nitroprusside (SNP) via cGMP/PKG Pathway
Previous studies in gastrointestinal smooth muscle have shown that SNP, an NO donor,
activates sGC and induces muscle relaxation via cGMP/PKG pathway [96]. L-cysteine-induced
increase in H2S production (60 ± 2.6 nmol H2S/mg tissue above basal levels of 24.5 ± 3.4 nmol
H2S/mg tissue) was significantly augmented by the NO donor, SNP (1 µM) (118 ± 5 nmol H2S/mg
tissue, 48.3% increase) in smooth muscle from rabbit colon. The effect of SNP was inhibited in
the presence of DL-PPG (53±2 nmol H2S/mg tissue, 55% inhibition) (Figure 6C).
Similarly, L-cysteine-induced increase in H2S production (39 ± 2 nmol H2S/mg tissue
above basal levels of 19.8 ± 2.3 nmol H2S/mg tissue) was significantly augmented by SNP (1 µM)
(102 ± 5 nmol H2S/mg tissue, 50.9% increase) in smooth muscle from human stomach tissues. The
effect of SNP was inhibited in the presence of DL-PPG (59 ± 3 nmol H2S/mg tissue, 42%
inhibition) (Figure 6D). These studies raise the possibility that activation of sGC/cGMP/PKG
pathway can stimulate CSE resulting in the generation of endogenous H2S in response to NO. This
notion was examined by measurements of H2S production in response to cGMP analogue, 8-BrcGMP in the presence or absence of a selective PKG inhibitor, Rp-cGMPS (10 µM) in smooth
muscle homogenates from rabbit colon. L-cysteine-induced H2S production (58.6 ± 2.4 nmol
H2S/mg tissue above basal levels of 24.5 ± 3.4 nmol H2S/mg tissue) was significantly augmented
by 8-Br-cGMP (121 ± 4 nmol H2S/mg tissue, 52% increase). Augmentation of cGMP-induced H2S
production was significantly inhibited in the presence Rp-cGMPs (72 ± 2 nmol H2S/mg tissue,
41% inhibition) (Figure 6E). These results suggest that activation of sGC/cGMP/PKG pathway in
response to NO donor, SNP and cGMP analogue, 8-Br-cGMP stimulates CSE activation and H2S
production.
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6.3.3 Phosphorylation of CSE by NO/cGMP/PKG Pathway
A back phosphorylation approach was used to determine in vivo phosphorylation of CSE
using [-32P] by exogenous PKG-Iα holoenzyme as previously described for other proteins such
as IP3 receptor [155]. The amount of [32P] incorporated onto CSE immunoprecipitates derived
from control muscle cells was taken as 100% phosphorylation. The amount of [32P] incorporated
into the CSE immunoprecipitates derived from cells treated with SNP (PKG activator) (1 M) was
calculated as percentage of control value. The decrease in [32P] incorporation after treatment with
SNP reflected endogenous phosphorylation of CSE by PKG. Maximum back phosphorylation
(100%) by PKG-Iα occurred in CSE immunoprecipitates derived from control cells.
Phosphorylation was blocked in CSE immunoprecipitates derived from cells treated with SNP
reflecting endogenous phosphorylation of CSE in response to SNP (Figure 6F). Phosphorylation,
however, was restored in CSE immunopreciptates derived from cells treated with SNP in the
presence of PKG inhibitor, RpcGMPS. These results suggest that the endogenous phosphorylation
of CSE in response to SNP is mediated via activation of PKG in smooth muscle (Figure 6F).
6.3.4 Inhibition of Contraction by L-Cysteine in Muscle Strips
Isometric contraction was measured in muscle strips isolated from the circular layer of the
colon from rabbit. Muscle strips were allowed to equilibrate to a passive tension of 2 gram for 30
minutes before experiments were conducted. Area under curve (AUC) measurements representing
force versus time in response to acetylcholine (ACh) was defined as muscle tone above basal. AUC
was recorded for the first 2 minutes in response to ACh. The strips were then incubated in NO
donor, SNP (1 M) in the presence or absence of DL-PPG (1 mM) for 5 minutes before the addition
of ACh and AUC measurements are recorded again to estimate the amount of inhibition of
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contraction in response to SNP. These force measurements are normalized by tissue mass and
demonstrate the variability among strips used in these experiments.
As shown previously [41], carbachol (ACh, 10 µM) induced a significant contraction of
260.74 ± 25.87 gram-seconds above basal tension. Addition of NO donor, SNP (1 μM) caused
39.9 ± 9% inhibition of ACh-induced contraction (Figure 6G). Incubation of muscle strips with
DL-PPG (1 mM) caused 71.4 ± 4% inhibition of ACh-induced contraction (Figure 6G) indicating
a significant reversal of NO-induced inhibition by CSE inhibitor, DL-PPG. These results suggest
that inhibition of ACh-induced contraction by NO was partly due to H2S production via the
activation of CSE.
Our studies showed that activation of cGMP/PKG in response to NO donor causes
phosphorylation of CSE leading to generation of H2S. We examined the contribution of this
CSE/H2S pathway to relaxation in response to NO. Treatment of colonic smooth muscle with SNP
induced relaxation of ACh-induced contraction (39.9% relaxation). Relaxation was partly
inhibited (~32% difference in relaxation) by incubation of smooth muscle with DL-PPG
suggesting that H2S generated via activation of CSE partly mediates relaxation in response to NO.
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Figure 6A

Figure 6A. Stimulation of CSE activity in response to L-cysteine in rabbit colonic smooth
muscle. Homogenates prepared from rabbit colonic muscle were treated with L-cysteine (10 mM)
for 90 minutes in the presence or absence of CSE inhibitor, DL-propargylglycine (DL-PPG, 1
mM). Formation of H2S was measured by spectrophotometry and expressed as nmol/mg tissue.
Values are means ± S.E.M. of 5 experiments. **p<0.001, significant inhibition of L-cysteineinduced H2S production by DL-PPG.
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Figure 6B

Figure 6B. Stimulation of CSE activity in response to L-cysteine in human gastric muscle.
Homogenates prepared from human gastric smooth muscle were treated with L-cysteine (10 mM)
for 90 minutes in the presence or absence of CSE inhibitor propargylglycine (PPG, 1 mM).
Formation of H2S was measured by spectrophotometry and expressed as nmol/mg tissue. Values
are means ± S.E.M. of 4 experiments. **p<0.001significant inhibition of L-cysteine-induced H2S
production by DL-PPG.
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Figure 6C

Figure 6C. Stimulation of CSE activity in response to NO donor, sodium nitropruside (SNP)
in rabbit colonic muscle. Homogenates prepared from rabbit colonic smooth muscle were treated
with L-cysteine (10 mM) plus SNP (1 M ) for 90 minutes in the presence or absence of CSE
inhibitor DL-propargylglycine (DL-PPG, 1 mM). Formation of H2S was measured by
spectrophotometry and expressed as nmol/mg tissue. Values are means ± S.E.M. of 5 experiments.
##p<0.001, significant increase in H2S production by SNP. **p<0.001, significant inhibition of
SNP-induced H2S production by DL-PPG.
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Figure 6D

Figure 6D. Stimulation of CSE activity in response to NO donor, sodium nitropruside (SNP)
in human gastric muscle. Homogenates prepared from human gastric smooth muscle were treated
with L-cysteine (10 mM) plus SNP (1 mM ) for 90 minutes in the presence or absence of CSE
inhibitor PPG (1 mM). Formation of H2S was measured by spectrophotometry and expressed as
nmol/mg tissue. Values are means ± S.E.M. of 4 experiments. ##p < 0.001, significant increase in
H2S production by SNP. **p < 0.001, significant inhibition of SNP-induced H2S production by
DL-PPG.

128

Figure 6E

Figure 6E. Stimulation of CSE activity in response to cGMP/PKG activation in rabbit
colonic smooth muscle. Homogenates prepared from rabbit colonic smooth muscle were treated
with L-cysteine (10 mM) plus cell-permeable cGMP analog (8-Br-cGMP, 10 M) for 90 minutes
in the presence or absence of cGMP-dependent protein kinase inhibitor (Rp-cGMPS, 10 mM).
Formation of H2S was measured by spectrophotometry and expressed as nmol/mg tissue. Values
are means ±S.E.M. of 5 experiments. ##p < 0.001, significant increase in H2S production by 8-BrcGMP. **p < 0.001, significant inhibition of 8-Br-cGMP-induced H2S production by Rp-cGMPs.
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Figure 6F

Figure 6F. Phosphorylation of CSE induced by SNP and forskolin in rabbit colonic muscle
cells. Cultured colonic smooth muscle cells were incubated with NO donor, SNP (1 µM) for 5
minutes in the presence or absence of PKG inhibitor, Rp-cGMPS (10 µM). Cells were lysed and
immunoprecipitated with an anti-CSE antibody; after immunoprecipitation, CSE was
phosphorylated in vitro in the presence of PKG-Iα holoenzyme and [γ-32P]ATP. Control cells were
treated in similar fashion without SNP. The difference between 32P incorporation in control cells
(100%) and cells treated with SNP represents the extent of endogenous (in vivo) phosphorylation
by SNP.
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Figure 6G

Figure 6G. Partial reversal of NO-induced relaxation by CSE inhibitor, DLpropargylglycine. Muscle strips from the circular layer of rabbit colon were allowed to equilibrate
at a passive tension of 2 grams for 30 minutes and then treated with 10 M acetylcholine (Ach).
In some experiments, the strips are incubated with NO donor, sodium nitroprusside (SNP, 10 M),
in the presence or absence of CSE inhibitor, DL-PPG (1 mM). Relaxation was measured as percent
decrease of maximal area under curve (AUC) response to SNP. Values are expressed as SNPinduced relaxation (%) of maximal contraction in the presence of Ach, SNP and DL-PPG. Values
are means ± S.E.M. of 4 experiments. *p < 0.001, significant inhibition of SNP-induced inhibition
by DL-PPG.
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6.4 Discussion
H2S is an endogenous gaseous signaling molecule similar to NO and CO. Both NO and
CO stimulate sGC activity and initiate signaling via the cGMP/PKG pathway. H2S on the other
hand directly S-sulfhydrates target proteins and modifies protein function and activity. Although
the physiological function of H2S in the GI tract has been studied by a number of research groups
[29, 47, 137], the endogenous regulation of H2S production by H2S-synthesizing enzyme CSE and
the mechanism of activation are still unclear.
CSE and CBS are reported to be localized in different regions of the GI tract, stomach,
small intestine and colon in different gut layers-enteric neurons, ICCs and smooth muscles [27,
55, 57, 138, 139, 140]. The generation of H2S in the GI tract is shown to be inhibited by CBS
inhibitor, amino-oxyacetic acid (AOAA) as well as CSE inhibitor, DL-PPG [58]. The blockade
of H2S production also increased GI motility in rat colon, suggesting that H2S is an endogenous
inhibitory signaling molecule in the GI tract [75]. Although these studies show the importance of
the endogenous H2S production from CSE and CBS, they do not identify the loci of synthesis and
mechanism of the activation of these enzymes in the GI tract.
Our studies provide evidence for the synthesis of H2S in smooth muscle from different
regions (stomach and colon) and different species (rabbit and human) by the CSE activator Lcysteine as well as by NO donor, SNP. Our studies also identified the mechanism of activation of
CSE involving PKG-mediated phosphorylation via NO/sGC/cGMP pathway. This is a novel
finding that defines the underlying signaling pathways that regulate CSE activity in smooth muscle
cells. The evidence was based on direct measurement of H2S production in response to L-cysteine
and SNP, and use of specific inhibitor of CSE, DL-PPG and an inhibitor of PKG, Rp-cGMPS. Lcysteine and SNP-induced increase in H2S production was blocked by DL-PPG demonstrating that
activation of CSE is involved in the synthesis of H2S in response to NO. Two experimental
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strategies that yielded similar results were used to characterize PKG-mediated phosphorylation of
CSE. In the first strategy, a cell-permeable cGMP analogue mimicked the effect of NO and a
selective PKG inhibitor blocked the effect of 8-Br-cGMP suggesting the involvement of PKGmediated phosphorylation in the activation of CSE. In the second strategy, immunoprecipitated
CSE from control cells and from cells treated with SNP in the presence or absence of PKG inhibitor
(Rp-cGMPS) were subsequently phosphorylated by PKG-Iα holoenzyme. In these experiments,
phosphorylation by PKG-Iα in vitro was obtained in control cells and in cells treated with SNP
plus PKG inhibitor, but not in cells treated with SNP alone. The lack of phosphorylation in vitro
in SNP treated cells reflects in vivo phosphorylation by PKG. The physiological relevance of the
CSE/H2S pathway activated by NO was evident from the partial inhibition of NO-mediated
relaxation by the CSE inhibitor.
The cross talk between H2S and NO in regulating GI motility is intriguing. Previous studies
showed that H2S can regulate generation of NO [145, 146] and facilitates release of NO in vascular
tissue [65]. Studies in the GI system also show that H2S regulates generation of NO in the mouse
colon [143]. This study shows that endogenous generation of NO was significantly higher in
muscle preparations of CSE-KO mice demonstrating that H2S inhibits NO synthesis in the mouse
colon. Other studies show that H2S regulates the availability of NO by increasing its release from
nitrosothiols [144].
Rat aortic tissue homogenates incubated with a NO donor for 90 minutes showed
significant increase in H2S generation [65]. These studies suggested that NO-dependent increase
in H2S generation could be due to direct activation of CSE by NO via S-nitrosylation or due to
stimulation of CSE by NO/sGC/cGMP pathway. These studies also showed that incubation of
vascular SMCs with NO donor for 6 hours significantly increased the expression of CSE [65]. A
role for PKG in H2S mediated relaxation was also demonstrated using PKG-I null mice [71].
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Relaxation to both NaHS and L-cysteine were reduced in vessels of PKG-I null mice
demonstrating that endogenous PKG-I is partially responsible for NaHS and L-cysteine-stimulated
vasodilation in the cardiovascular system [71]. A key study showed that both H2S and NO are
both required and mutually dependent for physiological functions in the cardiovascular system
such as regulation of angiogenesis and endothelium-dependent vasorelaxation [111]. This was a
pioneer study that showed the collaborative action of the two gasotransmitters, H2S and NO on
increasing and maintaining intracellular cGMP levels and PKG activation and consequent
regulation of angiogenesis and endothelium-dependent vasorelaxation.
In summary, studies in this chapter provide strong evidence for the interplay between NO
and H2S. NO contributes to the generation of H2S via cGMP/PKG pathway and H2S, in turn, as
shown in Chapter 6, inhibits PDE5 activity and augments NO-induced cGMP levels. Thus, H2S
promotes NO function, and its own synthesis, via cGMP/PKG pathway. These studies also suggest
that pharmacological inhibitors of PKG may be a potentially powerful approach for the inhibition
of H2S production in the GI tract. These current findings may lead to novel approaches which
focus on the simultaneous restoration of NO and H2S homeostasis in the gastrointestinal smooth
muscle cells.
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Chapter 7
DISCUSSION
Recent studies have demonstrated that hydrogen sulfide (H2S), like nitric oxide (NO) and
carbon monoxide (CO) fulfilled all of the criteria to be defined as a physiological gasotransmitter.
Like NO and CO, H2S is a small gaseous and freely permeable molecule. The physiological
importance of H2S has been underscored by its significance in the regulation of several functions
including gastrointestinal functions [55, 56, 70, 145, 148, 149, 150]. In the GI system, H2S acts to
regulate secretory, inflammatory and motility functions [138].

Endogenous synthesis and

metabolism of H2S is also regulated [138, 139, 140, 141]. H2S is endogenously synthesized via
cystathionine-γ-lyase

(CSE),

cystathionine-β-synthase

(CBS)

and

3-mercaptopyruvate

sulfurtransferase (3-MST) [153, 154, 155, 159]. Of these three enzymes, CSE and CBS have been
well-studied. Both enzymes are pyridoxal-5’-phosphate-dependent and use L-cysteine as a
substrate to produce H2S [156, 157]. Although the pattern of expression of CSE and CBS in
different tissues is largely known, the regulatory mechanisms for expression and activities are not
clear.
Using exogenous H2S donors (e.g., NaHS) or activators of endogenous synthesis (e.g., Lcysteine), pharmacological inhibitors of enzymes that generate H2S (e.g., DL-PPG) and molecular
approaches (siRNA, and CSE/CBS null mice), several functions of H2S have been demonstrated
in the cardiovascular system, central nervous system, gastrointestinal tract and energy metabolism
[73, 82, 169, 172, 177, 178]. Reduction in the levels of H2S accompanied by hypertension and
reduced endothelium-dependent relaxation of vascular muscle in mouse lacking H2S generating
enzyme CSE, and downregulation of CSE/L-cysteine pathway in spontaneously hypertensive rats
underscores the importance of endogenous H2S in the regulation of smooth muscle function [83].
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H2S exerts its function by acting on various targets, but, unlike NO and CO, it does not
affect soluble guanylyl cyclase (sGC) activity and cGMP formation [141]. One of the most studied
targets of H2S is the KATP channel [82, 179]. It is established that the effect of H2S on vasodilation
is mainly brought about by activation of KATP channels and this is consistent with the blockade of
H2S effect by the KATP channel inhibitor, glibenclamide [82]. Additional targets such as voltagedependent Ca2+ channels, Ca2+-dependent K+ channels and an ill-defined endothelium-dependent
mechanism appear to play a minor role in H2S induced vasodilation [73, 132, 162]. A
glibenclamide insensitive effect of NaHS was also observed in mouse aorta [146] and mouse
bronchial rings [164].
Although it is well-established that H2S inhibits gastrointestinal motility in vivo, and both
agonist- and electrically-induced contractions in vitro, it is not known for certain the site of H2S
biosynthesis and its mechanism of action. In guinea pig ileum and mouse stomach and colon, the
inhibitory effect of H2S was not affected by the KATP channel inhibitor, glibenclamide [56, 148],
whereas in the isolated segments of human, mouse and rat colon the inhibitory effect of H2S was
dependent on both glibenclamide-sensitive and apamin-sensitive K+ channels [70]. H2S effect also
involves TRPV1 receptors on afferent neurons [162]. The mechanism of inhibition of contraction
by H2S appears to be species- and tissue-specific, and varies with activation of the muscle.
In studies using nerve-muscle preparations, H2S may also affect enteric neurons to regulate
smooth muscle function. A direct effect on muscle was implicated in distal colon of mouse and
human since the Na+ channel blocker tetrodotoxin had no effect on the relaxation [87]. However,
an effect on ICCs would also influence the function of smooth muscle in these preparations.
Increase in spontaneous contraction in the presence of CSE inhibitors suggests a role for
endogenous production of H2S via CSE in the regulation of GI motility [148]. In the GI tract, the
loci of generation and action of H2S include several cell types such as epithelial cells, enteric
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neurons, ICCs and smooth muscle cells. The questions remained to be answered are: Which
specific enzyme is expressed in smooth muscle? If expressed, how is the activity of this enzyme
regulated to generate H2S? Do smooth muscle cells have a target for H2S? And what is the
mechanism of action of H2S in smooth muscle? Our aims in the present study are to: i) identify
the expression of enzymes in isolated muscle cells, ii) determine the effects of endogenously
released and exogenously applied H2S on smooth muscle function; and iii) identify the targets and
mechanism involved in mediating the effects of H2S using muscle strips and isolated muscle cells
from colon.
The important findings of our study are summarized as follows: i) transcripts of the H2Ssynthesizing enzymes CSE, but not CBS, have been detected in isolated muscle cells, where it is
responsible for H2S production; ii) L-cysteine (activator of CSE) and NaHS (H2S donor) inhibited
carbachol-induced contraction in muscle strips and isolated muscle cells in a concentrationdependent manner: inhibition was blocked by a selective inhibitor of CSE (DL-PPG), but not by
selective inhibitors of KATP channels (glibenclamide), PKA (myristoylated PKI) or PKG (RpcGMPS); iii) L-cysteine or NaHS caused S-sulfhydration of RhoA leading to inhibition of RhoA
and Rho kinase activities: inhibition was blocked by DL-PPG or CSE siRNA; iv) L-cysteine and
NaHS inhibited NO-stimulated PDE5 activity leading to augmentation of NO-induced cGMP
formation and muscle relaxation; v) SNP (NO donor) and 8-Br-cGMP (cGMP analogue) caused
an increase in H2S production: increase in H2S production was blocked by DL-PPG and a selective
PKG inhibitor (Rp-cGMPS); vi) SNP induced phosphorylation of CSE which was blocked by the
PKG inhibitor, Rp-cGMPS.
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7.1 Expression of CSE
Expression of CSE and CBS are tissue- and species-specific. Both enzymes are localized
in the cytosol [153, 157]. In the GI tract, H2S-synthesizing enzymes have been shown to be
expressed by enteric neurons, ICCs and epithelial cells [55, 57, 166, 150]. Expression of CBS and
CSE is tissue-specific [57, 150]. Both CBS and CSE are expressed in the epithelium of rat colon
[139] and the enteric neurons of mouse, guinea pig and human [55, 57]. Expression of CSE in the
guinea pig colon [55] and lack of expression of both CSE and CBS [76] in the ICCs of mouse
small intestine was reported. Studies by Linden et al [57] showed intense immunoreactivity for
CSE, but not for CBS, in the cell bodies of mouse myenteric neurons and submucosal neurons.
The absence of CBS immunoreactivity in the enteric neurons of mouse colon is at variance with
the reports of its expression from the guinea pig and human [55] and may reflect species
differences. Our studies using mRNA from cultured muscle cells devoid of enteric neurons and
ICCs clearly demonstrated mRNA expression of CSE, but not CBS, in smooth muscle. This was
further corroborated by western blot analysis demonstrating the expression of CSE protein in
homogenates prepared from dispersed smooth muscle cells. Control studies demonstrated
expression of CBS in homogenates prepared from mouse brain. This is in agreement with the
previous reports that CBS expression is abundant in central nervous system, and rare in peripheral
system such as cardiovascular and respiratory systems, testes, spleen and adrenals [115]. In
contrast, CSE is abundantly expressed in cardiovascular and respiratory systems, and liver, kidney,
uterus and pancreatic islets [115]. Expression of CSE in muscle cells is also consistent with our
studies on the production of H2S and biochemical and functional studies in response to L-cysteine.
L-cysteine induced production of H2S was blocked by a selective CSE inhibitor, DL-PPG.
Inhibition of CCh-induced RhoA and Rho kinase activities and smooth muscle contraction by Lcysteine was also blocked by DL-PPG as well as by suppression of CSE expression by CSE
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siRNA. These studies demonstrate a functional role of smooth muscle CSE in the generation of
H2S and inhibition of muscle contraction.

7.2 Inhibition of smooth muscle contraction by H2S: mechanism of action
L-Cysteine and/or NaHS were commonly used in vivo and in vitro, in whole organ and
nerve-muscle preparation, to study the physiological significance of H2S in the regulation of GI
motility. Although H2S inhibits contractions, as discussed above, there are considerable
differences in the mechanism of action. Interpretation of results was also confounded by the
multiple cells types present in the tissue preparation used in these experiments. Our studies showed
that both endogenous H2S, generated via CSE, and exogenous H2S inhibits CCh-induced sustained
contraction in muscle strips and isolated muscle cells. These results clearly establish the direct
effect of both endogenous and exogenous H2S on muscle cells devoid of the enteric neurons and
the ICCs. In both muscle strips and isolated muscle cells, L-cysteine and NaHS are effective at
µM and mM concentrations. In virtually all in vitro studies, a tissue bath H2S concentration of
high µM (100 µM) or mM has been required to produce significant effect [56, 71, 72]. These
concentrations have been considered to be physiologic, as several reports suggest that the tissue
H2S concentration normally range from high μM to low mM range (30 µM - >100 µM) [151]. The
free H2S concentrations in GI smooth muscle and the significance of H2S at low µM concentration
as a messenger molecule are yet to be determined. Our studies also showed that the inhibitory
effect of H2S is independent of KATP channels, a known target of H2S. H2S, unlike NO and CO,
does not affect soluble guanylyl cyclase (sGC) activity [124]. L-cysteine and NaHS had no effect
on cAMP or cGMP. Our recent studies demonstrated that the inhibitory effect of L-cysteine and
NaHS on gastric muscle contraction was not affected by inhibitors of nitric oxide synthase or
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soluble guanylyl cyclase in both muscle strips and isolated muscle cells [39]. These results suggest
a distinct cAMP/PKA-and cGMP/PKG-independent mechanism in the inhibition of contraction.
In the present study, we have identified RhoA as S-sulfhydration target of H2S in mediating
the inhibitory effect on muscle contraction. S-sulfhydration provides a possible mechanism by
which H2S alters the function of proteins and this post-translational modification appears akin to
S-nitrosylation of proteins by NO [87, 152]. During S-sulfhydration, cysteine -SH groups are
covalently modified to hydropersulfide (-SSH groups) resulting in altered function of proteins. In
GI smooth muscle, activation of RhoA by contractile agonists causes sustained contraction via
Rho kinase-mediated phosphorylation of MYPT1, the regulatory subunit of MLCP, and inhibition
of MLC phosphatase; the latter leads to an increase in MLC20 phosphorylation and muscle
contraction [78]. H2S exerts an inhibitory effect on RhoA activity. This leads to inhibition of Rho
kinase activity and disinhibition of Rho kinase mediated MLCP activity, augmentation of MLC 20
dephosphorylation and inhibition of sustained contraction. Evidence for the activation of CSE in
mediating the effect of L-cysteine was based on the use of DL-PPG in dispersed muscle cells and
CSE siRNA in cultured muscle cells. Inhibition of CSE, to reduce H2S generation, by DL-PPG,
reversed the effect of L-cysteine on RhoA and Rho kinase activities and sustained contraction.
Suppression of CSE expression by siRNA also blocked the effect of L-cysteine on Rho kinase
activity providing strong evidence that H2S generated via CSE may be responsible for L-cysteineinduced inhibitory effects. Based on these results we conclude that both endogenous and
exogenous H2S inhibit muscle contraction, and the mechanism involves inhibition of RhoA/Rho
kinase pathway, leading to stimulation of MLCP activity and MLC20 dephosphorylation and
inhibition of muscle contraction (Figure 7A).
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7.3 Augmentation of smooth muscle relaxation by H2S: mechanism of action
It is known that relaxation of smooth muscle in the gastrointestinal tract is initiated by the
synthesis of NO by neuronal NO synthase (nNOS) [78]. NO diffuses through the smooth muscle
cells and stimulates sGC activity, cGMP formation and PKG activity. Activation of PKG results
in the inhibition of Ca2+ mobilization and MLCK activity, and stimulation of MLCP activity
leading to MLC20 dephosphorylation, an essential step in smooth muscle relaxation [78]. The
levels of cGMP in gastrointestinal smooth muscle are well controlled by the balance between its
synthesis by sGC and degradation by PDE5. Expression of PDE5 is abundant in smooth muscle
[106, 107]. Rapid and efficient degradation of cGMP by cGMP-specific PDE5 plays an important
role in the regulation of intracellular cGMP levels and rapid termination of relaxation in smooth
muscle [108]. PDE5 activity is regulated by an increase in cGMP levels. PDE5 is a dimer
containing two allosteric cGMP-binding sites in its regulatory N-terminal domain and a specific
cGMP-binding site in its catalytic C-terminal domain that hydrolyses cGMP [108]. An increase in
cGMP levels not only stimulates PKG, but also augments PDE5 activity by allosteric activation
via binding to its regulatory N-terminal domain, and also by PKG-mediated phosphorylation of
PDE5 at a conserved serine residue in the N-terminal region.
In recent studies, H2S and NO have been reported to interact through a number of
mechanisms. H2S can regulate generation of NO in the mouse colon [143] and also regulate the
availability of NO by increasing its release from nitrosothiols [144]. Studies have shown that H2S
augments NO signal by regulating cGMP levels. In aortic smooth muscle cells, overexpression of
CSE increased intracellular cGMP levels, whereas suppression of CSE expression decreased
cGMP levels [110]. These studies suggest a role for endogenous H2S in the regulation of cGMP
levels. Relaxation in response to H2S was not affected by the sGC inhibitor, ODQ in rat aorta
[109, 111] suggesting that the effects of H2S are independent of sGC activation. A similar
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conclusion was based on our results showing that H2S had no effect on cGMP levels. In these
experiments, cGMP levels were measured in the presence of IBMX to eliminate the effect of H2S
on PDE5. NaHS was shown to inhibit purified PDE5 activity as effectively as the known PDE5
inhibitor, sildenafil [106, 110]. Our studies in colonic smooth muscle showed that H2S augments
NO-induced smooth muscle relaxation. We also provide evidence that H2S inhibits PDE5 activity
to cause augmentation of NO-induced increase in cGMP levels and smooth muscle relaxation
(Figure 7B). Both L-cysteine and NaHS inhibited NO-stimulated PDE5 activity and augmented
cGMP levels when measured in the absence PDE inhibitor, IBMX. The exact mechanism by which
H2S inhibits PDE5 activity awaits further studies. Our results suggest that H2S can augment cGMP
levels upon concurrent release of NO, NO-induced activation of sGC and generation of cGMP.

7.4 Activation of CSE by NO: mechanism of action
H2S is generated by several cell types in mammals. Linden et al [57] reported for the first
time the ability of mouse colon to generate and release H2S supporting a role for H2S as an
endogenous signaling molecule in GI tract. The physiological signal and the mechanism of
activation of CSE to release endogenous H2S is not known. Studies by Zhao et al [65] reported
that NO increased H2S generation in vascular tissue and it was speculated that activation could be
either due to phosphorylation of CSE by PKG, direct effect of NO on CSE protein, or upregulation
of CSE expression. Prolonged incubation (6 hours) of vascular smooth muscle cells with NO donor
was shown to increase expression of CSE [65]. Bucci et al [71] have shown that L-cysteineinduced relaxation in aorta was reduced in PKG-I null mice suggesting that the effect of L-cysteine
is partly mediated via activation of cGMP/PKG pathway. These studies did not address whether
the effect of PKG is due to activation of CSE.
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Our studies provide evidence for the synthesis of H2S in smooth muscle from different
regions (stomach and colon) and different species (rabbit and human) by L-cysteine and by an NO
donor, SNP. The effect of L-cysteine and SNP was blocked by CSE inhibitor (DL-PPG) suggesting
that H2S production was enzymatic. Our studies also identified that NO generates H2S via
cGMP/PKG pathway. This was based on results of blockade of GMP-induced H2S production by
a selective PKG inhibitor and direct phosphorylation of CSE by PKG-Iα. The physiological
relevance of the CSE/H2S pathway activated by NO was evident from the partial inhibition of NOmediated relaxation by the CSE inhibitor. Our studies show that there is a novel interplay between
NO and H2S. NO generates H2S via cGMP/PKG pathway and H2S, in turn, inhibits PDE5 activity
and augments NO-induced cGMP levels. Thus, H2S promotes NO function via inhibition of PDE5
activity, and its own synthesis, via cGMP/PKG pathway (Figure 7B).

Conclusion
Our studies have identified the selective expression of CSE in colonic smooth muscle and
demonstrated that both exogenous and endogenous H2S inhibit muscle contraction and augment
muscle relaxation. Inhibition of contraction is mediated via S-sulfhydration of RhoA and inhibition
of RhoA/Rho kinase pathway. Augmentation of relaxation is mediated via inhibition of PDE5
activity and stimulation of cGMP/PKG pathway, which in addition initiates generation of H2S via
PKG-mediated phosphorylation and activation of CSE.
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Figure 7A

Figure 7A. Inhibition of contraction by H2S: mechanism of action. In colonic smooth muscle
sustained contraction is mediated via activation of RhoA/Rho kinase pathway. Rho kinase
phosphorylates MYPT1, the targeting subunit of MLCP, leading to decrease in MLCP activity and
increase in MLC20 phosphorylation and sustained muscle contraction. H2S synthesized from Lcysteine via cystathionine--lyase (CSE) inhibits agonist-induced stimulation of RhoA activity,
via S-sulfhydration of RhoA, leading to decrease in Rho kinase activity. Inhibition of Rho kinase
activity prevents phosphorylation MYPT1 leading to stimulation of MLCP activity and MLC 20
dephosphorylation, and inhibition of muscle contraction.
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Figure 7B

Figure 7B. Interplay between NO and H2S in colonic smooth muscle. In colonic smooth
muscle, relaxation in response to nitric oxide (NO) is mediated via stimulation of soluble guanylyl
cyclase (sGC) activity, cGMP generation and cGMP-dependent protein kinase activity. PKG
phosphorylates various targets in the contractile pathway to decrease intracellular Ca2+ and/or
increase MLCP activity, key requirements in muscle relaxation. Stimulation of PKG, in addition,
phosphorylates CSE and stimulates the synthesis of H2S, which in turn, inhibits PDE5 activity and
augments cGMP/PKG pathway.
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